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“As we train our senses and focus our disciplined imaginations on 
the vastness of space it seems to me that we are missing something 
close to home. There is more than the contempt of familiarity in the 
extraordinary circumstance that, in our eagerness to learn of life far 
beyond earth, we overlook the life on our own surface - on the surface 
of man himself.” 
               -  Theodor Rosebury, Life On Man, 1969. 
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THESIS ABSTRACT 
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The ability to adapt to and respond to increases in external osmolarity is 
an important characteristic that enables bacteria to survive and proliferate in 
different environmental niches. When challenged with increased osmolarity, due 
to sodium chloride (NaCl) for example, bacteria elicit a phased response; firstly 
via uptake of potassium (K+), which is known as the primary response. This 
primary response is followed by the secondary response which is characterised 
by the synthesis or uptake of compatible solutes (osmoprotectants). The overall 
osmotic stress response is much broader however, involving many diverse 
cellular systems and processes. These ancillary mechanisms are arguably more 
interesting and give a more complete view of the osmotic stress response. The 
aim of this thesis was to identify novel genetic loci from the human gut 
microbiota that confer increased tolerance to osmotic stress using a functional 
metagenomic approach. Functional metagenomics is a powerful tool that 
enables the identification of novel genes from as yet uncultured bacteria from 
diverse environments through cloning, heterologous expression and phenotypic 
identification of a desired trait. Functional metagenomics does not rely on any 
previous sequence information to known genes and can therefore enable the 
discovery of completely novel genes and assign functions to new or known 
genes.  
 Using a functional metagenomic approach, we have assigned a novel 
function to previously annotated genes; murB, mazG and galE, as well as a 
putative brp/blh family beta-carotene 15,15’-monooxygenase. Finally, we report 
the identification of a completely novel salt tolerance determinant with no current 
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known homologues in the databases. Overall the genes identified originate from 
diverse taxonomic and phylogenetic groups commonly found in the human 
gastrointestinal (GI) tract, such as Collinsella and Eggerthella, Akkermansia and 
Bacteroides from the phyla Actinobacteria, Verrucomicrobia and Bacteroidetes, 
respectively. In addition, a number of the genes appear to have been acquired 
via lateral gene transfer and/or encoded on a prophage. To our knowledge, this 
thesis represents the first investigation to identify novel genes from the human 
gut microbiota involved in the bacterial osmotic stress response. 
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Metagenomics and Novel Gene Discovery: 
Promise and Potential for Novel Therapeutics 
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Abstract  
Metagenomics provides a means of assessing the total genetic pool of all 
the microbes in a particular environment, in a culture-independent manner. It 
has revealed unprecedented diversity in microbial community composition, 
which is further reflected in the encoded functional diversity of the genomes, a 
large proportion of which consist of novel genes. Herein, we review both 
sequence-based and functional metagenomic methods to uncover novel genes 
and outline some of the associated problems of each type of approach, as well 
as potential solutions. Furthermore, we discuss the potential for metagenomic 
bio-therapeutic discovery, with a particular focus on the human gut microbiome 
and finally, we outline how the discovery of novel genes may be used to create 
bio-engineered probiotics. 
 
Keywords: metagenomics, functional metagenomics, novel gene discovery, gut 
microbiome, microbiota, bio-therapeutics, meta-biotechnology, bio-engineered 
probiotics 
 
Abbreviations: DNA, deoxyribonucleic acid; bp, base pair; NGS, next 
generation sequencing; ATP, adenosine triphosphate; Gb, gigabase; CAZyme, 
carbohydrate-active enzyme; ORF, open reading frame; NCBI, National Centre 
for Biotechnology Information; PCR, polymerase chain reaction; PKS, polyketide 
synthase; KSβ, ketosynthase beta/ chain length factor; MRSA, methicillin-
resistant Staphylococcus aureus; VRE, vancomycin-resistant Enterococcus; 
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NRPS, non-ribosomal peptide synthetase; MHT, methyl halide transferase; 
HGT, horizontal gene transfer; TRACA, transposon-aided capture; 59-be, 59-
base element; HMP, Human Microbiome Project; SSH, suppressive subtractive 
hybridisation; BAC, bacterial artificial chromosome; RBS, ribosome binding site; 
GFP, green fluorescent protein; Mb, megabases;  SAM protein, S’-
adenosylmethionine protein; MetaHit, Metagenomics of the Human Intestinal 
Tract; IBD, inflammatory bowel disease; STEC, shigatoxigenic-E. coli; ETEC, 
enterotoxigenic-E. coli; LPS, lipopolysaccharide; HIV, human immunodeficiency 
virus; CLA, conjugated linoleic acid; EGF, epidermal growth factor; CFU, colony 
forming unit; BSH, bile salt hydrolase; GABA, gamma-aminobutyric acid; GMO, 
genetically-modified organism; IL-10, interleukin 10. 
 
Introduction 
Metagenomics is a term that describes both a field of scientific research 
and a set of techniques that enables the culture-independent analysis of a 
microbial community in any environmental sample.1 The field has grown 
exponentially in the last ten to fifteen years, allowing researchers unparalleled 
access to the “uncultured majority”2 of our microbial counterparts in our 
environments and closer to home, on and in our own bodies. This review aims 
to provide a concise overview of the principal methods of metagenomic analysis 
and how metagenomics can be used for the discovery of novel genetic loci. We 
will also discuss the potential uses of such genes for the creation of bio-
engineered probiotics, as well as the potential for the discovery of novel bio-
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therapeutics for human medicine. A wealth of information has been gained in 
the relatively short history of metagenomics and thus, it is timely to discuss the 
future directions of this ever expanding field of research.  
 It has been estimated that there are more than 1030 microbial cells on 
Earth; nine orders of magnitude greater than the number of known stars in the 
universe.3, 4 It is estimated that a large proportion of microbes in many 
environments are, as yet, uncultured5, while cultured prokaryotic representatives 
are overwhelmingly from just four phyla; the Actinobacteria, Bacteroidetes, 
Firmicutes and Proteobacteria.6, 7 Metagenomics provides a means to access, 
characterise and quantify this untapped diversity of microbes and discover novel 
genes, metabolic pathways and important products with biotechnological, 
pharmaceutical and medical relevance. 
 Metagenomic analysis can take a sequence-based or a functional 
approach (or a combination of both) to study a complex microbial community, 
but always begins with the isolation of DNA from the environment of interest. 
 
Sample DNA isolation 
 Careful and considered isolation of total metagenomic DNA is the key 
step to ensure the sample obtained is truly representative of the community as a 
whole and is of high-quality, high-purity and as unbiased as possible. Due to the 
obvious heterogeneity of environmental samples it is difficult to lyse cells of all 
species with equal efficacy. Harsh lysis methods may result in physical damage 
to DNA, whilst a more gentle approach is likely to result in an under-
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representation of DNA from more difficult to lyse Gram-positive and archaeal 
members of the community.8 This is a particular issue with regard to recovery of 
DNA from low abundance species.  
Different methods can be used to access the DNA, such as one or a 
combination of mechanical, enzymatic, chemical or temperature-based cell 
lysis. Extraction can either be direct or indirect. Direct extraction is carried out 
from the environmental sample of interest by cell lysis and subsequent 
separation of the DNA from sample particles and cell debris9, while indirect 
extraction first involves the separation of cells from the environmental sample 
followed by subsequent lysis.10, 11 There are numerous methods to extract 
metagenomic DNA that have been optimised to suit the nature of the particular 
sample in question and which take into consideration the physico-chemical 
conditions, microbial make-up and origin of the environmental sample.11-14 For 
example, Salonen and co-workers14 compared four different methods of 
metagenomic DNA extraction from a human faecal sample and found that the 
average DNA yield varied from approximately 40µg to 1000µg, depending on 
the method used, while variations of 10-20 fold between methods were 
observed for yields of archaeal DNA. Two methods were studied in further detail 
and a method using repeated bead-beating and sequential precipitation steps 
was deemed most suitable. Despite a lower initial DNA yield, it was noted that 
the effectiveness of cell breakage was the main factor affecting the final 
microbial composition and level of diversity.14  
 
 
 
9 
 
STRATEGIES TO IDENTIFY NOVEL GENES 
Sequence-based metagenomics 
Traditional metagenomic sequencing relied upon Sanger sequencing, 
which produces relatively long reads of greater than 700 base pairs (bp) with a 
low error rate.15 However, the development of next-generation sequencing 
(NGS) technologies coupled with significant reductions in sequencing costs has 
resulted in a movement away from Sanger sequencing as the gold standard, 
primarily due to the relative high cost and intensive cloning required by this 
approach compared to NGS methods such as 454 and Illumina. One of the first 
large scale metagenomic projects employed Sanger sequencing to characterise 
the microbial population of the Sargasso Sea.13 Over 1 billion bp of DNA was 
sequenced and more than 1.2 million novel genes identified, including over 700 
that encoded bacterial rhodopsin proteins (proteorhodopsins). Proteorhodopsins 
are retinal-binding membrane proteins that function as light-activated proton 
pumps. At the time, proteorhodopsins had been recently discovered in bacteria 
using metagenomics and were previously thought to exist only in halophilic 
archaea (bacteriorhodopsins).16 This discovery prompted a major rethink about 
carbon and energy flux in the world’s oceans, as it became apparent that 
bacteria were able to harness light energy to generate ATP non-
photosynthetically.17   
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Next generation sequencing (NGS) technologies 
Ever improving sequencing technologies coupled with dramatically 
decreasing costs means that a “sequence everything” approach can be applied 
to diverse environmental samples, followed by assembly and annotation to gain 
a comprehensive picture of the abundance and encoded functional potential of 
the microbial community members. Some of the most widely used NGS 
platforms include the GS-FLX 454 pyrosequencer (Roche), MiSeq, HiSeq and 
Genome Analyser II platforms (Illumina), SOLiD system (Life Technologies/ 
Applied Biosystems), Ion Torrent and Ion Proton (Life Technologies) and the 
PacBio RS II (Pacific Biosciences). For detailed information and technical 
aspects of these technologies the reader is directed to comprehensive reviews 
elsewhere.18-21 
Large-scale sequencing projects employing such technologies generate 
huge datasets that can consist of millions of gene sequences, and owing to the 
nature of metagenomes, a large proportion of these will be novel, but with no 
known function. This initial, untargeted sequencing approach can subsequently 
be used in combination with a more targeted approach which aims to identify a 
specific type of gene or gene family.  It should be noted that we mean 
untargeted in relation to identifying specific genes initially, but focused rather on 
the overall community composition, phylogeny and/ or functional capacity. In 
addition, metagenome sequencing using NGS technologies followed by 
annotation, homology searches and phylogenetic clustering will uncover genes 
that are more divergent and more interesting than the consensus genes with 
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known sequences used to design probes or primers for initial gene-focused 
studies.22 For example, Hess and co-workers sequenced 286 gigabytes (Gb) of 
cow rumen metagenomic DNA using Illumina GAIIx and HiSeq 2000 platforms. 
They then searched for carbohydrate active enzyme (CAZymes) sequences 
bioinformatically and minimised the dependence on known CAZyme sequences 
by searching for individual functional domains of such enzymes rather than 
overall sequence similarity. This approach revealed 27,755 potential candidate 
genes from over 2.5 million predicted open reading frames (ORFs). Interestingly 
24% of the genes were most similar to “hypothetical proteins” or “predicted 
proteins” in the non-redundant NCBI database. The sheer volume of candidate 
genes identified and the novelty of many sequences validates the initial high-
throughput bioinformatic search. A sub-group of genes were subsequently 
amplified by PCR and the activity of their encoded proteins was assessed 
through functional heterologous expression.23 
 
Gene targeting or Meta-gene analysis 
Identification of novel genes for particular gene families or enzyme 
classes can be achieved by using DNA probes or PCR. Firstly a multiple 
sequence alignment of many sequences of the type of gene of interest is 
generated to identify the most conserved regions. Consensus primers are then 
designed and used to amplify target sequences from isolated metagenomic 
DNA. Subsequently, gene-specific primers can be designed and genome-
walking can be carried out to retrieve the full gene sequence and those of 
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neighbouring genes if desired.24 This method is effective as large libraries do 
not need to be constructed and screened and novel genes can be identified 
irrespective of gene expression, which is a major hurdle to function-based 
screening (discussed later). Furthermore, full-length sequences are not required 
to identify genes initially, although they will have to be determined at a later 
stage.25 This approach suffers from bias due to primer and probe design being 
limited to known sequences of similar gene family members as well as 
prejudices due to over-representation of dominant species in the metagenomic 
library. This will lead to PCR bias and less chance of amplification of genes from 
less abundant community members. Furthermore, it is unlikely that functionally 
homologous genes that have arisen due to convergent evolution will be 
identified.26 While a significant limitation of this approach is its inability to 
uncover completely novel, non-homologous genes, this approach has 
nonetheless been used successfully to identify genes that encode 
biotechnologically and industrially relevant enzymes such as esterases, lipases 
and oxidoreductases.9, 27, 28  
Of therapeutic relevance, a number of sequence-based screens have 
focused on identifying novel antimicrobial compounds. Type I and type II 
polyketide synthases (PKS) which are encoded on operons for biosynthesis of 
antibiotics and anti-cancer compounds are often the target genes. In one study, 
a soil metagenomic library was screened by PCR for type I PKS genes using 
primers that target regions flanking the highly conserved active site of the 
ketoacyl synthetase domain. Eleven novel type I PKS sequences were 
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identified, with amino acid identity to known sequences ranging from 46-61%.29 
Feng and co-workers used degenerate primers to amplify ketosynthase beta 
chain length factor (KSβ) genes from a metagenomic library and used the 
amplicons as probes to identify PKS containing clones. Functional analysis of 
the clones revealed both known and unknown antimicrobial compounds, some 
of which had potent activity against methicillin-resistant Staphylococcus aureus 
(MRSA) and vancomycin resistant Enterococcus (VRE).30 In a recent extensive 
study, conserved domains within non-ribosomal peptide synthetase (NRPS) and 
PKS genes were used as targets to screen a >15 million member cosmid mega-
library. Multiplex sequencing of PCR products, followed by clustering and 
BLAST analyses to identify sequences of most interest, revealed 18 gene 
clusters predicted to encode novel glycopeptide- and lipopeptide-like antibiotics, 
as well as anti-cancer and immunosuppressive compounds.31 A PCR based 
approach was used to identify genes encoding OxyC enzymes, which are often 
found on biosynthetic gene clusters for glycopeptide antibiotics such as 
vancomycin and teicoplanin. In a twist on the previous examples, modifying 
enzymes found on these gene clusters were used to create 15 new sulphated 
glycopeptide antibiotic derivatives.32, 33 Development of analogues, which could 
substitute for last-line antibiotics such as vancomycin, is an important research 
finding. Finally, Iwai et al, used a number of sets of degenerate primers for PCR, 
coupled with 454 pyrosequencing to identify genes encoding aromatic 
dioxygenases. This approach provides a more comprehensive view of the 
diversity of sequences present in the environment and this sequence 
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information can be used to design probes to recover full-length genes 
subsequently.34  
 
Data mining and “synthetic metagenomics” 
 An innovative approach to identify novel genes has been described in 
recent years, which involves mining existing sequence databases and/ or 
metagenomic datasets for sequences of interest, followed by chemical synthesis 
of selected genes.35 The authors name this process “synthetic metagenomics” 
and successfully applied it to identify novel methyl halide transferase (MHT) 
enzymes, which are important in agriculture and industrial applications for more 
efficient production of biofuels. Eighty nine putative MHTs were identified, with 
amino acid identities to a known MHT as low as 18% and an average of 28% 
amino acid identity between sequences. The genes included 61 bacterial, 13 
fungal, 1 archaeal and 14 from plants. The genes were codon optimised for 
heterologous expression in Escherichia coli and yeast cells and then chemically 
synthesised. Only 6% of the synthesised genes showed no MHT activity, which 
is remarkable considering only one was actually annotated as a MHT and only 
55% were annotated as generic methyltransferases.35 A similar study has also 
applied this approach to glycoside hydrolases.36  Both demonstrate the utility of 
“synthetic metagenomics”, which of course could be applied to any gene of 
interest. 
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Plasmid and integron capture 
 Horizontal gene transfer (HGT), mediated by mobile genetic elements 
such as plasmids and integrons play a crucial role in bacterial evolution, 
adaptation and survival.37 Plasmids are likely to contain genes necessary for 
niche colonisation and encode functions important in that environment. 
Furthermore, genes encoding antibiotic resistance, virulence and antimicrobial 
production can often be found on plasmids.  Developed to capture plasmids 
from the human gut mobile metagenome, the TRACA (transposon-aided 
capture) method identified a number of novel plasmids of both Gram-positive 
and Gram-negative origin.38, 39 TRACA could be applied to any environment 
once sufficient quantities of DNA can be isolated and would provide a valuable 
means to identify novel mobile genes within specific environments. Indeed, 
TRACA has been recently used to identify plasmids from bacteria in the human 
oral cavity and activated sludge.40, 41 
 Integrons are gene recombination and expression systems. They encode 
an integrase protein and contain a integration site (attI) to capture genes from 
what are known as mobile gene cassettes which contain a conserved site-
specific recombination sequence called a 59-be (base element).42 By targeting 
conserved sequences associated with integron-gene cassettes using PCR one 
can retrieve full-length, novel genes from metagenomes in the absence of any 
other sequence information.43 The overwhelming majority of integron-associated 
genes lack known homologues or cannot be assigned a function. A recent study 
found that 85% of Treponema-associated integron genes from the Human 
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Microbiome Project (HMP) dataset were of unknown function.44 Furthermore, 
proteins with novel structure and folds have been identified among integron-
gene cassettes which belong to as yet uncharacterised protein families.45  
 
Suppressive Subtractive hybridisation 
 Suppressive subtractive hybridisation (SSH) is a PCR-based approach 
that can be used to compare and identify differences in the genomes of closely 
related bacterial species or differentially expressed mRNA transcripts within a 
cell.46, 47 Differences between “driver” (control) and “tester” sequences are 
highlighted by the removal of sequences or transcripts of similar abundance. 
This approach has been used to identify novel sequences from complex 
metagenomic samples. Ninety-six bacterial and archaeal DNA fragments were 
identified from a rumen metagenome using this approach, of which 39 had no 
significant similarity to any database sequences.48  
 More recently, SSH has been adapted to recover full-length, novel genes 
from metagenomes.49 Degenerate primers are first used to generate multiple 
target-gene amplicons (“driver DNA”), which are then used as hybridisation 
probes to capture full-length genes. “Driver DNA” is biotinylated and immobilised 
on streptavidin-coated magnetic beads. Metagenomic DNA (“tester DNA”) is 
then added to the coated beads to capture full-length genes of interest. This 
approach has greater specificity and less non-specific amplification compared to 
other PCR-based techniques, but does require the creation of a genomic DNA 
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library. Nevertheless, this approach can retrieve numerous gene targets in a 
single reaction.49  
 
Functional metagenomics 
 The second main area of metagenomic analysis is functional 
metagenomics. The oft-stated, broad aims of metagenomic analyses are to 
discover “who is there?” and “what are they doing?” Large scale NGS projects 
can tell us about the former, but is limited with regard to the latter, due to the 
dependence on known sequences already in the databases. Functional 
metagenomics on the other hand suffers no such reliance on previous sequence 
information and is a powerful approach with the potential to discover new 
functions for known genes and also, completely novel genes, gene families and 
their encoded proteins.  
 Functional metagenomics requires the creation of a metagenomic library 
containing fragments of community metagenomic DNA. The process follows the 
same general steps for the creation of a genomic DNA library; enzymatic 
digestion or random shearing of DNA, ligation to a suitable vector and 
transformation to a heterologous host.50 One of the biggest technical challenges 
is constructing a library with sufficient coverage of the community metagenome 
and requires an extremely large number of clones, especially for complex 
environments. This is compounded further when one considers a library would 
need to contain 100- to 1,000-fold coverage in order to possess a significant 
proportion of clones carrying sequences form rare (<1%) community species.51 
 
 
18 
 
Nonetheless, it is achievable; cosmid megalibraries have been created from soil 
which contain >1.5 x 107 unique clones. At clone densities such as this, it is 
believed the library approaches saturation.31  
 
Insert size and vector 
 Two types of library can be constructed depending on the type of screen 
to be performed and the desired library size. Libraries can be small-insert 
libraries, created using plasmids and containing inserts of <10kb, or large-insert 
libraries, created using fosmid (25-45kb inserts) or cosmid (15-40kb inserts) 
vectors or BAC (bacterial artificial chromosome; 100-200kb inserts) vectors.52 
Small insert libraries are maintained on high copy number plasmids with strong 
promoters, which are usually used in activity screens where a single gene is 
responsible for the activity. Large insert libraries are suitable for the 
identification of multi-gene encoded products, operons and entire biochemical 
pathways and usually utilise low-copy number or inducible vectors. Inducible 
vectors are advantageous in that the library may be stably maintained at low 
copy, but can be induced to high-copy for downstream applications such as 
transposon mutagenesis, as well as DNA extraction, cloning and sequencing. 
Large inserts also facilitate gene neighbourhood analysis and increase the 
probability of phylogenetic and taxonomic assignment of sequences.53, 54 
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Cloning host 
 To date, E. coli has been the cloning host of choice for the vast majority 
of metagenomic projects. E. coli possesses a number of desirable attributes that 
make it the host of choice; in depth knowledge of its physiology and 
biochemistry following decades of intensive research being primary among 
them. Furthermore, E. coli, (i) has a high transformation efficiency, (ii) is 
somewhat promiscuous with regard to the diversity of foreign expression signals 
it recognises, (iii) lacks genes for restriction modification and homologous 
recombination, and (iv) is capable of translating mRNA with diverse translation 
signals because the normal translational dependency on the degree of 
complementarity of the 3’ terminus of the 16S RNA and the Shine-Dalgarno 
sequence, is not as strict in E. coli, which is more promiscuous with regard to 
complementary sequences recognised.55, 56 Despite these advantages, E. coli, 
like any expression host, is unable to express all foreign DNA due to differences 
in the transcriptional, translational and post-translational machinery of the 
originating organism. For example, cis-acting factors such as a promoter and a 
ribosome binding site (RBS) compatible with the host machinery, as well as 
factors that may need to be supplied in trans by the host cell, such as 
chaperones, transcription factors or a compatible secretion system, are all 
potentially negative effectors of efficient expression. 
 Mathematical formulae have been developed to predict the chance of a 
given gene of interest being expressed in E. coli. Thirty-two sequenced bacterial 
genomes from three different phyla (Actinobacteria, Firmicutes and 
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Proteobacteria), as well as 10 Archaeal genomes were used in the analysis. 
Approximately 40% of genes in total were predicted to be functional in E. coli, 
but this ranged from 7% of Actinobacterial genes, to 73% of genes from 
Firmicutes.57  
 
Hit rates  
 The hit rates (i.e. the chances of identifying a gene of interest through 
functional metagenomic expression) are traditionally quite low and can vary 
widely. Several factors influence the hit rate such as the source of the 
metagenomic DNA, the size of the gene of interest, its abundance in the 
metagenome and consequently the library, the vector system and host of 
choice, the screen itself and the ability of the host to successfully express the 
gene.58  Hit rates have been shown to range from one positive hit per 2.7 
megabases (Mb) of DNA screened to one per 3979.5 Mb.58-60 
 
Strategies to improve heterologous expression 
(a) Alternative or dual hosts 
The use of different cloning hosts or the use of one host to maintain the 
library followed by transfer of the library to a different host (usually from a 
different Phylum or genera) for screening have been shown to be successful, 
whist demonstrating the “different host, different hit” effect.55 Considering the 
environment of study in choosing a suitable host can increase the success of a 
functional metagenomic screen. Streptomyces species are commonly found in 
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soil, are genetically amenable and produce a diverse range of medically 
relevant secondary metabolites such as antibiotics. Thus, numerous studies 
have employed Streptomyces species as screening hosts. McMahon and co-
workers modified an integrative E. coli -Streptomyces cosmid vector to increase 
its recoverability and used it to create a cosmid metagenomic library. Initially the 
library was created in E. coli and then transferred via conjugation to a 
Streptomyces lividans mutant strain, which was defective in pigmented antibiotic 
production (increasing the ability to identify active clones). Screens for 
haemolytic activity and the production of secondary metabolites and pigments 
identified twelve biologically active clones due to functional expression of 
metagenomic DNA. The key observation however, is that none of the 
phenotypes were detectable in E. coli, demonstrating the utility of using a 
different host system.61 A functional metagenomic screen to identify antibiotic 
production, altered colony morphology and pigmentation identified a number of 
clones expressing the desired traits using a cosmid library maintained in six 
different Proteobacterial hosts (E.coli, Pseudomonas putida, Burkholderia 
graminis, Caulobacter vibrioides, Ralstonia metallidurans and Agrobacterium 
tumefaciens). Interestingly, there was little overlap between the active clones, 
revealing substantial inter-Phylum variations in gene expression, even among 
more closely related species.62 Other alternative hosts include Bacillus subtilis, 
Rhizobium leguminosarum and a dual E. coli - Thermus thermophilus system for 
screening extremophilic microorganisms.63-65 Development of different hosts 
and molecular tools to make them genetically malleable will expand the 
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repertoire and diversity of novel genes that can be recognised and 
heterologously expressed. 
 
(b) Modified vectors 
The use of alternative hosts is often coupled with the use or creation of 
novel expression vectors that can function in multiple hosts or maximise the 
chances of expression in said hosts. One example of a broad host-range fosmid 
and BAC vector is pRS44. Created for metagenomic screening, pRS44 contains 
two origins of replication, can be induced from low to high-copy with L-arabinose 
and contains an origin of transfer to allow conjugation to additional hosts, as 
well as a stabilisation element (parDE). A 20,000 member clone library with 
insert sizes of up to 200kb was successfully created and subsequently 
transferred to two other putative host organisms, Pseudomonas fluorescens and 
Xanthomonas campestris.66 Similarly, Kakirde et al, (2010) created a BAC 
vector capable of replication and expression in diverse genera of Gram-negative 
bacteria such as Escherichia, Salmonella, Enterobacter, Pseudomonas, Serratia 
and Vibrio.67 Recently, viral gene expression elements have been used to 
increase the expression and hit rate of metagenomic clones. Using phage T7 
RNA polymerase to drive transcription and an inducible phage anti-termination 
protein to bypass many transcriptional terminators present on the insert, a 6-fold 
increase in the number of carbenicillin resistant clones identified in the screen 
was observed.68 Furthermore, the use of a vector with dual-orientation 
promoters allows for bi-directional transcription and the possibility to significantly 
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increase the hit rate. Such expression does not rely on the presence of a native, 
insert-borne promoter, or on the orientation of the cloned insert.59  
 
(c) Codon optimisation 
The majority of organisms have a particular preference for certain 
translation initiation codons and for overall codon usage, which is known as 
codon usage bias.69 E. coli for example uses AUG as a start codon to initiate 
approximately 90% of translation, therefore non-AUG start codons such as GUG 
and UUG may not be efficiently recognised.58 Foreign genes highly transcribed 
in E. coli have been shown to possess similar promoter sequences that bind the 
sigma factor RpoD (σ70) of E. coli.70 The effect of codon usage bias on 
expression has been investigated by introducing synonymous mutations to the 
third base position of the gene encoding green fluorescent protein (GFP). 
Expression levels between the 154 protein variants differed by up to 250-fold. 
Variable expression however, did not correlate with codon bias but rather, with 
the stability of mRNA folding near the ribosomal binding site. Codon bias on the 
other hand influenced the overall translation efficiency and cellular fitness.71 
Interestingly a recent study suggests (on the basis of analysing eleven diverse 
metagenomes) that regardless of phylogeny, microbes in the same 
environmental niche share common preferences for synonymous codon usage 
at the community level. These codon usage signatures differ between different 
metagenomes and can be used to predict functionally relevant genes for the 
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community as a whole and also identify and characterise unknown genes with 
similar codon usage patterns to those genes.72 
Knowledge of such issues and data mining large metagenomic datasets 
will enable the design of the most suitable expression systems with the greatest 
chance of success and also enable the creation of novel metagenome-derived 
synthetic genes or operons that are optimised for expression in E. coli or 
another relevant host.35, 36 An overview of the main methods to identify novel 
genes through metagenomics is presented in Figure 1. 
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Figure 1.  
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Figure 1. An overview of the main methods of novel gene discovery using 
metagenomics. A sample from the environment of interest (e.g. soil, human 
gastrointestinal tract, ocean) is collected (A), total metagenomic DNA is isolated 
directly or indirectly from the sample either by harsh or gentle lysis (B); 
metagenomic DNA is subsequently subjected to sequence-based analysis (C), 
which can include; creating a clone library followed by random Sanger 
sequencing or direct sequencing of metagenomic DNA using next generation 
(NGS) methods (C-1); Gene targeting using degenerate primers designed from 
conserved regions of homologous sequences followed by PCR amplification (C-
2); Data mining of existing metagenomic sequence datasets for genes or 
conserved domains of interest, followed by complete synthesis of host-
optimised genes (C-3); Capture of novel genes from plasmids using the TRACA 
(transposon-aided capture) method or integron-associated genes using PCR 
with primers that target conserved integration site sequences (C-4). Functional 
metagenomics (D) involves; The creation of a small- or large-insert library using 
a specific type of vector (plasmid, fosmid, cosmid or bacterial artificial 
chromosome (BAC)) depending on the needs of the user or aims of the project 
(D-1); Choosing a suitable heterologous host for expression of metagenomic 
DNA. The most widely used host is E. coli, but species of Streptomyces and 
Bacillus, for example, have also been utilised. The library is maintained in 96- or 
384-well micro-titre plates and stored at -80ºC (D-2); Clones containing 
metagenomic DNA can be screened to identify a phenotype of interest by 
replicating all or a portion of the library into new micro-titre plates or onto agar 
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plates. Growth of library clones can be assessed for production of 
antimicrobials, pigmentation, altered morphology or increased resistance to 
various stressors relative to control strains carrying empty vectors (D-3). 
Transposon mutagenesis may be carried out on positive clones to identify the 
gene or genes of interest (D-4), which may be subsequently cloned as an 
isolated gene(s) to confirm the phenotype (D-5). Novel genes are discovered 
using sequence-based or functional metagenomic strategies, or a combination 
of both (E). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
28 
 
Functional metagenomic discovery of therapeutically relevant compounds 
 The majority of microbes in many environments are as yet uncultured 
and many will harbour the ability to produce therapeutically-relevant novel 
compounds. By utilising one or more of the strategies mentioned above to 
increase the chances of successful heterologous expression, there is potential 
to discover such novel compounds from uncultured members of well-known 
producers such as the Actinomycetes and also from novel microbial species. 
Nevertheless, novel compounds have been successfully discovered using 
functional metagenomics. The antibiotics Turbomycin A and B were discovered, 
somewhat serendipitously, following a functional screen for haemolytic clones in 
an E. coli metagenomic library. Turbomycin A had been reported previously as a 
fungal metabolite, but not bacterial, while Turbomycin B was a novel compound. 
The production of both antibiotics is proposed to occur via a single gene on the 
insert coupled with endogenous indole production from the E. coli host. Both 
antibiotics displayed broad-spectrum activity against a number of Gram-positive 
and Gram-negative pathogens.73  
 Gene clusters for the biosynthesis of novel compounds have often been 
found to be silent in both culturable organisms and also when cloned and 
expressed in a heterologous host. To overcome this, clones found to harbour 
PKS genes were subsequently screened for the presence of putative 
transcription factors in the neighbouring DNA, which usually tightly regulate 
such gene clusters. By cloning the genes encoding the transcription factors 
(under the control of the strong, constitutive promoter of the erythromycin 
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resistance gene ermE) and subsequently transforming the corresponding PKS 
clone with the expression plasmid, a dramatic increase in expression was 
observed and a clone producing an antibacterial metabolite was identified. The 
compound, Tetarimycin A, is a Gram-positive specific antibiotic with potent 
activity against MRSA. The authors suggest that there are likely to be more 
members of this class of novel antibiotic encoded by similar gene clusters 
present in the environment.74 A combination of sequence-based metagenomics 
and heterologous expression using a transcription factor (similar to the example 
above) has identified a compound with inhibitory activity against disease-related 
protein kinases, while another study identified a compound with potent anti-
tumour activity.75, 76  
 
Therapeutics from within: “bio-prospecting” the human microbiome 
 A microbiome is the totality of all microbes, their genes and interactions 
in a particular environment. The sequencing of the human genome was a 
historic scientific achievement and heralded exciting opportunities to decipher 
many of the intricacies of human diseases and conditions. It soon became 
apparent however, that studying the human genome and organism as a single 
entity gave an incomplete picture without considering the role of the human 
microbiome.77, 78 Whilst the previous examples have dealt with the identification 
of novel genes that encode secondary metabolites such as antibiotics, the 
majority of these have been identified in the external environment. Large-scale 
metagenomic research projects, such as Metagenomics of the Human Intestinal 
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Tract (MetaHit), the Human Microbiome Project (HMP) and ELDERMET 
amongst others79-83  have focused on looking within the human body, not only 
for novel genes and compounds, but also for novel species and for changes in 
the abundance and diversity of extant species of the human microbiome and 
how these may be “mined” or manipulated in a positive way for human health. 
 Thuricin CD was discovered from a screen of more than 30, 000 colonies 
from human faecal samples. Produced by Bacillus thuringiensis, thuricin CD is a 
novel bacteriocin with narrow-spectrum, potent antimicrobial activity against 
clinical isolates of Clostridium difficile. Importantly thuricin is as effective as the 
clinically-indicated antibiotics, vancomycin and metronidazole, in killing C. 
difficile and causes negligible “collateral damage” to other members of the gut 
microbiota in an ex vivo colon model, making it an attractive therapeutic 
compound to pursue for clinical application. While thuricin was not identified 
using a metagenomics approach, its discovery and its desirable properties 
indicate that applying sequence-based or functional metagenomic approaches 
(or a combination of both) could identify similar and also other novel 
antimicrobials.84, 85 Indeed, similar to the in silico data-mining approach 
mentioned previously, gene clusters similar to that of thuiricin have been 
identified in genomic and metagenomic sequence datasets.86 Using the amino 
acid sequences of the radical S’-adenosylmethionine (SAM) proteins (TrnC and 
TrnD) encoded on the thuricin gene cluster as driver sequences, 100 TrnC and 
54 TrnD homologues were identified in the genomes of 112 unique microbial 
strains, none of which had been previously associated with bacteriocin 
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production. Further analysis revealed 15 novel, putative thuricin gene clusters. 
In addition, 365 TrnC and 151 TrnD homologues were found in metagenomic 
datasets from diverse environments indicating the widespread presence of such 
genes in the environment. At the time of publication in 2011, the HMP dataset 
would have been unavailable, but it would be interesting to investigate the 
abundance of such gene clusters in the different anatomical human 
microbiomes, particularly the gut microbiome.  
Discovery of novel antimicrobials has become of paramount importance 
due to significant increases in global antibiotic resistance and the emergence of 
multi-antibiotic resistant “superbugs”.87 In a recently published annual report on 
infection and antimicrobial resistance, England’s’ Chief Medical Officer, 
Professor Dame Sally Davies, highlights the seriousness of the problem, makes 
a number of recommendations and states that, “it (antimicrobial resistance) 
should be placed on the national risk register (specifically, the National Security 
Risk Assessment) and the Government should campaign for it to be given 
higher priority internationally, including collaborations to ensure the 
development of new antimicrobials and vaccines, such as Private Public 
Partnerships.” 88 The full report can be downloaded at: 
https://www.gov.uk/government/publications/chief-medical-officer-annual-report-
volume-2. Furthermore, overall societal costs due to antimicrobial resistant 
infections in the European Union, Iceland and Norway is estimated to be 
approximately €1.5 billion annually.89 Research to identify novel antimicrobials 
or targets thereof has been scaled down or completely abandoned by some 
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pharmaceutical companies.90 Payne and co-workers give an insight from the 
perspective of a pharmaceutical company of the difficulties and costs associated 
with such research and the poor returns, both financial and of novel products.91 
This is compounded by the fact that only two new classes of antibiotics have 
been marketed since 1962.92 Overall, these facts emphasise the need for novel 
and alternative strategies to combat antimicrobial resistance.  
In a recent study, Eggerthella lenta, a common actinobacterial member of 
the gut microbiota, was shown to be solely responsible for the inactivation of the 
cardiac drug digoxin.93 A highly up-regulated, two-gene (cgr1 and 2) operon was 
likely responsible for reducing digoxin to an inactive form, while arginine 
inhibited expression and strains lacking the operon were unable to reduce 
digoxin. Germ-free mice colonised with E. lenta had lower serum and urine 
digoxin compared to mice colonised with E. lenta cgr-negative strains. 
Furthermore, mice fed a high protein diet had increased serum and urine 
digoxin indicating a reduction in digoxin inactivation, likely through increased 
dietary arginine.93  
Such studies open up new avenues for future therapeutic strategies.  
Profiling faecal samples for E. lenta in patients requiring digoxin could result in 
treatment interventions such as dietary supplementation with increased protein 
or arginine.  The continual reduction in sequencing costs may see metagenomic 
sequencing become part of a personalised medicine treatment strategy or to 
ascertain the microbiome composition of subjects for clinical trials or before, 
during and after a particular drug regimen. Bacterial beta-glucuronidases of the 
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human gut microbiota can reactivate CPT-11 (a chemotherapeutic agent used 
to treat colon cancer) in the human gut, causing severe diarrhea and limiting the 
dose intensification. Inhibitors of these beta-glucuronidases have been identified 
that could increase therapeutic efficacy.94 The opposite of the E. lenta example 
could also be exploited; identification of a novel probiotic species that positively 
correlates with drug metabolism (such as activation of a pro-drug) or 
detoxification that could be co-administered as a probiotic with the drug. 
Metagenomics can increase our understanding of the structure, function, 
diversity and interactions of our microbiota which will aid the development of 
personalised medicine programs and the identification of novel drug targets and 
compounds. Furthermore, metagenomics in combination with in vitro assays 
and animal models may be used to identify specific microbes or combinations of 
microbes responsible for different drug interactions.95 However, the inter-
individual variability of the microbiome, even between healthy subjects remains 
a challenge for targeted therapies.96, 97  
 
Bio-engineered probiotics 
“Let food be thy medicine and medicine be thy food” – Hippocrates 
 There has been an increasing interest in the development of bio-
engineered (also termed designer or recombinant) probiotics in recent years.98-
106 Probiotics are defined as “live microorganisms which when administered in 
adequate amounts confer a health benefit on the host.” 107 Numerous research 
groups have engineered probiotic strains that successfully target specific 
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pathogens and toxins, as well as developing probiotics as vaccine and drug 
delivery platforms.  
 Paton’s group has used host-cell receptor mimicry to bio-engineer 
probiotics that bind and neutralise toxins produced by shigatoxigenic- and 
enterotoxigenic-E. coli (STEC and ETEC, respectively), as well as Vibrio 
cholerae. Recombinant bacteria expressing different oligosaccharide toxin 
receptor mimics in their lipopolysaccharide (LPS) outer core were engineered 
and subsequently shown to bind the toxins (shiga toxin and cholera toxin). This 
proved to be an extremely successful approach with up to 100% survival rates 
in murine models infected with virulent STEC or V. cholerae compared to 
controls.108-110 A key advantage of this approach is that development of 
resistance is very unlikely as a selective pressure is not imposed on the 
pathogen.111 Identification of genes that encode specific glycosyl transferases 
and sugar precursors are required to create different structural receptor mimics. 
Metagenomics may be useful to identify novel variants of such genes for the 
construction of diverse mimics that can target a broader range of pathogens and 
toxins. Other recombinant probiotics include those that exert immunomodulatory 
effects and target cancer and HIV (for a review, see Paton, Morona and 
Paton112), that modulate the fatty acid composition of host adipose tissue by 
producing trans-10, cis12 conjugated linoleic acid (CLA), and that promote in 
vitro intestinal wound healing mediated by probiotic secretion of human 
epidermal growth factor (EGF).113, 114 
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 The above examples demonstrate the diverse therapeutic potential of 
bio-engineered probiotics, which could be made even more diverse through the 
use of food-grade lactococci and lactobacilli for receptor mimicry111 and the 
identification and cloning of novel, metagenome-derived genes in probiotic 
microbes. 
 
Meta-biotechnology: application of metagenome-derived genes to bio-
engineered probiotics 
We have previously coined the term “meta-biotechnology” to describe the 
use of metagenomics as a robust method of identifying novel genes for use in 
biotechnology and the creation of bio-engineered probiotics.115, 116 This is an 
extension of the patho-biotechnology concept which aims to exploit stress 
response, host evasion and virulence determinants of pathogenic microbes to 
enhance both physiological and technological robustness and stress resistance, 
as well as the clinical efficacy of probiotics.101, 105, 106, 117 An increased ability to 
overcome the many host-imposed stresses of the gastrointestinal tract (low pH, 
bile, low iron concentrations and increased osmolarity) is a desirable trait in 
what are sometimes promising, but physiologically or technologically fragile 
probiotic strains.118 
Listeria monocytogenes has been used as the model organism to 
successfully demonstrate proof-of-concept for patho-biotechnology. The betL 
gene (which encodes a betaine transporter involved in osmotic stress resistance 
and virulence119-122) was cloned in Lactobacillus salivarius UCC118, resulting in 
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a significant increase in tolerance to numerous in vitro and technological stress 
conditions.123 Furthermore, when expressed in Bifidobacterium breve UCC2003, 
betL also increased low pH and osmotic stress resistance in vitro, while also 
increasing gastrointestinal persistence and protecting against L. monocytogenes 
infection in a murine model.124 Using a similar approach, the bile exclusion 
system (BilE) of L. monocytogenes was used to increase the bile tolerance and 
gastrointestinal persistence of both L. lactis NZ9000 and B. breve UCC2003, 
while B. breve alone reduced the listerial load in murine livers.100 
The identification of similar genes to those mentioned above from the 
symbiotic gut microbiota using metagenomics could provide a large suite of 
genes for creating novel therapeutic probiotics and concerns regarding the use 
of genes from pathogens may be somewhat alleviated by these “self” genes. It 
is also likely that certain genes from the permanent inhabitants of the human gut 
microbiota will provide more robust protection against various GI stresses, as 
gut microbes will be better adapted for survival in this niche. Examples of genes 
discovered through metagenomics which could be used to create bio-
engineered probiotics are outlined below. 
 The ability to colonise the gastrointestinal tract is one of a number of 
important characteristics for a probiotic strain to possess.125 A functional 
metagenomic approach has been used to identify novel genes which conferred 
enhanced colonisation potential when expressed in E. coli.126 An initial screen of 
a BAC library created from the murine gut metagenome identified a number of 
clones with enhanced ability to form biofilms. Further analysis of two clones in 
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detail revealed four- and three-gene operons, respectively responsible for the 
phenotype. The operons were cloned in isolation and expressed in E. coli. The 
clones exhibited between 4- and 17-fold enhanced adherence to HT-29 human 
cell lines in vitro, as well as enhanced intestinal colonisation of antibiotic pre-
treated mice, with approximately 6- to 28-fold more colony forming units (CFUs) 
recovered from plated intestinal homogenates.126 Such genes could be 
especially useful for lactococcal-based engineered probiotics; while these 
strains are able to reach the intestine, they cannot usually colonise.127 
 The gastric juice in the stomach is the first major hurdle to overcome for 
potential probiotics. The pH of gastric juice ranges from pH 3 to pH 5 , but can 
be as low as pH 1.5 during fasting.128 The ability to survive this initial challenge 
significantly influences microbial numbers that reach the intestine. Metagenomic 
analysis of extreme environments has proved fruitful in identifying novel stress 
resistance genes. Fifteen novel acid resistance genes from eleven clones were 
identified in a small-insert E. coli metagenomic library from the extremely acidic 
Tinto River.129 Some clones were conferred with extreme acid resistance to pH 
1.8, with up to 53% survival after 60 minutes treatment. The various genes 
responsible for the phenotype were both functionally and phylogenetically 
diverse and some could confer broad-host range acid resistance to 
Pseudomonas putida and B. subtilis, in addition to E. coli. Increasing the acid 
resistance of probiotics thus has the potential to enable greater persistence and 
enhanced therapeutic effect. 
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 Recent work in our laboratory has identified novel salt tolerance genes 
from the human gut microbiota using functional metagenomics.130 From a 
screen of over 20,000 clones and subsequent transposon mutagenesis and 
cloning, five genes were identified that could confer increased salt tolerance to 
E. coli. The ability to respond and adapt to increases in external osmolarity 
caused by salt and other solutes is an important survival determinant.131 Like 
the examples with the betL salt tolerance locus mentioned above,123, 124 these 
metagenome-derived genes could be used in a similar manner to increase the 
stress resistance of probiotic strains.  
 Bile resistance is also a desirable trait in a probiotic.125 In addition to bile 
exclusion systems, some microorganisms possess bile salt hydrolase (BSH) 
genes which convert conjugated bile acids into their unconjugated form.132 Bile 
acids, and consequently BSH, can influence host physiology in the form of lipid 
absorption and cholesterol homeostasis.132 A comprehensive metagenomic 
study of the human gut microbiota revealed that BSH activity is highly 
conserved in this environment, being found in all major bacteria and archaeal 
divisions in the human gut. Furthermore, BSH activity increased bile resistance 
in vitro and gastrointestinal survival in vivo.133 Consequently probiotics and BSH 
have been investigated as potential cholesterol-lowering therapeutics.134, 135 
Discovery of novel BSH genes and engineering probiotics with increased BSH 
activity may therefore be a viable and attractive therapeutic goal.  
 Finally, the gut-brain axis and the increasing evidence that the gut 
microbiota play a role in influencing processes in the brain has received much 
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attention of late.136-139 In addition, some microbes are capable of producing 
many neuroactive compounds such as gamma-aminobutyric acid (GABA), 
norepinephrine, serotonin and dopamine.140 A recent study has shown that mice 
administered with a probiotic strain of Lactobacillus rhamnosus exhibited 
reduced anxiety and differential expression of GABA receptors in the brain. 
Animals that underwent vagotomy surgery (effectively cutting the main neural 
link between the gut and brain) did not display any of the effects seen in non-
vagotomised animals when administered L. rhamnosus.141 Such probiotics have 
recently been termed “psychobiotics”; a live organism that, when ingested in 
adequate amounts, produces a health benefit in patients suffering from 
psychiatric illness.142 While much of the data is pre-clinical, it is certainly an 
exciting area to monitor in the future for further research and clinical trials. 
Perhaps metagenomics could be used to (a) identify genes from pathways that 
produce neuroactive compounds in the gut metagenome, (b) reveal the 
differences in the abundance of microbes capable of producing these 
compounds in the general population, (c) design functional assays to detect 
clones that produce known or novel neuroactive compounds or (d) create bio-
engineered psychobiotics for specific psychiatric illnesses. Some of the potential 
applications of metagenomic novel gene discovery can be seen in Figure 2. 
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Figure 2. 
 
Figure 2. Applications of novel genes discovered by metagenomics. Novel 
genes or gene clusters discovered through metagenomics will encode proteins 
for the production of novel antimicrobial compounds such as antibiotics and 
bacteriocins (A) and bio-therapeutics (B). Novel genes may also be used to 
create bio-engineered probiotic strains (C). Bio-engineered probiotics can be 
created that are more resistant host-associated stresses of the gastrointestinal 
tract such as low pH, bile and increased osmolarity (D-1), which will lead to 
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increased survival and persistence in the gastrointestinal tract (D-2). This will 
ultimately increase their therapeutic efficacy; using them to target specific 
pathogens or toxins by expressing receptor-mimic structures on their surface, 
thus preventing infection (D-3). The use of probiotics that have a health benefit 
to persons with a psychiatric illness have been termed “psychobiotics”. The 
creation of bio-engineered psychobiotics that can produce neuroactive 
compounds at an increased level or for a specific illness may be possible by 
identifying novel genes through metagenomics (E). 
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Biological Containment  
 The potential use of bio-engineered probiotics essentially involves the 
use of a genetically modified organism (GMO) and raises genuine concerns 
regarding what would be the deliberate release of a GMO into the environment 
when used as a bio-therapeutic. A number of containment strategies have been 
developed and can be categorised as either passive or active containment. With 
passive containment, an auxotrophic mutant is created which cannot grow 
without the exogenous provision of an essential metabolite. The most 
successful example of this is thymidine auxotrophy. Steidler et al, replaced the 
essential thyA gene (encoding thymidylate synthase) in L. lactis, with a gene 
encoding human interleukin 10 (IL-10) by chromosomal integration.143 The 
mutant strain cannot grow in the absence of thymidine or thymine, which are 
absent in the environment, and cell death is induced by the phenomenon of 
“thymineless-death”.144 This strain has been used in a human clinical trial for the 
treatment of IBD.145 Active containment strategies are usually more complex 
and specific for the micro-organism in question, involving many gene deletions, 
tightly regulated gene expression and an inherent “suicide” system.146, 147 
 
Conclusions and outlook 
 As we have outlined, metagenomic analyses enable comprehensive 
investigations of microbial communities and provide unprecedented access to 
the genetic diversity therein. An incredible amount of information has been 
gained in a relatively short time with regard to the taxonomic, phylogenetic and 
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genetic novelty within diverse metagenomes. The development of new 
technologies and the continual reduction in sequencing costs will expand this at 
an ever increasing rate in the future, while the development of novel hosts and 
expression systems will increase hit rates and the variety of novel genes that 
can be discovered, thus helping to overcome some of the limitations of 
metagenomics. Development of novel and innovative screening assays will 
facilitate the discovery of previously unknown gene functions and novel 
therapeutic compounds. Greater emphasis will need to be placed on correct 
functional annotation of genes, as this already greatly lags behind the 
generation and deposition of metagenome sequences, which hampers 
subsequent analyses due to incorrect or absent database annotations. Synthetic 
biology is likely to come to the fore in the near future148, 149, which will be 
coupled with decreasing costs and new opportunities to combine metagenomics 
and synthetic biology, possibly to synthesise optimised collections of genes 
mined from metagenome datasets for functional experiments. Identification of 
novel species or information from metagenomes will give clues to the metabolic 
and physiological requirements to enable the development of culture conditions 
to grow novel species. Bio-engineered probiotics face tough challenges if they 
are ever to be realised as clinical therapeutics; the creation and use of GMOs is 
a sensitive issue and acceptance by consumers would require undeniable 
demonstrations of biological containment, safety and ultimately, efficacy in 
large, double-blind, placebo controlled clinical trials.150 Nevertheless, the 
extreme seriousness of increasing rates of antibiotic resistance and 
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dissemination means that now is the time to think outside the box and 
intensively search out novel antimicrobials and therapeutics. It would be 
unfortunate to reach a stage where consumer acceptance of such novel 
therapies is based solely on a lack of alternatives. Metagenomics is likely to play 
a key role in identifying and developing such novel therapeutics. 
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Abstract 
Metagenomics is a powerful tool that allows for the culture-independent 
analysis of complex microbial communities.  One of the most complex and 
dense microbial ecosystems known is that of the human distal colon, with cell 
densities reaching up to 1012 per gram of faeces.  With the majority of species in 
many environments considered as yet uncultured, there are an enormous 
number of novel genes awaiting discovery.  In the current study, we conducted 
a functional screen of a metagenomic library of the human gut microbiota for 
potential salt-tolerant clones.  Using transposon mutagenesis, three genes were 
identified from a single clone exhibiting high levels of identity to a species from 
the genus Collinsella (closest relative being Collinsella aerofaciens) 
(COLAER_01955, COLAER_01957 and COLAER_01981), a high GC, Gram 
positive member of the Actinobacteria commonly found in the human gut. The 
encoded proteins exhibit a strong similarity to GalE, MurB and MazG.  
Furthermore, pyrosequencing and bioinformatic analysis of two additional 
fosmid clones revealed the presence of an additional galE and mazG gene, with 
the highest level of genetic identity to Akkermansia muciniphila and Eggerthella 
sp. YY7918 respectively.  Cloning and heterologous expression of the genes in 
the osmosensitive strain, Escherichia coli MKH13, resulted in increased salt 
tolerance of the transformed cells.  It is hoped that the identification of atypical 
salt tolerance genes will help to further elucidate novel salt tolerance 
mechanisms, and will assist our increased understanding how resident bacteria 
cope with the osmolarity of the gastrointestinal tract. 
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Introduction 
The ability to respond and adapt to changes in external osmolarity is a 
key determinant for bacterial survival and proliferation in various environmental 
niches (Sleator and Hill, 2002).  Microorganisms are continually exposed to 
fluctuations and perturbations in osmolarity in their environment caused by 
rainwater, drought, salinity and changing solute concentrations. Both transient 
and symbiotic microorganisms that colonize the gastrointestinal (GI) tract are 
particularly susceptible to water loss due to osmotic stress (Gralla and Huo, 
2008).  It has been demonstrated that free water is not evenly distributed along 
the gut, but exists as pockets, meaning changes in osmolarity can be rapid 
(Schiller et al., 2005).  The elevated osmolarity of the upper small intestine (the 
equivalent of 0.3M NaCl (Chowdhury et al., 1996)), represents an initial 
challenge to ingested microorganisms and the osmolarity is likely to be higher in 
the distal colon following further water absorption in the final stages of the 
digestive process.  Bacteroides fragilis isolates from human stool samples have 
shown increased resistance to both NaCl and bile stress compared to isolates 
from blood or abscesses, indicating the potential importance of to such stress 
tolerance mechanisms in the gastrointestinal tract (Pumbwe et al., 2007). 
In general, bacteria respond to hyper-osmotic stress in a phased manner.  
Firstly, during the primary response, which is activated within seconds of 
osmotic up-shift, potassium (K+) is rapidly transported into the cell (for a review 
see; (Epstein, 2003)).  However, a more sophisticated osmotic stress response 
system is required once the cellular osmolality has been initially stabilized. The 
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next phase, or secondary response, involves the uptake and/or synthesis of 
compatible solutes (also termed osmolytes or osmoprotectants).  As their name 
suggests, these diverse compounds (Kempf and Bremer, 1998)  are for the 
most part compatible with vital cellular functions and can restore cell volume 
and turgor without adversely affecting metabolism (Kunte, 2006).  While the 
primary and secondary responses constitute the classical response to hyper-
osmotic stress, the overall osmoadaptation strategy is much more complex, and 
involves a diverse range of cellular systems and processes seemingly unrelated 
to the primary and secondary responses.  Identifying such diverse 
genes/proteins will provide us with a broader and more complete view of salt 
tolerance and the cellular response to salt-induced osmotic stress in bacteria.  
Indeed, many such ancillary mechanisms have been identified and range from 
two-component systems and proteolytic systems to numerous general stress 
and heat stress proteins and can also involve changes to the cell membrane 
(Gardan et al., 2003; Kilstrup et al., 1997; Lopez et al., 2006; Piuri et al., 2003; 
Sakamoto and Murata, 2002; Sleator and Hill, 2005; Wonderling et al., 2004).   
Since their inception, metagenomic strategies have led to the 
identification of numerous novel and diverse genes, enzymes and proteins from 
many diverse environments through sequence-based and/or functional 
approaches (Banik and Brady, 2008; Beja et al., 2000; Gillespie et al., 2002; 
Heath et al., 2009; Lee et al., 2007; Meilleur et al., 2009).  In principle, 
metagenomics can provide access to all of the genetic resources in a given 
environmental niche and as such is an extremely powerful tool to access the 
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genomes of difficult-to-culture or unculturable microorganisms (Sleator et al., 
2008).  A recent study identified novel genes from a pond water metagenome 
that increased resistance to salt-induced osmotic stress when expressed in E. 
coli (Kapardar et al., 2010(b); Kapardar et al., 2010(a)).  While some studies 
have used functional metagenomics to screen for various phenotypes from the 
human gut environment (Gloux et al., 2011; Kazimierczak et al., 2008; Lakhdari 
et al., 2010) to our knowledge this study is the first to identify genes that confer 
salt tolerance from the human gut microbiota. 
 
Materials and methods 
Bacterial strains and growth conditions 
Bacterial strains and plasmids used in this study are listed in Table 1.  
Primers (Eurofins, MWG Operon, Germany) used in this study are listed in 
Table 2.  E. coli EPI300::pCC1FOS (Epicentre Biotechnologies, Madison, WI, 
USA) was grown in Luria-Bertani (LB) medium (Maniatis, 1982) containing 
12.5g/ml chloramphenicol (Cm) and in 12.5g/ml chloramphenicol plus 
50g/ml kanamycin (Kan) following EZ-Tn5 transposon mutagenesis 
reactions.  E. coli MKH13 was grown in LB medium and in LB medium 
supplemented with 20µg/ml Cm for strains transformed with the plasmid pCI372.  
LB media was supplemented with 1.5% agar when required.  All overnight 
cultures were grown at 37°C with shaking.  
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Table 1. Bacterial strains, plasmids and transposon used in this study 
Strain, plasmid or transposon 
 
Genotype or characteristic(s) Source or 
reference 
 
Strains 
 
E. coli EPI300 
 
 
 
F
-
 mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80dlacZΔM15 ΔlacX74 recA1 endA1 
araD139 Δ(ara, leu)7697 galU galK λ
-
 rpsL nupG trfA dhfr; high-transformation 
efficiency of large DNA 
 
 
 
 
Epicentre 
Biotechnologies, 
Madison, WI, USA 
E.coli MKH13 MC4100Δ(putPA)101D(proP)2D(proU) 
 
(Haardt et al., 
1995) 
E. coli MKH13::pCI372-murB(3) MKH13 containing pCI372 with murB 
gene from SMG 3 (similar to Collinsella 
aerofaciens ATCC 25986) 
 
This study 
E. coli MKH13::pCI372-mazG(3) MKH13 containing pCI372 with mazG 
gene from SMG 3 (similar to Collinsella 
aerofaciens ATCC 25986) 
 
This study 
 
 
E. coli MKH13::pCI372-galE(3)   
 
MKH13 containing pCI372 with galE gene 
from SMG 3 (similar to Collinsella 
aerofaciens ATCC 25986) 
 
This study 
E. coli MKH13::pCI372-mazG(5)   
 
MKH13 containing pCI372 with mazG 
gene from SMG 5 (similar to Eggerthella 
sp. YY7918 
 
This study 
E. coli MKH13::pCI372-galE(25)   
 
MKH13 containing pCI372 with galE gene 
from SMG 25 (similar to Akkermansia 
muciniphila ATCC BAA-835) 
 
This study 
Plasmids 
 
pCI372 
 
 
Shuttle vector between E. coli and L. 
lactis, Cm
R  
 
 
 
(Hayes et al., 1990) 
pCC1FOS 
 
Fosmid cloning vector, Cm
R
 Epicentre 
Biotechnologies, 
Madison, WI, USA 
Transposon 
 
EZ-Tn5 <oriV/ KAN-2> 
 
 
 
Hyperactive Tn5 transposon, Kan
R
, 
inducible high copy origin of replication – 
oriV 
 
 
 
Epicentre 
Biotechnologies, 
Madison, WI, USA 
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Metagenomic library construction 
A metagenomic library which had been constructed previously  (Jones 
and Marchesi, 2007) was used to screen for salt-tolerant clones.  Briefly, 
metagenomic DNA was isolated from a human faecal sample (from a 26 year-
old healthy Caucasian male) and from this a fosmid library (average insert size 
of approximately 40kb) was created using a Copy ControlTM fosmid library 
production kit (Epicentre biotechnologies) according to the manufacturer’s 
instructions.  A Genetix QPix 2 XT colony picking robot was used to transfer 
fosmid clones to 384-well micro-titer plates, which were stored at -80°C until 
needed. 
 
Screening the metagenomic library 
A total of 23,040 clones from the library (average insert size of ~40kb) 
were screened on LB agar supplemented with 6.5% NaCl for clones showing 
increased tolerance to NaCl compared to the E. coli EPI300 host strain 
(containing an empty pCC1FOS cloning vector).  A Genetix QPix 2 XT colony 
picking/gridding machine was used to plate the clones onto Q-Trays (Genetix) 
containing LB agar supplemented with 12.5g/ml Cm and 6.5% NaCl.  Q-Trays 
were incubated at 37°C for 72 hours.  Following incubation, likely salt-tolerant 
clones were replica plated onto LB containing 12.5g/ml Cm and 6.5% NaCl 
and onto LB containing 12.5g/ml but without NaCl (which served as a positive 
control). 
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Growth experiments 
Cultures were grown overnight with shaking in LB broth.  Subsequently, 
cells were harvested, washed in one quarter strength sterile Ringer’s solution 
and resuspended in fresh LB broth.  A 2% inoculum was sub-cultured in fresh 
LB broth containing the appropriate stress (i.e. 0-10% (w/v) NaCl, 0-8% (w/v) 
KCl, 0-90% (w/v) sucrose or 0-80% (v/v) glycerol as required) and 200µl was 
transferred to a sterile 96-well micro-titer plate (Starstedt Inc. Newton, USA).  
Plates were incubated at 37°C for 48 hours in an automated spectrophotometer 
(Tecan Genios) which recorded the OD 595nm every hour.  After 48 hours the 
data was retrieved and analysed using the Magellan 3 software program.  
Results are presented as the average of triplicate experiments, with error bars 
being representative of the standard error of the mean (SEM). 
 
DNA manipulations 
Extraction of fosmids containing metagenomic DNA: 5ml of bacterial 
culture was grown overnight with 12.5g/ml Cm.  One millilitre of culture was 
used to inoculate 4 ml of fresh LB broth.  To this, 5l of 1000x Copy Control  
Induction solution (Epicentre Biotechnologies) and 12.5g/ml Cm were added.  
The mixture was incubated at 37°C for 5 hours with vigorous shaking (200-250 
r.p.m.) to ensure maximum aeration.  Cells were harvested from the whole 5ml 
of induced culture by centrifuging at 2100 x g for 12 minutes.  Qiagen QIAprep 
Spin mini-prep kit was used to extract fosmids as per manufacturer’s 
instructions. PCR products were purified with a Qiagen PCR purification kit and 
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digested with XbaI and PstI (Roche Applied Science), followed by ligation (T4 
DNA ligase (Roche) for mazG(3) and murB(3); FastLink DNA ligase for galE(3), 
galE(25) and mazG(5) (Epicentre Biotechnologies) as per manufacturer’s 
instructions) to similarly digested plasmid pCI372. Electrocompetent E. coli 
MKH13 were transformed with the ligation mixture and plated on LB agar plates 
containing 20µg/ml Cm for selection.  Colony PCR was performed on all 
resistant transformants using primers across the multiple cloning site (MCS) of 
pCI372 to confirm the presence and size of the insert. 
 
Transposon mutagenesis  
Transposon mutagenesis was carried out on SMG 3 according to the 
manufacturer’s instructions using the EZTn-5 <oriV/ KAN-2> in vitro 
transposition kit (Epicentre Biotechnologies).  E. coli EPI300 cells were 
transformed with the transposon reaction mixture and selected on plates 
containing Cm and Kan (12.5 and 50µg/ml, respectively).  Subsequently, the 
transposon insertion clones were replica plated onto LB with and without 6.5% 
NaCl.  Clones which grew on LB but not on LB + 6.5% NaCl indicates a likely 
insertion event in a gene involved in salt tolerance.  Presumptive salt- tolerant 
knock-outs were grown overnight and a fosmid DNA extraction was performed.  
The extracted fosmid containing metagenomic DNA was subjected to 
sequencing from the ends of the transposon using the primers EZTn-FP-1 and 
EZTn-RP-1 (Table 2.).  All sequencing was performed by GATC Biotech 
(Germany).   
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Sequencing and bioinformatic analysis 
Fosmids SMG 1, 3, 5, 6 and 25 were fully sequenced and assembled by 
GATC Biotech (Germany) using the GS FLX (Roche) platform.  Putative open 
reading frames were predicted using Softberry FGENESB bacterial operon and 
gene prediction software (Mavromatis et al, 2007).  Retrieved nucleotide and 
translated amino acid sequences were functionally annotated by homology 
searches using the Basic Local Alignment and Search Tool (BLAST), to identify 
homologous sequences from the National Centre for Biotechnology Information 
(NCBI) website: http://www.ncbi.nlm.nih.gov/blast/Blast.cgi.   
End sequencing was performed on all fosmid clones (SMG1-53) using T7 or 
M13 R primers and the taxonomic distribution of end sequences were assigned 
using the BLASTP program (Table 4).    
Nucleotide sequences identified in this study were compared against the 
healthy individuals in the MetaHit dataset (Qin et al., 2010) using the BLAST 
program to identify homologous sequences (>50% identity; e-value < 1^10-5).  
This data was used to determine the relative abundance of the identified genes 
in the data set and estimate the amount of DNA that would need to be screened 
(Mb) to return a hit to one of the genes.  
In addition, BLASTP analysis was undertaken to identify the protein 
sequences in GenBank, which showed the highest identity to genes isolated 
here and which were shown to be responsible for the salt tolerance phenotype.  
The closets hits were aligned using ClustalW (Thompson et al., 1994) in BioEdit 
(http://www.mbio.ncsu.edu/bioedit/bioedit.html).  The aligned proteins were 
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analysed using MEGA 5 (Tamura et al., 2011) and the evolutionary history was 
inferred using the Neighbour-Joining method (Saitou and Nei, 1987) from the 
evolutionary distances which were computed using the Poisson correction 
method (Zuckerkandl and Pauling, 1965) and are in the units of the number of 
amino acid substitutions per site.  The bootstrap method (500 replicates) was 
used to test the percentage of replicate trees in which the associated taxa 
clustered together (Felsenstein, 1985) (Figure 5). 
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Table 2. Primers used in this study 
Primer Sequence (5’ – 3’)a 
pCI372 FP CGGGAAGCTAGAGTAAGTAG 
 
pCI372 RP CCTCTCGGTTATGAGTTAG 
 
mazG(3) FP 
 
AAAACTGCAGGCCCGTCGTTCCCGCAGTCTTAC 
mazG(3) RP 
 
GCTCTAGAATCTACGAGGGCGGCGCGTTC 
murB(3) FP 
 
AAAACTGCAGCCACCTCCTGGGCGATCTGCTTGAG 
murB(3) RP 
 
GCTCTAGACGACACACCGGACTGGGTTATCTGA 
galE(3) FP 
 
AAAACTGCAGATGGGTGTGCAGTCCGCCTC 
galE(3) RP 
 
GCTCTAGAGTCCCAACGATTTCCACGAACG 
 
mazG(5) FP 
 
AAAACTGCAGCTAAACAGGAGGCGAAGCTC 
mazG(5) RP 
 
GCTCTAGAGCAGAAGGCGTCAACGATA 
galE(25) FP 
 
GCTCTAGACCGGCTTAACAGCATTGATA 
galE(25) RP 
 
AAAACTGCAGGCTGCGTTGTCTTTCCAGTT 
EZTn-FP-1 
 
GCCAACGACTACGCACTAGCCAAC 
 
EZTn-RP-1 
 
GAGCCAATATGCGAGAACACCCGAGAA 
 
T7 
 
TAATACGACTCACTATAGGG 
M13 R 
 
CAGGAAACAGCTATGACC 
aRestriction enzyme recognition sequences are underlined;  
FP= forward primer; RP= reverse primer. 
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Results 
Screening the metagenomic library 
In this study, a metagenomic fosmid library constructed from DNA 
isolated from human gut microbiota was screened for clones which conferred 
increased salt tolerance using a combined functional metagenomic, transposon 
mutagenesis and bioinformatic analysis approach.  The cloning host is 
incapable of growth on LB agar supplemented with 6.5% NaCl, providing a 
positive selection for clones able to cope with elevated osmolarity. In total, 53 
salt-tolerant clones were identified which were annotated SMG (salt 
metagenome) 1-53.  Six clones (SMG 1-6) grew within 24 hours; while a further 
47 CFUs appeared within 36 hours.  Physiological growth experiments were 
conducted on host strain EPI300::pCC1FOS and SMG 1-6. All six clones 
showed increased salt tolerance relative to the control at 7% NaCl (E. coli 
EPI300::pCC1FOS host strain) (Figure 1). The clones were subjected to further 
study through transposon mutagenesis. 
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Figure 1. 
 
 
 
 
 
 
 
 
 
Figure 1:  Growth in LB broth supplemented with 7% NaCl.  Growth of E. coli 
EPI300::pCC1FOS host strain ( closed circle), SMG 1 ( open circle), SMG 2 
( closed triangle), SMG 3 ( open triangle), SMG 4 ( closed square), SMG 
5 ( open square) and SMG 6 ( closed diamond). 
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Transposon mutagenesis 
Transposon mutagenesis was carried out using the EZ-Tn5TM <oriV/ 
KAN-2> insertion kit (Epicentre Biotechnologies).  Transposon mutagenesis 
proved unsuccessful for SMG 1, SMG 5 and SMG 6, possibly due to difficulty in 
obtaining sufficiently high yields of fosmid DNA for in vitro transposon 
mutagenesis, so SMG 3 was chosen for further investigation.  Transposon 
mutagenesis of SMG 3 yielded nine clones incapable of growth on 6.5% NaCl.  
Sequencing revealed transposon insertions in three distinct genes with high 
genetic identity (95-98%) to genes encoding hypothetical proteins from a 
member of the genus Collinsella (closest relative being C. aerofaciens).  The 
genes; galE(3) (COLAER_01955), murB(3) (COLAER_01957) and mazG(3) 
(COLAER_01981), encode hypothetical proteins similar to UDP-glucose 4-
epimerase (GalE), UDP-N-acetylenolpyruvoylglucosamine reductase (MurB) 
and nucleoside triphosphate pyrophosphohydrolase (MazG family protein) (see 
Table 3).  While GalE has been tentatively linked to salt tolerance in previous 
studies (Bohringer et al., 1995; Hengge-Aronis et al., 1991; Nguyen et al., 2004) 
we are unaware of any previous link between MurB or MazG and bacterial salt 
tolerance.
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Table 3.  Genes identified in this study 
SMG clone Putative gene Method of identification Top Blast hit % 
Identity 
(aa) 
e-value 
 
SMG 3–3 
 
mazG(3) 
COLAER_01981 
(861 bp) 
 
EZTn5 transposon mutagenesis 
 
Hypothetical protein; Collinsella aerofaciens, 
Similar to mazG encoding a MazG family protein 
(nucleoside triphosphate  
pyrophosphohydrolase) (286 aa) 
 
 
95 %  
 
2e- 94 
SMG 3–11 murB(3) 
COLAER_01957 
(963 bp) 
EZTn5 transposon mutagenesis Hypothetical protein; Collinsella aerofaciens, 
Similar to murB encoding UDP-N-
acetylenolpyruvoylglucosamine reductase (320 
aa) 
 
98% 5e- 83 
SMG 3-17 
 
galE(3) 
COLAER_01955 
(1062 bp) 
EZTn5 transposon mutagenesis 
 
Hypothetical protein; Collinsella aerofaciens, 
Similar to galE encoding UDP glucose 4- 
epimerase (353 aa) 
 
98% 
 
3e- 175 
 
SMG 5 
 
mazG(5) 
EGYY_03530  
(876 bp) 
 
Bioinformatic analysis 
 
Hypothetical protein; Eggerthella sp. YY7918, 
Similar to mazG encoding a MazG family protein 
(nucleoside triphosphate pyrophosphohydrolase) 
(291 aa) 
 
61%  
 
1e-117 
 
SMG 25 
 
galE(25) 
Amuc_1125 
(990 bp) 
 
Bioinformatic analysis Hypothetical protein; Akkermansia muciniphila, 
Similar to galE encoding a UDP glucose 4-
epimerase (329 aa) 
 
96%    0.0 
Abbreviations: aa = amino acid(s); bp = base pair(s). 
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Sequencing and bioinformatic analysis 
End sequencing was carried out on all 53 SMG clones, using T7 or M13 
R primers (GATC Biotech, Germany).  Forty-nine clones were successfully end 
sequenced and taxonomically assigned based on Blast hits. Of these, the 
Bacteroidetes dominated, representing 57.14% of the sequences, followed by 
the Actinobacteria and Proteobacteria at 14.29% and 12.24% respectively.  The 
Verrucomicrobia made up 8.16% of the sequences, while the Firmicutes were 
under-represented at 4.08%.  The remainder of the sequences were unidentified 
and one sequence came from a member of the Heterokontophyta (Blastocystis 
hominis), a eukaryote (2.04% each) (Table 4).  
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Table 4. End sequencing data from SMG clones 
Clone 
 
Best hit microorganism 
 
Top BLASTX hit 
 
e-value 
 
% 
coverage 
 
% 
identity 
 
Phylum 
 
SMG 1 Bacteroides thetaiotaomicron VPI-5482 
 
Hypothetical protein BT_1366 
 
0.00E+00 
 
100% 
 
100% 
 
Bacteroidetes 
 
SMG 2 Collinsella aerofaciens ATCC 25986 
 
Hypothetical protein COLAER_01951 
 
1.00E-133 
 
99% 
 
96% 
 
Actinobacteria 
 
SMG 3 Collinsella aerofaciens ATCC 25986 
 
Hypothetical protein COLAER_01951 
 
2.00E-146 
 
99% 
 
88% 
 
Actinobacteria 
 
SMG 4 Collinsella aerofaciens ATCC 25986 
 
Hypothetical protein COLAER_01951 
 
2.00E-41 
 
99% 
 
95% 
 
Actinobacteria 
 
SMG 5 Eggerthella sp. YY7918 
 
Aldehyde ferredoxin oxidoreductase  
 
6.00E-120 
 
99% 
 
42% 
 
Actinobacteria 
 
SMG 6  Bacteroides thetaiotaomicron VPI-5482 
 
Hypothetical protein BT_1366 
 
0.00E+00 
 
100% 
 
100% 
 
Bacteroidetes 
 
SMG 7 Bacteroides sp. 4_3_47FAA 
 
Two-component system; response regulator sensor kinase 
 
1.00E-135 
 
83% 
 
98% 
 
Bacteroidetes 
 
SMG 8 Bacteroides sp. 3_1_40A 
 
Hypothetical protein HMPREF9011_03915 
 
3.00E-160 
 
99% 
 
99% 
 
Bacteroidetes 
 
SMG 9 Alistipes putredinis DSM 17216 
 
Hypothetical protein ALIPUT_02368 
 
0.00E+00 
 
47% 
 
72% 
 
Bacteroidetes 
 
SMG 10 Paraprevotella xylaniphila YIT 11841 
 
Helicase protein  
 
8.00E-143 
 
99% 
 
99% 
 
Bacteroidetes 
 
SMG 11 Bacteroides sp. 3_1_40A 
 
Dipeptidyl aminopeptidase  
 
0.00E+00 
 
99% 
 
99% 
 
Bacteroidetes 
 
SMG 12 Collinsella aerofaciens ATCC 25986 
 
Hypothetical protein COLAER_01951 
 
6.00E-48 
 
92% 
 
98% 
 
Actinobacteria 
 
SMG 13 Bacteroides stercoris ATCC 43183 
 
Hypothetical protein BACSTE_02336 
 
5.00E-80 
 
91% 
 
64% 
 
Bacteroidetes 
 
SMG 14 Bacteroides sp. D2 
 
TonB-dependent receptor  
 
1.00E-65 
 
99% 
 
55% 
 
Bacteroidetes 
 
SMG 15 n/a 
 
No sequence data 
 
n/a 
 
n/a 
 
n/a 
 
n/a 
 
SMG 16 Pseudomonas syringae pv. aceris str. 
M302273PT 
 
Phage integrase, putative  
 
7.00E-31 
 
69% 
 
47% 
 
Proteobacteria (γ) 
 
SMG 17 Pseudomonas syringae pv. aceris str. 
M302273PT 
 
Phage integrase, putative  
 
1.00E-32 
 
50% 
 
51% 
 
Proteobacteria (γ) 
 
SMG 18 n/a 
 
No sequence data 
 
n/a 
 
n/a 
 
n/a 
 
n/a 
 
SMG 19 Prevotella copri DSM 18205 
 
Putative Tat pathway signal sequence  
 
2.00E-26 
 
59% 
 
52% 
 
Bacteroidetes 
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SMG 20 Slackia heliotrinireducens DSM 20476 
 
Fe-S oxidoreductase, coproporphyrinogen III oxidase  
 
2.00E-18 
 
22% 
 
70% 
 
Actinobacteria 
 
SMG 21 Bacteroides caccae ATCC 43185 
 
Hypothetical protein BACCAC_01367  
 
1.00E-126 
 
58% 
 
98% 
 
Bacteroidetes 
 
SMG 22 Prevotella oulorum F0390 
 
Hypothetical protein HMPREF9431_01698 
 
7.00E-61 
 
58% 
 
65% 
 
Bacteroidetes 
 
SMG 23 Clostridium methylpentosum DSM 5476 
 
Hypothetical protein CLOSTMETH_00476  
 
8.00E-19 
 
97% 
 
23% 
 
Firmicutes 
 
SMG 24 Bacteroides eggerthii 1_2_48FAA 
 
TonB-dependent receptor  
 
3.00E-123 
 
100% 
 
54% 
 
Bacteroidetes 
 
SMG 25 Akkermansia muciniphila ATCC BAA-835 
 
DNA polymerase III, alpha subunit Amuc_0374 
 
0.00E+00 
 
99% 
 
95% 
 
Verrucomicrobia 
 
SMG 26 Bacteroides fragilis 3_1_12 
 
Excinuclease ABC subunit B  
 
1.00E-34 
 
73% 
 
82% 
 
Bacteroidetes 
 
SMG 27 Alistipes sp. HGB 7 
 
Glycosyl hydrolase, family 57 
 
0.00E+00 
 
97% 
 
95% 
 
Bacteroidetes 
 
SMG 28 Pseudomonas fluorescens Pf-5 
 
Efflux; ABC transporter ATP-binding protein  
 
1.00E-72 
 
79% 
 
53% 
 
Proteobacteria (γ) 
 
SMG 29 Uncultured rumen bacterium 
 
Beta-D-xylosidase/alpha-L-arabinosidase  
 
1.00E-90 
 
82% 
 
66% 
 
Bacteroidetes 
 
SMG 30 Bacteroides caccae ATCC 43185 
 
Hypothetical protein BACCAC_01367  
 
2.00E-90 
 
59% 
 
98% 
 
Bacteroidetes 
 
SMG 31 n/a 
 
No sequence data 
 
n/a 
 
n/a 
 
n/a 
 
n/a 
 
SMG 32 Lacinutrix sp. 5H-3-7-4 
 
Primosomal protein N' 
 
9.00E-74 
 
92% 
 
44% 
 
Bacteroidetes 
 
SMG 33 Capnocytophaga sp. oral taxon 329 str. F0087 
 
RND transporter, HAE1/HME family, permease protein  
 
6.00E-84 
 
98% 
 
47% 
 
Bacteroidetes 
 
SMG 34 Bacterium Ellin514  
 
Antibiotic biosynthesis monooxygenase  
 
8.00E-41 
 
54% 
 
40% 
 
Verrucomicrobia 
 
SMG 35 Alistipes sp. HGB5 
 
Transporter; major facilitator family protein (sugar 
phosphate permease) 
 
9.00E-67 
 
73% 
 
56% 
 
Bacteroidetes 
 
SMG 36 Bacteroides coprosuis DSM 18011 
 
Hypothetical protein Bcop_0579  
 
5.00E-69 
 
99% 
 
48% 
 
Bacteroidetes 
 
SMG 37 Pseudomonas fluorescens SBW25 
 
Putative integrase  
 
1.00E-60 
 
66% 
 
61% 
 
Proteobacteria (γ) 
 
SMG 38 Prevotella buccae D17 
 
Glycine dehydrogenase (decarboxylating), subunit 2  
 
1.00E-57 
 
35% 
 
75% 
 
Bacteroidetes 
 
SMG 39 Bacteroides sp. 4_3_47FAA 
 
Dipeptidyl peptidase IV  
 
0.00E+00 
 
99% 
 
98% 
 
Bacteroidetes 
 
SMG 40 Oxalobacter formigenes OXCC13 
 
Conserved hypothetical protein  
 
3.00E-130 
 
81% 
 
79% 
 
Proteobacteria (β) 
 
SMG 41 Alistipes sp. HGB5 
 
3-dehydroquinate dehydratase, type II  
 
2.00E-16 
 
45% 
 
78% 
 
Bacteroidetes 
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SMG 42 Bacteroides sp. 9_1_42FAA 
 
V-type ATP synthase subunit E  
 
2.00E-128 
 
53% 
 
100% 
 
Bacteroidetes 
 
SMG 43 Eubacterium rectale DSM 17629 
 
RecA-family ATPase 
 
3.00E-131 
 
88% 
 
99% 
 
Firmicutes 
 
SMG 44 n/a 
 
No sequence data 
 
n/a 
 
n/a 
 
n/a 
 
n/a 
 
SMG 45 Blastocystis hominis 
 
Unnamed protein product  
 
4.00E-17 
 
91% 
 
47% 
 
Heterokontophyta 
 
SMG 46 Akkermansia muciniphila ATCC BAA-835 
 
Hypothetical protein Amuc_0150 
 
7.00E-25 
 
66% 
 
36% 
 
Verrucomicrobia 
 
SMG 47 Pseudomonas fluorescens Pf0-1 
 
GCN5-like N-acetyltransferase  
 
2.00E-82 
 
48% 
 
81% 
 
Proteobacteria (γ) 
 
SMG 48 Unidentified 
 
No significant similarity 
 
n/a 
 
n/a 
 
n/a 
 
n/a 
 
SMG 49 Bacteroides ovatus SD CMC 3f 
 
Conserved hypothetical protein  
 
7.00E-94 
 
98% 
 
48% 
 
Bacteroidetes 
 
SMG 50 Alistipes sp. HGB5 
 
Putative membrane protein  
 
7.00E-45 
 
52% 
 
90% 
 
Bacteroidetes 
 
SMG 51 Akkermansia muciniphila ATCC BAA-835 Small multidrug resistance protein Amuc_0621 
 
 
3.00E-39 
 
32% 
 
88% 
 
Verrucomicrobia 
 
SMG 52 Bacteroides thetaiotaomicron VPI-5482 
 
Hypothetical protein (BT_1366) 
 
0.00E+00 
 
100% 
 
100% 
 
Bacteroidetes 
 
SMG 53 Bifidobacterium bifidum PRL2010 
 
TrpS Tryptophanyl-tRNA synthetase  
 
1.00E-118 
 
100% 
 
99% 
 
Actinobacteria 
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Full fosmid sequencing was performed on clones SMG 1, 3, 5, 6 and 25, 
revealing insert sizes of 36, 39, 42, 36 and 44kb respectively. The sequences 
have been submitted to GenBank; with following accession numbers: SMG 1 = 
JQ269596; SMG 3 = JQ269597; SMG 5 = JQ269598; SMG 6 = JQ269599; 
SMG 25 = JQ269600. SMG 1 and SMG 6 were found to have the same 
metagenomic insert, with the highest genetic identity to Bacteroides 
thetaiotaomicron. SMG 5 shared highest genetic identity to Eggerthella sp. 
YY7918 (a member of the high G+C Gram-positive Actinobacteria). However, it 
should be noted that BlastP analysis of the predicted proteins encoded by the 
SMG 5 genes revealed many variations in the associated species.  While all but 
one corresponded to members of the phylum Actinobacteria, the genera were 
represented by various species of Eggerthella, Slackia, Cryptobacterium and 
Gordonibacter. This indicates that the SMG 5 insert represents DNA from a 
novel species from one of these genera or the occurrence of recombination 
events between species of these genera. SMG 25 shared highest genetic 
identity to Akkermansia muciniphila (a member of the Gram-negative 
Verrucomicrobia).  Putative open reading frames were identified using 
FGENESB bacterial operon and gene prediction software from Softberry 
(Mavromatis et al., 2007). BLAST analysis revealed the presence of a 
hypothetical protein (EGYY_03530) and a UDP glucose 4-epimerase encoded 
by putative mazG and galE genes respectively. These genes were present on 
SMG 5 and SMG 25 and were designated mazG(5) and galE(25) respectively. 
Having previously cloned and expressed homologous genes (galE(3) and 
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mazG(3)) from SMG 3 in E. coli MKH13, resulting in an increased salt tolerance 
phenotype, it was decided to clone these bioinformatically identified mazG(5) 
and galE(25) genes into E. coli MKH13 also.   
 The nucleotide sequences of the genes identified were compared with 
the MetaHit dataset from the healthy individuals (Qin et al., 2010) to determine 
the relative abundance of the genes among the gut metagenomes of the 
subjects.  Homologues of all of the genes identified in this study were found to 
be present in all MetaHit samples (>50% identity; e-value <1^10-5). The galE 
genes (galE(3) and galE(25)) were found to be much more abundant than both 
mazG(3) and murB(3), with a hit rate of approximately 1 per Mb of DNA 
screened, compared to approximately one per 4-6 Mb DNA for mazG and murB 
(Figure 2A, B and C). 
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Figure 2. Relative abundance of the genes identified in this study when BLASTed against the healthy individuals in the 
MetaHit dataset. (A) galE(3) = black; murB(3) = light grey; mazG(3) = dark grey, (B) galE(25) and (C) mazG(5).
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Growth experiments 
Three genes were identified by transposon mutagenesis from SMG 3, 
namely galE(3), murB(3) and mazG(3) and two further genes were identified 
through bioinformatic analysis; mazG(5) from SMG 5 and galE(25) from SMG 
25.  The genes were cloned with some flanking DNA into the shuttle plasmid 
pCI372 and transformed into electro-competent E. coli MKH13.  Growth 
experiments in LB and LB supplemented with NaCl or KCl (ionic osmotic stress) 
were conducted on MKH13::pCI372-mazG(3), MKH13::pCI372-murB(3), 
MKH13::pCI372-galE(3), MKH13::pCI372-mazG(5) and MKH13::pCI372-
galE(25).  Each of the five transformed clones showed a statistically significant 
increase in salt tolerance (to both NaCl and KCl) compared to control strain 
MKH13 (Figure 3B and 3C), while no difference in growth was observed in LB 
alone (Figure 3A).  Each of the five transformed clones was also tested in their 
ability to grow under conditions of non-ionic osmotic stress (i.e. sucrose or 
glycerol).  An increased growth phenotype was not observed under these 
conditions for any of the clones (Figure 4), indicating these genes may confer a 
salt-specific protective effect. 
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Figure 3.  
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(C) 
 
 
 
 
 
 
 
 
 
 
Figure 3. Growth in LB and LB supplemented with 3% NaCl or 4% KCl*.  
Growth of control strain MKH13::pCI372 ( closed circle), MKH13::pCI372-
galE(3) (P<0.006) (P=0.0004) ( open circle), MKH13::pCI372-murB(3) 
(P<0.0001) (P<0.0001) ( open triangle), MKH13::pCI372-mazG(3) (P<0.0001) 
(P=0.0017) ( closed triangle), MKH13::pCI372-galE(25) (P=0.0002) 
(P=0.0012) ( closed square) and MKH13::pCI372-mazG(5) (P=0.0003) 
(P<0.0001) ( open square) in (A) LB broth, (B) LB broth supplemented with 
3% NaCl and (C) LB broth supplemented with 4% KCl.  
 
* The first P-value in parentheses represents growth in NaCl, while the second 
P-value represents growth in KCl. 
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Figure 4. Growth of control strain MKH13::pCI372 ( closed circle), 
MKH13::pCI372-galE(3), ( open circle), MKH13::pCI372-murB(3), ( open 
triangle), MKH13::pCI372-mazG(3), ( closed triangle), MKH13::pCI372-
galE(25), ( closed square) and MKH13::pCI372-mazG(5), ( open square) in 
(A) LB supplemented with 20% glycerol, (B) LB broth supplemented with 30% 
sucrose. 
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Figure 5.  
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(B) 
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Figure 5. Phylogenetic analysis of identified genes. Phylogenetic analysis 
of (A) GalE(3) (COLAER_01955), MurB(3) (COLAER_01957),  MazG(3) 
(COLAER_01981), (B) GalE(25) (Amuc_1125) and (C) MazG(5) (EGYY_03530) 
and related proteins.  Phylogenetic analysis was performed using the program 
MEGA 5.0 (Tamura et al., 2011).  The bootstrap method (500 replicates) was used 
to test the percentage of replicate trees in which the associated taxa clustered 
together. 
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Discussion 
Metagenomics has the potential to allow us to advance, or for the 
most part to begin, the study of the genetic complement of uncultured 
microbes.  In the current study we used a combined functional metagenomic, 
transposon mutagenesis and bioinformatic strategy to screen a metagenomic 
library from the human gut microbiota for potential salt-tolerant clones and 
identified five genes (see Table 3.), namely galE(3) and galE(25), mazG(3) 
and mazG(5) and murB(3), involved in salt tolerance and likely to be 
important for life in the gut. 
In the most comprehensive analysis to date of the genetic 
complement of the human gut microbiome, a cohort of over 1200 genes 
(termed range clusters) were identified which encode functions important for 
life in the gut (Qin et al., 2010).  These included genes which encoded 
proteins similar to those which we have identified in this study, namely; UDP 
glucose-4-epimerase, NTP pyrophosphohydrolase (for which MazG is a 
functional homologue), as well as a protein containing a tetrapyrrole 
methyltransferase domain and a MazG-like domain and UDP-N-
acetylmuramate dehydrogenase (which is another name for MurB; UDP-N-
acetylenolpyruvylglucosamine reductase) (Supplementary Table 10 from Qin 
et al., 2010).  The presence of the genes encoding these proteins in the 
enriched gene set leads us to conclude that they are important for survival in 
the gut and their putative role in adapting to fluctuating levels of osmotic 
stress in the gut.  Also, homologues of the identified sequences from this 
study were found to be abundant in each of the individual metagenomes 
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from the MetaHit dataset (Figure 2A, B and C).  Furthermore, an analysis of 
human gut genomic and metagenomic datasets identified uncharacterized 
and novel protein families which are over-represented in the human gut 
(Ellrott et al., 2010).  Among these, and second on the list of over-
represented protein families, are coiled-coil osmosensory transporters.  The 
best characterized of the coiled-coil transporters is ProP of E. coli, which is 
responsible for the uptake of osmoprotectants such as proline and betaine 
during osmotic stress (Culham et al., 1993).  Such representative proteins 
were not found in any of the genomes analysed from microbes not 
associated with the human gut microbiome, indicating their importance to 
bacteria residing in the human gut.  This observation also reinforces the idea 
that the human gut microbiota may employ novel strategies and possess 
novel mechanisms for osmoadaptation.  
Transposon mutagenesis resulted in the identification of a gene (galE) 
from SMG 3 (galE(3)), encoding a UDP glucose 4-epimerase (GalE) (also 
termed UDP galactose 4-epimerase), while another galE gene was 
bioinformatically identified from SMG 25 (galE(25)).  This enzyme catalyses 
the direct inter-conversion of UDP glucose and UDP galactose (Leloir, 1951), 
which are precursors involved in the synthesis of capsular polysaccharide 
(CPS) and the compatible solute trehalose as well as the synthesis of 
lipopolysaccharide (LPS) and membrane-derived oligosaccharides (MDO’s) 
in Gram negative bacteria and lipoteichoic acids in Gram positive bacteria 
(Fukasawa et al., 1962; Giaever et al., 1988; Grundling and Schneewind, 
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2007; Markovitz, 1977; Schulman and Kennedy, 1977; Seltman and Holst, 
2002). 
The galE gene is often found in an operon with the galT and galK 
genes for galactose metabolism.  In SMG 3 (highest genetic identity to C. 
aerofaciens), the galE gene (COLAER_01955) is found not on a gal operon, 
but between two genes encoding hypothetical proteins similar to a peptidase 
and a 4-alpha-glucanotransferase (COLAER_01956 and COLAER_01953, 
respectively). COLAER_01957 (murB) is located 226 nucleotides 
downstream of COLAER_01956.  C. aerofaciens’ galE may still be involved 
in galactose metabolism as the organism can utilize galactose (Kageyama et 
al., 1999).  The galE gene from SMG 25 is not found on the galactose 
operon and also exhibits a different genomic arrangement to SMG 3. This 
gene, galE(25), which shares 96% identity to A. muciniphila (Amuc_1125), is 
located between a UDP-galactopyranose mutase homolog from 
Chthoniobacter flavus (52% identity) and a gene encoding a hypothetical 
protein similar to Amuc_1123 from A. muciniphila.  Furthermore, the fosmid 
insert of SMG 25 has a vastly different genomic arrangement to that of A. 
muciniphila.  This lack of synteny indicates that the fosmid insert is not from 
A. muciniphila, but from a related but as yet undiscovered species.  Indeed, 
sequences representing at least eight uncharacterized species of the genus 
Akkermansia have been identified from different gut metagenomic libraries 
(van Passel et al., 2011)..  Interestingly, a UDP glucose 4-epimerase 
homolog has been identified as a putative gene involved in drought tolerance 
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in rice by modulating the ability of rice roots to penetrate deeper into the 
substratum when exposed to drought conditions (Nguyen et al., 2004).  
A transposon insertion in the galE could potentially affect the cell in 
different ways; (1) by causing compositional changes in the LPS layer or in 
lipoteichoic acids of Gram negative and Gram positive bacteria, respectively, 
thus reducing the cell’s ability to sense, respond to or resist various 
environmental stress conditions. (2) by disrupting the inter-conversion of 
UDP-glucose and UDP-galactose. UDP glucose may be a key molecule as it 
can be converted to the osmoprotectant trehalose (Giaever et al., 1988), in 
addition to potentially modulating the expression of RpoS (which increases 
expression of a number of genes at high salt concentrations (Bohringer et al., 
1995; Hengge-Aronis et al.,1991). 
Expressing this galE gene in E. coli may result in increased UDP 
glucose levels which could be converted to trehalose resulting in an 
osmoprotective effect.  Padilla and co-workers increased the UDP glucose 
supply and consequently the levels of accumulated trehalose by expressing 
the E. coli galU gene in Corynebacterium glutamicum (Padilla et al., 2004).  
In our study, the expression of both the galE(3) and galE(25) genes in the 
osmosensitive strain E. coli MKH13 resulted in a statistically significant 
increased salt (NaCl and KCl) tolerance phenotype (Figure 3B and 3C).  Of 
the five genes identified and cloned, galE(3) had a lesser effect than the 
other four genes.  MKH13::pCI372-galE(3) also had a prolonged lag phase.  
It has been demonstrated that cellular stress may be caused by imbalances 
and accumulation of certain intermediary metabolites, particularly in the case 
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of amphibolic pathways (e.g. D-galactose pathway), as demonstrated in a 
galE mutant (Lee et al., 2009).  In the current study, supplying MKH13 with 
an additional plasmid encoded copy of galE may also cause an imbalance in 
an intermediary metabolite, leading to stress and ultimately a prolonged lag 
phase, which ends when the imbalance is corrected and homeostasis is 
restored.   
Peptidoglycan is a major component of the bacterial cell wall and 
plays an important role in withstanding osmotic stress (van Heijenoort, 1996).  
MurB is essential for cell wall biosynthesis and is involved in a two-step 
process with UDP-N-acetylglucosamine enolpyruvyl tranferase (MurA) to 
form UDP-N-acetylmuramate, which is a building block for peptidoglycan 
(Sylvester et al., 2001).  The murB gene has been shown to be essential for 
normal growth in Bacillus subtilis, E. coli and Staphylococcus aureus 
(Matsuo et al., 2003; Miyakawa et al., 1972; Real and Henriques, 2006).  In 
S. aureus, a mutation within the murB gene resulted in thermosensitive 
mutants which had thinner cell walls (Matsuo et al., 2003).  The murB(3) 
gene conferred an increased growth phenotype to E. coli MKH13 during both 
NaCl and KCl stress (Figure 3B and 3C).  Disruption or deletion of the murB 
gene could make cells acutely sensitive to osmotic stress due to a reduction 
in cell wall integrity as well as causing a reduction in turgor pressure which is 
a driving force for cellular growth and division.  Bacteria remodel the 
structure of their peptidoglycan in response to changes in environmental 
conditions (Quintela et al., 1997; Vijaranakul et al., 1995), which could be 
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important in the gut by allowing for varying levels of rigidity or elasticity 
depending on the conditions in the immediate environment.   
We have also identified two putative MazG family proteins (encoded 
by the mazG gene from SMG 3 and SMG 5 (mazG(3) and mazG(5), 
respectively). These are highly conserved proteins in bacteria and to date 
there has been no tangible link demonstrated between MazG and salt 
tolerance.  MazG is a nucleoside triphosphate pyrophosphohydrolase 
(NTPase) which can hydrolyse (deoxy)ribonucleoside triphosphates 
((d)NTPs) to their corresponding (deoxy)ribonucleoside monophosphates 
((d)NMPs) and pyrophosphate (PPi) (Zhang and Inouye, 2002).  It has been 
proposed that MazG plays a role in cellular “house-cleaning” by removing 
abnormal (d)NTP’s from nascent DNA strands (Galperin et al., 2006), in 
addition to regulating programmed cell (PCD) death in E. coli (Gross et al., 
2006).  It also regulates intracellular levels of (p)ppGpp, the main nutritional 
stress signal molecule involved in the stringent response, which has been 
shown to be an important response in Campylobacter jejuni during intestinal 
colonization (Stintzi et al., 2005).  By reducing (p)ppGpp levels, MazG plays 
a central role in maintaining cell viability during nutritional stress, which could 
be important in the gut during periods of intermittent availability of certain 
nutrients, while (p)ppGpp itself is required for growth during osmotic stress in 
L. monocytogenes (Okada et al., 2002).  Moreover, recent work has 
identified a role for MazG in the mycobacterial oxidative stress response and 
virulence (Lu et al., 2010; Sassetti and Rubin, 2003).  As outlined above 
MazG plays a number of different roles in different bacteria, but it is clear that 
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stress response is a common theme. This study provides evidence for a 
novel role of MazG in salt tolerance.  In the context of the gut environment, 
MazG may be important in removal of mutagenic nucleotides from growing 
DNA strands.  Damage to bacterial DNA is likely due to exposure to 
genotoxic compounds such as nitrosamines and heterocyclic amines 
(Kurokawa et al., 2007).  In addition MazG could provide energy to the cell 
during stress through the hydrolysis of ATP.  Due to the numerous roles of 
MazG in different stress conditions it may function as general stress 
response protein in the bacterial cell.  More research and discovery of novel 
MazG proteins will help identify new physiological roles, substrates and 
precise mechanisms of action for these proteins in the myriad of stress 
conditions imposed on microorganisms. 
In conclusion, we have identified five genetic loci involved in salt 
tolerance from within the human gut microbiome using a functional 
metagenomic approach.  The genes represent two different homologs of 
galE and two of mazG, as well as a murB homolog, from three different 
species of the genus’ Collinsella, Akkermansia and Eggerthella.  The 
identification of three genes within approximately 40kb of metagenomic DNA 
from SMG 3 (highest genetic identity to C. aerofaciens) is relevant in that 
functionally related proteins are often co-located on the chromosome of 
prokaryotic genomes (Sleator and Walsh, 2010; Sleator, 2011).  In addition 
to expanding our knowledge of salt tolerance mechanisms, this study may 
also facilitate the development of novel drug targets and related approaches 
to control resident gut microbiota (Sleator 2010a, Sleator 2010b).  Ultimately 
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some of the salt tolerance mechanisms identified might be used as part of a 
“patho-biotechnology” (Sleator and Hill, 2006) or “meta-biotechnology” 
(Culligan et al., 2009) strategy for the design of improved probiotic cultures 
with greater resistance to process induced stresses (such as spray and 
freeze drying), as well as improved gut colonization (see (Sheehan et al., 
2006; Sheehan et al., 2007; Watson et al., 2008) for such examples).  This 
will hopefully result in a broader and more comprehensive representation of 
salt tolerance mechanisms in this unique environment. 
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CHAPTER III  
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Mining the Human Gut Microbiome for 
Novel Stress Resistance Genes 
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Abstract 
With the rapid advances in sequencing technologies in recent years, 
the human genome is now considered incomplete without the 
complementing microbiome, which outnumbers human genes by a factor of 
one hundred.  The human microbiome, and more specifically the gut 
microbiome, has received considerable attention and research efforts over 
the past decade.  Many studies have identified and quantified “who is 
there?”, while others have determined some of their functional capacity, or 
“what are they doing?”  In a recent study, we identified novel salt-tolerance 
loci from the human gut microbiome using combined functional metagenomic 
and bioinformatics based approaches. Herein, we discuss the identified loci, 
their role in salt-tolerance and their importance in the context of the gut 
environment. We also consider the utility and power of functional 
metagenomics for mining such environments for novel genes and proteins, 
as well as the implications and possible applications for future research.  
 
Introduction  
Bacteria encounter numerous environmental stresses in various 
environments and the gastrointestinal tract is no exception.1 This dynamic 
environment poses a set of challenges that both transient and symbiotic 
microorganisms must overcome in order to colonise and proliferate.2 Low 
pH, bile acids, elevated osmolarity, iron limitation, intermittent nutrient 
availability and host immune factors are just some of the challenges faced in 
the gastrointestinal tract.3  The ability to cope with rapid changes in external 
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osmolarity is an important mechanism that allows microorganisms adapt to 
and colonise a given environmental niche.4 The cellular response to hyper-
osmotic stress is broad and involves a number of different processes such as 
potassium (K+) uptake5, compatible solute accumulation6 and numerous 
ancillary systems.7, 8  
 The emergence of metagenomics as a key area of scientific research 
in recent years has transformed how we view ourselves as living 
organisms.9, 10  Working with microbes in pure cultures is very reductive in 
terms of understanding microbial behaviour in complex ecological niches. 
Metagenomics can, in principle, allow us access the entire genetic 
complement of our associated microbiome without the need for classic 
microbiological culturing techniques. Despite recent advances in high-
throughput anaerobic culturing techniques with gnotobiotic animal 
husbandry, which suggests that the human faecal microbiota consists largely 
of taxa and predicted functions that are represented in its cultured 
members,11 functional metagenomics allows us to rapidly separate the 
‘wheat from the chaff’.  Gaining insights about the functional capacity of the 
human gut microbiome was a key aim in our efforts to elucidate novel 
genetic loci conferring a salt tolerance phenotype. We employed a functional 
metagenomic screen of a human gut metagenomic library which resulted in 
the identification of five novel genes involved in salt tolerance.12 An 
advantage of functional metagenomics is its ability to uncover completely 
novel functions for new or known genes without the need for any previous 
sequence information. 
 
 
 
1
2
7
 
Figure 1.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. An overview of novel gene discovery using functional metagenomics; from metagenomic library creation to novel 
therapeutics.
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Novel salt tolerance loci identified 
From our initial screen (the overall scheme is presented in Figure 1) of 
over 20,000 metagenomic clones, we identified 53 that could tolerate high 
sodium chloride (NaCl) concentrations. We termed these clones SMG 1-53 
(salt metagenome). Through a combined transposon mutagenesis and 
bioinformatic strategy we identified five novel salt tolerance genes from clone 
SMG 3 (namely galE, murB and mazG) as well as additional mazG and galE 
genes from clone SMG 5 and SMG 25, respectively.  Phylogenetic 
assignments revealed SMG 3 had the highest genetic identity to Collinsella 
aerofaciens, while SMG 5 and SMG 25 corresponded to Eggerthella sp. 
YY7918 and Akkermansia muciniphila, respectively. Each of the five genes 
was cloned separately and expressed in the osmosensitive strain 
Escherichia coli MKH13, which resulted in an increased tolerance to the ionic 
osmotic stressors NaCl and KCl (potassium chloride), but not to non-ionic 
stressors such as sucrose and glycerol, a finding which seems to suggest 
that these genes confer a salt-specific protective effect.  While E. coli has 
been shown to up-regulate a set of genes in response to both ionic and non-
ionic osmotic stress, it also regulates genes specific to each type of stress.13 
Furthermore each of the three genes was also found to be over-represented 
in the human gut metagenome and abundant among healthy subjects from 
the MetaHit dataset.12, 14 
 
galE 
The galE gene product (UDP glucose 4-epimerase) catalyses the 
inter-conversion of UDP glucose and UDP galactose and has been 
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previously linked to the osmotic stress response through different 
mechanisms such as the production of the osmoprotectant trehalose or 
through cellular signalling.15, 16 We theorise that galE may be important in 
maintaining the integrity of the lipopolysaccharide (LPS) in Gram negative or 
lipoteichoic acid (LTA) layers in Gram positive bacteria, making the cell more 
resistant to salt-induced osmotic stress. A recent functional metagenomic 
study identified a galE gene, that when cloned and expressed in E. coli 
conferred resistance to menadione, which can cause membrane damage 
through the generation of reactive oxygen species.17 The authors believe the 
resistance is mediated through galE by increasing the permeability barrier of 
the cell. Such menaquinones are also found at significant concentrations in 
the human gastrointestinal tract.18 The ability to form biofilms is likely to be 
critically important in the gut environment and for homeostasis within the 
community.19 Furthermore, it has been shown that galE mutants have 
reduced ability to form biofilms, while gal mutants are defective in intestinal 
colonisation, both of which could be an important factor in the gastrointestinal 
tract.20, 21 
 
murB 
The murB gene is involved in the biosynthesis of peptidoglycan and 
the bacterial cell wall, which itself plays an important role in withstanding 
osmotic stress.22 Disruption or deletion of the murB gene could make cells 
acutely sensitive to osmotic stress due to a reduction in cell wall integrity as 
well as causing a reduction in turgor pressure which is a driving force for 
cellular growth and division.  Bacteria remodel the structure of their 
 
 
130 
 
peptidoglycan in response to changes in environmental conditions 23, which 
could be important in the gut by allowing for varying levels of rigidity or 
elasticity depending on the conditions in the immediate environment. One of 
the more interesting functions of peptidoglycan, and a possible reason why 
genes for its synthesis are enriched among the human gut microbiota, is its 
stimulation of host immunity.  Clarke et al (2010), have demonstrated 
peptidoglycan from the commensal microbiota modulate the innate immune 
system by improving neutrophil function even in the absence of infection.24  
The authors note that peptidoglycan can be translocated to the bloodstream, 
with concentrations at similar levels to those in faeces, indicating that there is 
constant peptidoglycan turnover among the microbiota and that immune 
stimulation by the microbiota can affect sites distal from the GI tract.  
Stimulated neutrophils demonstrated increased killing of the pathogenic 
bacteria Streptococcus pneumoniae and S. aureus.24  This may indicate a 
co-evolution of a mutually beneficial arrangement by removing potentially 
harmful host pathogens and competitors to our symbiotic gut microbiota. 
 
mazG 
The mazG gene represents the most interesting of the identified 
genes, in that its possible mode of action in response to salt stress is not as 
immediately clear as galE or murB. As the latter two genes are related to 
outer membrane or cell wall functions, one can envisage how they could 
mediate resistance to external environmental stresses. MazG has been 
shown to play a role in different cellular processes, such as the removal of 
aberrant dNTP’s from DNA strands,25 as well as the oxidative26 and 
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nutritional stress responses.27 Often found in association with the mazEF 
toxin-antitoxin (TA) system, the mazG gene product can delay programmed 
cell death and allow the cell to survive for longer periods under stress in the 
event that additional nutrients become available.27 TA systems such as 
mazEF can induce cell death or arrest in response to various cellular 
stresses,28 particularly those which induce DNA damage. MazG may delay 
apoptosis in salt-stressed cells as well as providing a mechanism to reduce 
or repair salt-induced damage to DNA. It has been speculated that individual 
TA systems may respond to specific stresses29 and play a role in biofilm and 
persister cell formation, as well as having numerous other putative 
functions.30 The development of persister cells allows for the survival of a 
small subpopulation through the death of the majority of the population.31 
Such an altruistic characteristic benefits long term survival and it seems, at 
the microscopic level, that the sacrifice of many for the good of a few may be 
a tenet of bacterial survival. Although the mazG genes identified in our 
study12 are not located in the genomic neighbourhood of any obvious TA 
system, it is possible their encoded proteins could still regulate such TA 
systems at distant chromosomal locations or indeed regulate as yet 
unidentified, stress responsive genes or function as a general stress 
responsive protein itself. 
 
Future perspectives 
 Whilst expanding our current knowledge on the diverse mechanisms 
employed by bacteria to overcome salt stress, the identification of novel 
genes may also assist in the development of novel drugs and drug targets as 
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well as novel strategies to control some of the resident gut microbiota.32, 33 
Interestingly murB has been investigated as a possible target for novel 
antibiotics and antibacterial compounds34 as it is exclusively found in bacteria 
and it has an important role in maintaining cellular integrity and viability. 
Furthermore, galE has been investigated as target for novel therapeutics 
against African sleeping sickness35 and a galE mutant of Salmonella enterica 
serovar Typhi has been used to create an oral live attenuated vaccine for 
typhoid.36 TA systems have also received attention as possible novel 
antibacterial drug targets.37 MazG could also be a putative target, if 
disruption of its function could allow the toxin component of the TA system to 
cause cell death to certain bacterial populations.  
 Ultimately we would envisage that some of these novel salt tolerance 
genes could be used as part of a “meta-biotechnology”38 strategy for the 
development of technologically more robust probiotic cultures and with 
greater ability to survive gastrointestinal transit and colonise the gut. Meta-
biotechnology describes the “mining” of the human gut metagenome for 
novel genes for use in medicine, science and industry for the development of 
novel therapeutics38 and is an extension of the patho-biotechnology39, 40 
concept. Patho-biotechnology has been used with success to engineer 
probiotic strains with increased stress resistance, improved gastrointestinal 
persistence and colonisation and therapeutic efficacy.41  
Mining the metagenome is not limited to the identification of novel 
stress tolerance genes but may be used for the identification of novel 
antimicrobial compounds or genes that may be used for the development of 
designer probiotics which can be used to target specific pathogens or 
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toxins.42 New ways of thinking and alternative therapies are needed to 
control and combat pathogenic microorganisms in the era of increasing 
antibiotic resistance and emerging superbugs. The identification of such 
novel genes will broaden our understanding of salt tolerance in bacteria and 
uncover novel mechanisms employed for survival in the gastrointestinal tract 
as well as providing a platform for the development of novel biological 
therapeutics or novel drug targets. 
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Abstract 
The human gut microbiome consists of at least 3 million non-
redundant genes, 150 times that of the core human genome. Herein, we 
report the identification and characterisation of a novel stress tolerance gene 
from the human gut metagenome. The locus, assigned brpA, encodes a 
membrane protein with homology to a brp/blh-family beta-carotene 
monooxygenase. Cloning and heterologous expression of brpA in 
Escherichia coli confers a significant salt tolerance phenotype. Furthermore, 
when cultured in the presence of exogenous beta-carotene, cell pellets adopt 
a red/orange pigmentation indicating the incorporation of carotenoids in the 
cell membrane. 
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Introduction 
 Metagenomics provides a culture-independent means to access and 
study the genetic content of all of the microorganisms in a particular 
environmental niche. Metagenomic analysis can be sequence-based or 
functional (or a combination of both). The development of faster, cheaper 
and more accurate next-generation sequencing (NGS) technologies has 
allowed new insights into microbial community structure and diversity and 
has led to the discovery of many novel genetic loci [1-4]. Functional 
metagenomics has also been utilised to identify many novel functions 
through cloning and heterologous expression of metagenomic DNA and 
subsequent phenotypic detection of a desired trait conferred on the cloning 
host. Some notable examples include genes encoding proteins of industrial, 
pharmaceutical and medical relevance such as lipases, esterases and novel 
antibiotics [5-8]. 
 The human gut microbiome has become perhaps the most intensively 
studied environment using metagenomics [9,10]. Collectively, there are at 
least 150 times as many genes in the human gut microbiome than there are 
human genes in the genome, a large proportion of which are uncharacterised 
[11]. The ability to respond and adapt to external environmental stresses is 
key to microbial survival and it is possible to use metagenomics to identify 
novel mechanisms that enable such survival [12]. In the gastrointestinal (GI) 
tract microorganisms are faced with numerous challenges such as low pH, 
low iron concentrations, increased osmolarity, bile, immunity mechanisms 
and competing microbes [13,14]. Different sets of genes are activated in 
response to environmental cues [15]. Work in our lab is focused on genes 
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that confer increased tolerance to osmotic stress [16]. The response to 
osmotic stress is broad and encompasses many diverse cellular processes 
and systems [17]. Metagenomics makes it possible to identify novel systems 
unrelated to the classical (and comprehensively studied) primary and 
secondary responses of potassium (K+) uptake and osmoprotectant 
utilisation [18-20]. We have previously identified a number of novel salt 
tolerance loci from the human gut microbiota using a combination of 
functional metagenomic screening, next-generation sequencing and 
bioinformatic analyses [21-23]. 
 In this study we report the identification of a novel salt tolerance gene 
from a human gut metagenomic library we have previously described [22]. 
An in silico analysis revealed the gene (which we have termed brpA) 
encoded a carotenoid modifying enzyme with homology to a brp/blh-family 
beta-carotene 15,15’-monooxygenase protein, which cleaves beta-carotene 
to two molecules of all-trans retinal (vitamin A aldehyde) [24,25]. Finally, we 
demonstrate that brpA confers an increased salt tolerance phenotype when 
heterologously expressed in Escherichia coli. 
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Materials and methods 
Bacterial strains and growth conditions 
Bacterial strains and plasmids used in this study are listed in Table 1.  
Oligonucleotide primers (synthesised by Eurofins, MWG Operon, Germany) 
are presented in Table 2. E. coli EPI300::pCC1FOS (Epicentre 
Biotechnologies, Madison, WI, USA) was cultured in Luria-Bertani (LB) 
medium containing 12.5g/ml chloramphenicol (Cm) and in 12.5g/ml 
chloramphenicol plus 50g/ml kanamycin (Kan) following EZ-Tn5 
transposon mutagenesis.  E. coli MKH13 was grown in LB and LB 
supplemented with 20g/ml Cm for strains transformed with the plasmid 
pCI372. E. coli strains containing the pBAD expression vector were cultured 
in the presence of 100g/ml ampicillin.  
For growth in minimal media, strains were grown in M9 (Fluka) 
minimal salts supplemented with final concentrations of 0.4% glucose, 0.2% 
casamino acids, 2mM magnesium sulphate (MgSO4) and 0.1mM calcium 
chloride (CaCl2). When required, stock solutions of beta-carotene were 
added to media at a final concentration of 20µM. Growth media was 
supplemented with 1.5% agar for plate assays. All overnight cultures were 
grown with shaking at 37°C.  
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Table 1. Bacterial strains and plasmids  
Strain, plasmid or transposon 
 
Genotype or characteristic(s) Source or 
reference 
 
 
Strains 
E. coli EPI300 
 
 
F
-
 mcrA Δ(mrr-hsdRMS-mcrBC) Φ80dlacZΔM15 ΔlacX74 
recA1 endA1 araD139 Δ(ara, leu)7697 galU galK λ
-
 rpsL 
nupG trfA dhfr; high-transformation efficiency of large DNA 
 
 
 
Epicentre 
Biotechnologies, 
Madison, WI, 
USA 
SMG 6 
 
EPI300 containing pCC1FOS fosmid with ~34kb of 
metagenomic DNA from human gut microbiome 
 
This study 
SMG 6-EZTn5  #24 
 
Transposon insertion in gene 24 (which precedes 
acyltransferase gene atfA) 
 
This study 
SMG 6-EZTn5  #26 
 
Transposon insertion in brpA gene  This study 
SMG 6-EZTn5  #34  
 
Transposon insertion in acyltransferase gene (atfA) 
 
This study 
SMG 6-EZTn5  #38  
 
Transposon insertion in brpA gene This study 
E.coli MKH13 MC4100Δ(putPA)101D(proP)2D(proU) 
 
[26] 
E.coli MKH13::pCI372 
 
MKH13 containing  empty pCI372 plasmid This study 
E. coli MKH13::pCI372-brpAS MKH13 containing pCI372 with brpAS gene from SMG 6; “S” 
subscript denotes shorter predicted gene with TTG start 
codon 
 
This study 
E. coli MKH13::pCI372-brpAL MKH13 containing pCI372 with brpAL gene from SMG 6; “L” 
subscript denotes longer predicted gene with ATG Start 
codon 
 
This study 
 
 
E. coli MKH13::pCI372-brpAatfA   
 
MKH13 containing pCI372 with brpAatfA genes from SMG 6 
 
This study 
E. coli EPI300::pBAD-brpAS 
 
EPI300  containing pBAD with brpAS gene from SMG 6 
This study 
E. coli EPI300::pBAD-brpAL 
 
EPI300 containing pBAD with brpAL gene from SMG 6 
 
This study 
E. coli EPI300::pBAD-brpAatfA 
 
EPI300 containing pBAD with brpA and atfA genes from 
SMG 6 
This study 
Plasmids 
 
pCI372 
 
 
Shuttle vector between E. coli and L. lactis, Cm
R  
 
 
 
[27] 
pCC1FOS 
 
Fosmid cloning vector, Cm
R
 Epicentre 
Biotechnologies, 
Madison, WI, 
USA 
 
pBAD 
 
L-arabinose inducible expression vector, Amp
R
  
 
Invitrogen, USA 
 
Transposon 
 
EZ-Tn5 <oriV/ KAN-2> 
 
 
 
 
Hyperactive Tn5 transposon, Kan
R
, inducible high copy 
origin of replication – oriV 
 
 
 
 
Epicentre 
Biotechnologies, 
Madison, WI, 
USA 
Cm
R
, Kan
R
 and Amp
R
 = chloramphenicol, kanamycin and ampicillin resistance respectively. 
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Table 2. Oligonucleotide primers  
Primer Sequence (5’ – 3’)a 
 
pCI372 FP 
 
CGGGAAGCTAGAGTAAGTAG 
 
pCI372 RP CCTCTCGGTTATGAGTTAG 
 
pBAD FP 
 
ATGCCATAGCATTTTTATC 
pBAD RP 
 
GATTTAATCTGTATCAGG 
brpAS FP 
 
AAAACTGCAGACCCAACACGATGCCATATT 
 
brpAS RP 
 
GCTCTAGATAACAGGGTGCGGTGATACA 
 
brpAatfA FP 
 
AAAACTGCAGTAGCGGCTGGATCGGTAGTA 
 
brpAatfA RP 
 
GCTCTAGAACCCAACACGATGCCATATT 
 
brpAL FP 
 
AAAACTGCAGGCCGAATATCAACCCAACAC 
 
brpAL RP GCTCTAGAAGGTATTTGTGCCTTGTGCT 
 
EZTn-FP-1 
 
GCCAACGACTACGCACTAGCCAAC 
 
EZTn-RP-1 GAGCCAATATGCGAGAACACCCGAGAA 
aRestriction enzyme cut-sites are underlined  
(PstI, CTGCAG; XbaI, TCTAGA) 
 
 
 
 
 
 
 
 
 
 
 
 
148 
 
Construction and screening of the human gut metagenomic library 
A previously constructed fosmid clone library, created from 
metagenomic DNA from the human gut microbiome isolated from a stool 
sample from a 26 year-old healthy Caucasian male [28] was used to screen 
for salt-tolerant clones. The library was screened using the protocol outlined 
by Culligan et al [22]. Briefly, a total of 23,040 library clones were screened 
on LB agar supplemented with 6.5% (w/v) NaCl using a Genetix QPix 2 XT 
colony picking/gridding robotics platform. Plates were incubated at 37°C for 
2-3 days and checked periodically for growth of likely salt-tolerant clones. 
 
Sequencing and bioinformatic analysis 
The fosmid insert from clone SMG 6 was fully sequenced and 
assembled by GATC Biotech (Konstanz, Germany) using the GS-FLX 454 
pyrosequencing (Roche) platform on a Titanium mini-run.  Putative open 
reading frames were predicted using Softberry FGENESB bacterial operon 
and gene prediction software (www.softberry.com) and also GeneMark [29].  
Retrieved nucleotide and translated amino acid sequences were functionally 
annotated by homology searches using the Basic Local Alignment and 
Search Tool (BLAST) to identify homologous sequences from the National 
Centre for Biotechnology Information (NCBI) website: 
http://www.ncbi.nlm.nih.gov/blast/Blast.cgi.  The following databases and 
tools were used to gain additional information on the BrpA protein: 
Conserved Domain Database (CDD), PROSITE motif search, SignalP 4.0, 
HMMER, TMHMM, HHPred, and Softberry BProm promoter search 
(www.softberry.com) [30-36]. 
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The Fold and Functional Assignment System (FFAS03) is a profile-
profile and fold recognition algorithm that can detect remote homology 
between proteins [37]. Profile-profile comparisons have increased sensitivity 
compared to sequence-sequence or profile-sequence algorithms. FFAS03 
searches numerous databases including non-redundant (nr) NCBI, Global 
Ocean Sampling (GOS) from JCVI, PDB, SCOP, and COG, as well as 
numerous metagenome datasets including MetaHit [11] which contains over 
3 million unique genes from the human gut microbiome. The BrpA protein 
sequence was submitted to the server to identify proteins with distant 
homology based on FFAS profiling or homologues by BLAST and PSI-
BLAST against the databases and metagenome datasets. The FFAS03 
server can be found at: http://ffas.burnham.org/ffas-cgi/cgi/document.pl 
The Integrated Microbial Genomes and Metagenomes (IMG/M) [38] is 
a data management system for the comparative analysis of metagenome 
sequence data. IMG/M-HMP [39] specifically contains metagenome data 
from the Human Microbiome Project (HMP) [40]. It contains 748 
metagenome datasets generated from sequencing samples from different 
body sites and also, tools for comparative analysis between hosted 
sequences and user supplied sequences. The BrpA protein sequence was 
used a query sequence to BLAST (1e-05 and 1e-50 maximum e-value cut-off) 
against all the available metagenomes from 17 body sites from the HMP 
dataset. The IMG/M-HMP server can be found at: http://www.hmpdacc-
resources.org/cgi-bin/imgm_hmp/main.cgi 
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DNA manipulations and cloning 
Induction of fosmids from low to high copy number was performed as 
per the manufacturer’s instructions.  The Qiagen QIAprep Spin mini-prep 
kit was used to extract fosmids using the protocol outlined by manufacturer. 
The brpAL, brpAS and brpAatfA genes were amplified using ReddyMix PCR 
mastermix (Thermo Scientific). PCR products were purified with a Qiagen 
PCR purification kit and digested with restriction enzymes XbaI and PstI 
(Roche Applied Science), followed by ligation using the Fast-Link DNA ligase 
kit (Epicentre Biotechnologies) to similarly digested plasmid pCI372. Electro-
competent E. coli MKH13 were transformed with the ligation mixture and 
plated on LB agar plates containing 20µg/ml Cm for selection.   
The pBAD TOPO® TA expression kit (Invitrogen, Carlsbad CA, USA) 
was used to clone the PCR products into the pBAD expression vector 
according to the manufacturer’s instructions. The brpAL, brpAS and brpAatfA 
genes were amplified as outlined above. The resulting plasmids, containing 
the genes of interest were electroporated into freshly competent E. coli 
EPI300 and plated on LB agar containing 100µg/ml of ampicillin.  
Colony PCR was performed on resistant transformants using a using 
a gene and plasmid (pCI372 or pBAD) specific primer combination to confirm 
the presence and size of the insert. Inserts were sequenced to confirm the 
correct nucleotide sequence (GATC Biotech, Germany). 
 
 
 
 
 
 
151 
 
Growth experiments 
Cultures were grown overnight in the relevant media (LB or M9 broth).  
Cells were subsequently harvested, washed in one quarter strength sterile 
Ringer’s solution and re-suspended in fresh media.  A 2% (v/v) inoculum was 
sub-cultured in fresh broth containing sodium chloride (NaCl), and 200µl was 
transferred to a sterile 96-well micro-titer plate (Starstedt Inc. Newton, USA). 
For minimal media experiments, filter-sterilised stock solutions of the 
osmoprotectants betaine, L-carnitine and L-proline were added to a final 
concentration of 1mM.  Micro-titer plates were incubated at 37°C for 24-48 
hours in an automated spectrophotometer (Tecan Genios) which recorded 
the OD 595nm every hour.  The data was subsequently retrieved and 
analysed using the Magellan 3 software program.   
Survival in high salt media in the presence and absence of 20µM 
beta-carotene was assessed by harvesting overnight cultures as above and 
sub-culturing in either 3% NaCl or 7% NaCl for MKH13 and EPI300 strains 
respectively. Cultures were incubated at 37°C both aerobically (with shaking) 
and anaerobically (static) for 48 hours. Subsequently, serial dilutions of 
cultures were made in one quarter strength sterile Ringers solution and 
plated on LB agar. Viable cells were enumerated and calculated as the 
number of colony forming units per millilitre (CFU/ ml). 
Graphs (created using SigmaPlot 10.0) are presented as the average 
of triplicate experiments, with error bars being representative of the standard 
error of the mean (SEM).  
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Transposon mutagenesis  
Transposon mutagenesis was carried out on SMG 6 using the EZTn-5 
<oriV/KAN-2> in vitro transposition kit (Epicentre Biotechnologies) in 
accordance with the manufacturer’s instructions. E. coli EPI300 cells were 
transformed with the transposon reaction mixture and selected on plates 
containing Cm and Kan (12.5 and 50µg/ml, respectively). Transposon 
insertions in the regions of interest were confirmed by PCR. Regions 
containing the EZTn5 transposon are approximately 1.9kb larger than the 
region covered by the primers.  PCR products of the correct size were 
subjected to sequencing from the ends of the transposon using the primers 
EZTn FP-1 and RP-1 (Table 2) to confirm the location of transposon 
insertion.  All sequencing was performed by GATC Biotech (Germany).   
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Results 
Screening the human gut metagenomic library 
Fifty-three salt-tolerant clones were identified from a screen of 
approximately 23,000 fosmid library clones. The clones were annotated as 
SMG (for Salt MetaGenome) 1-53. Six clones grew within 24 hours (SMG 1-
6) and the remaining 47 grew over the following 24-48 hours. The focus of 
this study were clones SMG 1 and SMG 6, both of which were found to 
contain the same insert. SMG 6 was chosen for further analysis. Previous 
work has focused on clones SMG 3 and SMG 5 and SMG 25 [22,23]. End 
sequencing revealed that another clone, SMG 52, shared the same 
sequences at the 5’ and 3’ ends of the fosmid as SMG 1 and SMG 6. 
Furthermore, SMG 52 displayed a similar growth profile to SMG 1 and 6 
when grown under sodium chloride (NaCl) stress and all three clones have a 
significant (P <0.0001 for all clones) growth advantage in the presence of 7% 
added NaCl compared to the EPI300 host strain carrying the empty fosmid 
vector (pCC1FOS) (Figure 1B). No difference in growth between any of the 
clones was observed in LB alone (Figure 1A). Further investigation involving 
pyrosequencing revealed SMG 52 contained the same insert as SMG 1 and 
SMG 6.  
 
 
 
 
 
 
 
 
154 
 
Growth in LB broth
Time/ hrs
10 20 30 40 50
O
D
 5
9
5
 n
m
0.2
0.4
0.6
0.8
1.0
EPI300::pCC1FOS
SMG 1
SMG 6
SMG 52
Growth in LB + 7% NaCl
Time/ hrs
10 20 30 40 50
O
D
 5
9
5
 n
m
0.1
0.2
0.3
0.4
0.5
EPI300::pCC1FOS
SMG 1
SMG 6
SMG 52
Figure 1.  
(A) 
 
 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
 
 
Figure 1. Growth of metagenomic clones SMG 1, 6 and 52 compared to EPI300 carrying an 
empty fosmid vector (pCC1FOS) in (A) LB broth and (B) LB broth supplemented with 7% 
NaCl. 
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Fosmid sequencing and bioinformatic analysis  
The fosmid inserts from SMG 1, 6 and 52 were fully sequenced and 
assembled by GATC Biotech (Germany) using the GS-FLX Titanium mini 
run. All three inserts were found to be identical, sharing 100% nucleotide 
identity over the entire length of the fosmid insert (~34 kb). Gene prediction 
using FGENESB predicted the presence of thirty putative open reading 
frames (see Table 3.). Translated nucleotide sequences were subjected to 
BLASTP (maximum e-value cut-off of 1e-05) analysis to identify homologous 
sequences in the database. The vast majority corresponded to proteins from 
the Gram-negative Bacteroidetes phylum, with amino acid identities ranging 
from 26% to 100%. Proteins with between 99%-100% amino acid identity 
corresponded to three species of Bacteroides, namely Bacteroides 
thetaiotaomicron VPI-5482, Bacteroides sp. 1_1_6 and Bacteroides sp. 
1_1_14. The remainder corresponded to other members of the phylum 
Bacteroidetes from genera Alistipes, Prevotella and Odoribacter, as well to 
Gram-positive Firmicutes from the family Lachnospiraceae and genera 
Clostridium and Veillonella. 
Functional assignment of the encoded proteins on SMG 6 based on 
homology searches using BLASTP revealed that gene 26 was predicted to 
encode a putative membrane protein, although none of the potential 
homologues identified shared greater than 30% amino acid identity (placing 
them in the “twilight zone” of evolutionary relatedness). This protein also 
shared sequence similarity with a brp/blh-family 15,15’-beta-carotene 
monooxygenase from Prevotella marshii DSM 16973 (28% identity over 254 
amino acids) and to a proline symporter from Bifidobacterium bifidum BGN 4 
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(25% identity over 222 amino acids). Given that proline is an important 
osmoprotectant utilised by bacteria to counteract the deleterious effects of 
salt-induced osmotic stress [41,42], we elected to pursue this gene, which 
we have named brpA, for further study.  
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Table 3.  List of putative proteins encoded on SMG 6 fosmid insert. 
Gene 
# 
Strand Length 
(a.a) 
BlastP top hit Best hit organism (BlastP) e-value Query 
coverage 
% ID 
(a.a) 
% G+C 
1 + 418 Hypothetical protein (BT_1366) Bacteroides thetaiotaomicron VPI-5482 0.00E+00 100% 100% 48.05 
2 - 124 Conserved hypothetical protein (DUF 3127) Bacteroides sp. 1_1_6 6.00E-67 100% 100% 52.00 
3 + 374 DNA polymerase III, chain beta (beta clamp superfamily) Bacteroides thetaiotaomicron VPI-5482 0.00E+00 100% 100% 47.64 
4 + 255 DNA polymerase III, epsilon chain (DDEHh exonuclease 
domain) 
Bacteroides sp .1_1_6 4.00E-149 100% 100% 45.57 
5 + 400 Phosphopantothenoylcysteine decarboxylase 
(Flavoprotein, DFP domains) 
Bacteroides sp. 1_1_6 0.00E+00 100% 99% 49.38 
6 + 555 DNA repair protein, RecN (ABC_RecN domains) Bacteroides sp. 1_1_14 0.00E+00 100% 99% 50.66 
7 + 247 tRNA/ rRNA methyltransferase (SpoU_sub_bind and 
methylase domains) 
Bacteroides thetaiotaomicron VPI-5482 5.00E-143 100% 100% 47.98 
8 + 568 Tetratricopeptide repeat family protein (Trypsin_2 and 
TPR domains) 
Bacteroides sp. 1_1_6 0.00E+00 100% 99% 46.34 
9 + 190 Putative transcriptional regulator 
(NGN_SP_UpxY domain; NusG) 
Bacteroides thetaiotaomicron VPI-5482 4.00E-135 100% 99% 42.76 
10 + 122 Transcriptional regulator (UpxZ domain) Bacteroides sp. 1_1_14 2.00E-63 100% 97% 42.82 
11 + 789 Capsule polysaccharide export protein (Poly_export and 
SLBB domains) 
Bacteroides thetaiotaomicron VPI-5482 0.00E+00 100% 99% 48.90 
12 + 378 Uncharacterised protein, putative chain-length 
determining  
Bacteroides faecis CAG:32 0.00E+00 100% 71% 42.83 
13 + 647 Capsular polysaccharide biosynthesis protein (CapD) 
(UDP_invert_4-6DH_SDR_e domain) 
Bacteroides sp. 1_1_6 0.00E+00 98% 87% 44.24 
14 + 410 UDP-glucose dehydrogenase (NAD_Gly3P_dh_N and 
UDPG_MGDP_dh domains) 
Bacteroides fragilis HMW 610 0.00E+00 100% 82% 43.23 
15 + 348 NAD dependent epimerase/ dehydratase 
(NADB_Rossmann superfamily) 
Bacteroides sp. 4_1_36 3.00E-176 100% 84% 42.50 
16 + 189 dTDP-4-dehydrorhamnose 3,5-epimerase 
(dTDP_sugar_isom domain) 
Bacteroides fragilis CL07T00C01 3.00E-124 100% 90% 43.33 
17 + 451 Alanine ABC transporter permease (DltB domain; MBOAT 
superfamily) 
Alistipes onderdonkii  2.00E-136 97% 57% 37.20 
18 + 292 Hypothetical protein Alfi_2997 (DUF 535 superfamily) Alistipes finegoldii DSM 17242 1.00E-38 96% 30% 36.61 
19 + 172 Hypothetical protein BF638R_1544 (RimL domain) Bacteroides fragilis 638R 2.00E-67 99% 68% 39.35 
20 + 368 Putative LPS biosynthesis transmembrane  
protein  
Bacteroides fragilis 638R 4.00E-51 98% 36% 33.06 
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21 + 331 Hypothetical protein BSHG_0833 Bacteroides sp. 3_2_5 2.00E-83 100% 43% 31.02 
22 + 479 Hypothetical protein, polysaccharide export 
(MATE_tuaB_like domain) 
Clostridium hathewayi WAL-18680 6.00E-150 98% 46% 36.11 
23 + 376 Hypothetical protein HMPREF9447_00823 (AHBA_syn 
domain; AAT_I superfamily) 
Bacteroides oleiciplenus YIT 12058 0.00E+00 100% 81% 47.48 
24 + 184 Putative acetyltransferase 
(LbetaH_MAT_like domain) 
Prevotella sp. CAG:1092 6.00E-57 94% 55% 40.00 
25 + 98 Hypothetical protein, putative acyltransferase Prevotella saccharolytica F0055 7.00E-07 98% 37% 30.64 
26 + 271 Putative membrane protein Prevotella sp. CAG:873 6.00E-10 99% 26% 32.05 
27 + 288 Hypothetical protein HMPREF0994_06876 (ATP-
grasp_tupA domain) 
Lachnospiraceae bacterium 
3_1_57FAA_CT1 
2.00E-81 99% 70% 35.01 
28 + 366 Uncharacterised protein BN814_01473, putative 
glycosyltransferase (GT1_ams_like domain) 
Veillonella sp. CAG:933 1.00E-132 98% 54% 39.69 
29 + 366 Putative glycosyltransferase Bacteroides thetaiotaomicron VPI-5482 2.00E-53 98% 37% 40.05% 
30 + 364 Hypothetical protein HMPREF9449_00933 Odoribacter laneus YIT 12061 0.00E+00 98% 69% 40.43 
Abbreviations: aa = amino acid; %ID = % identity at amino acid level over the entire length of the protein; DUF = Domain of Unknown Function. 
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Features of SMG 6 and brpA/BrpA 
 The brpA gene is number 26 of the 30 predicted genes on SMG 6 
(Fig. 2). It is predicted to be a lone open reading frame, preceded by and 
followed by a 7 and a 4 gene operon, respectively. It is flanked upstream and 
downstream by a number of genes predicted to encode proteins with acetyl-, 
acyl- and glycosyl-transferase activities. There are indications that brpA and 
a number of adjacent genes have been acquired through lateral gene 
transfer (LGT). The SMG 6 fosmid insert is ~34.26 kb and its overall %G+C 
content is 41.92%. The highest genetic identities of a large proportion of the 
genes are to Bacteroides species, with up to 100% identity in some cases. 
The %G+C content of genus Bacteroides ranges from 40-48%, with B. 
thetaiotaomicron VPI-5482, Bacteroides sp. 1_1_6 and Bacteroides sp. 
1_1_14 all having a %G+C content of approximately 43% (Genomes Online 
Database, GOLD; http://www.genomesonline.org/). The %G+C content of the 
genes on the SMG 6 fosmid insert is illustrated in Figure 2A. Genes in the 
first half of the insert, up to and including gene 16, have a %G+C content of 
~45%; similar to the average %G+C content of the genus Bacteroides. The 
second half of the insert displays a clear drop in %G+C content to ~37%. 
The %G+C content of some individual genes is also low, including atfA and 
brpA (Figure 2A), which share BLAST homology to low G+C Gram-positive 
bacteria, mainly from the Phylum Firmicutes.  
The brpA gene was predicted to have different start codons using 
FGENESB depending on the settings used; the alternative start codon TTG 
(leucine) was predicted using “generic bacterial”, resulting in a 232 amino 
acid protein. Given that a number of the proteins on SMG 6 shared 100% 
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amino acid identity with Bacteroides thetaiotaomicron VPI-5482, it was also 
chosen as the closest organism for gene prediction and predicted an ATG 
(methionine) as the start codon, 117 base-pairs upstream of the predicted 
TTG start codon (encoding a protein of 271 amino acids). GeneMark was 
used for gene prediction as a comparison and it also predicted the same 
ATG as the start codon. A putative ribosome binding site (RBS) sequence 
(AGGTTT) was found ending seven base-pairs upstream of TTG, while a 
stronger RBS sequence (AGTAGG) ended 19 base-pairs upstream of the 
ATG start codon. Putative E. coli-type -10 and -35 promoter regions were 
detected using BProm (www.softberry.com) upstream of both putative start 
codons. Manual inspection of upstream sequences also revealed the 
presence of a near perfect Bacteroidetes -7/-33 promoter region 
(TAGGTTTG/TTTT; consensus TAnnTTTG/TTTG) [43,44] upstream of the 
TTG start codon and a GGTATTTG/TTTT at -14/-30 upstream of ATG. The 
predicted promoter sequences along with putative transcription factor binding 
sites can be seen in Figure 2C. A putative RpoS binding site is found 
upstream of the ATG start codon, while an OxyR binding sequence is 
predicted to be located upstream of the TTG start codon.  
The BrpA protein was predicted to be a 30.9 kDa membrane protein 
with seven transmembrane regions as predicted with TMHMM (Figure 2D). 
BrpA has a predicted pI of 9.42 and is composed of ~46% hydrophobic 
amino acids, similar to other microbial Brp/Blh proteins (pI range 8.89-9.56 
and 48-56% hydrophobic amino acids) [24]. No signal peptide sequence, 
conserved domains or sequence motifs were detected for BrpA. We also 
searched for motifs in the protein sequences homologous to BrpA from 
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BLAST. A lipocalin motif was detected in a hypothetical protein from 
Clostridium sp KLE-1755. Interestingly, lipocalin motifs are found in proteins 
that bind small hydrophobic molecules such as retinoids, carotenoids, lipids 
and steroids [45]. Table 4 shows the lipocalin motif and the corresponding 
motif identified in Clostridium sp KLE-1755. The BrpA amino acid sequence 
along with the top 10 BLAST homologues were aligned to identify conserved 
residues in these proteins. The residues that match the lipocalin motif are 
displayed in green and those that do not are in red (Table 4).  
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Figure 2.  
 
Figure 2. Bioinformatic analysis of SMG 6 and brpA/BrpA. 
(A) Gene map of SMG 6 insert, displaying gene orientation and individual %G+C content 
indicated with a gradient colour bar. Gene numbers correspond to those in Table 3 and are 
drawn approximately to scale. (B) Focus on genes 25 (atfA) and 26 (brpA), showing the 
regions cloned for each construct. (C) Detailed view of putative ATG and TTG start codons 
of brpA, including upstream regions, as well as predicted promoter regions (highlighted in 
bold) and transcription factor binding site sequences (blue and orange boxes). (D) TMHMM 
prediction of seven transmembrane regions in BrpA. 
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Table 4. Putative lipocalin motifs in BrpA and its homologues 
 
LIPOCALIN MOTIF [DENG] {A} 
[DENQG 
STARK] 
X 
(0,2) 
[DENQ 
ARK] [UVFY] {CP} G {C} W [FYWLRH] {D} [LIVMTA] 
Clostridium sp. KLE 1755 NPSRLAGAWYLVP N P S   R L A G A W Y L V 
BrpA SMG 6 LFSSMRDSIYLIPS L F S   S M R D S I Y L I 
Prevotella sp. CAG:873 DVHGALHSWWFVP D V H   G A L H S W W F V 
Prevotella buccalis ATCC 35310 VWQGMLDDSLFMF V W Q   G M L D D S L F M 
Prevotella sp. CAG:279 DVHSWLHSWAFVP D V H   S W L H S W A F V 
Prevotella marshii DSM 16973 PQTDFITSWSFLP P Q T   D F I T S W S F L 
Lachnospiraceae bacterium
1
  NPSQMADKWYLVP N P S   Q M A D K W Y L V 
Prevotella saccharolytica F0055 PQTDFITSWSFLP P Q T   D F I T S W S F L 
Clostridium nexile CAG:348 KPYQFANSSFIIL K P Y   Q F A N S S F I I 
Firmicutes bacterium CAG:24 NALTGRLGDFWNIVP N A L TG R L G D F W N I V 
Firmicutes bacterium CAG:65 GSDRIDGAVSLLL G S D   R I D G A V S L L 
1
strain 3_1_57FAA_CT1 
Table 4.  A lipocalin motif was found in a homologue of BrpA from Clostridium sp. KLE1755. Lipocalin proteins can bind hydrophobic molecules such as 
carotenoids and retinoids. The top ten BLASTP homologues to BrpA were aligned to compare these protein sequences and identify putative lipocalin motifs. 
The consensus motif is displayed on the top row of Table 4. Residues that match the consensus are shown in green and mismatches are shown in red. 
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Due to low BLAST sequence identity, the FFAS03 server was used 
with the aim of identifying distant structural homologues to BrpA. The best 
structural homologues were an uncharacterised bacterial protein (COG 3274; 
acyltransferase) and a predicted membrane protein (COG 4763) with 
significant scores of -40.70 and -23.30 respectively. Interestingly the best 
structural homologue in the protein databank (PDB) was to an archaeal-type 
rhodopsin (3ug9), although the score of -9.43 did not reach significance (-
9.50).  
The IMG/M-HMP database which contains all metagenomic datasets 
encompassing 17 body sites from the Human Microbiome Project (HMP) was 
also screened for BrpA homologues. Using a combination of the most lenient 
and strictest search criteria (maximum e-value cut-off of 1e-05 and 1e-50) 
BrpA homologues were identified in the HMP datasets (Figure 3). In addition, 
there were 145 hits to the MetaHit dataset using BLAST on the FFAS03 
server. 
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Figure 3.  
Body site location from HMP (total number of samples)
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Figure 3. BrpA homologues identified when BLAST searched against Human Microbiome 
Project (HMP) datasets from 17 body sites at maximum e-value cut-off of (A) 1e
-50
 and (B) 
1e
-05
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The brpA gene confers a salt tolerance phenotype when heterologously 
expressed in Escherichia coli  
The brpA gene (gene 26) was cloned from both predicted start codons 
and expressed in E. coli MKH13. Both fragments increased the salt tolerance 
of MKH13 significantly. Cells expressing the larger fragment (brpAL) had the 
most significant effect (P =0.0002) in the presence of 3% NaCl. Although 
cells expressing the smaller fragment (brpAS) had a slower growth profile 
and a longer lag phase than the larger fragment (brpAL), both exhibited a 
significant growth advantage compared to the E. coli MKH13 harbouring the 
empty plasmid pCI372 (P = 0.0039) (Figure 4B). The gene immediately 
upstream of brpA is predicted to encode a 98 amino acid putative membrane 
protein (putative acyltransferase), which we have named atfA, was also 
cloned in combination with brpA (brpAatfA). Both genes in combination did 
not increase the salt tolerance of MKH13 relative to brpAL alone, when grown 
in LB + 3% NaCl, but the increase in salt tolerance was significant (P 
=0.0002) (Figure 4B).  
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(A) 
 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
 
 
Figure 4. Growth of E. coli MKH13::pCI372 and E.coli MKH13 carrying a plasmid encoded 
copy of either brpAL, brpAS or brpAatfA in (A) LB broth or (B) LB + 3% NaCl. All of the genes 
confer a significant salt tolerance phenotype to MKH13 relative to cells with an empty 
plasmid vector. All values are the average of triplicate experiments and error bars are 
representative of the standard error of the mean (SEM). 
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L-proline did not increase salt tolerance further 
Once we had shown that the brpA gene could confer a salt tolerance 
phenotype when expressed in E. coli, we aimed to decipher the mechanism 
of action and thereby assign a function to the encoded protein. Given that 
BLASTP analysis of the BrpA sequence revealed homology to a proline 
symporter, growth curves were carried out in minimal media supplemented 
with L-proline and also other common osmoprotectants, betaine and L-
carnitine (final concentration of 1mM). However, no growth advantage was 
seen in the presence of any of the added osmoprotectant compounds, 
suggesting that BrpA is not an osmoprotectant uptake system. 
 
Functional annotation of brpA 
BLASTP analysis also revealed that the BrpA protein exhibited 
homology to a brp/blh-family beta-carotene 15,15’-monooxygenase. Such 
proteins are related to bacteriorhodopsins [24], and are annotated as 
bacterio-opsin related protein (brp)/brp-like homologue (blh) protein. Brp/Blh 
proteins have been shown to have beta-carotene 15,15’-monooxygenase 
activity; cleaving beta-carotene into two molecules of all-trans retinal (vitamin 
A aldehyde) (Figure 5) [25]. The derived retinal is bound by a rhodopsin 
protein and cells expressing such proteins acquire an orange/red colour, 
indicative of the presence of retinal in the cell membrane [46-48]. Strains 
harbouring brpA were grown in the presence of beta-carotene and cell 
pellets were observed for the development of the characteristic red/orange 
colour. E. coli MKH13 cells carrying the brpA gene on the pCI372 plasmid 
did not show any obvious colour development (Figure 6).  
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Figure 5.  
 
 
 
 
 
 
 
Figure 5. Representation of the reaction for the formation of retinal. Beta-carotene is 
cleaved at its central 15,15’ bond by brp 15,15’- beta-carotene monooxygenase to form two 
molecules of all-trans retinal (Vitamin A aldehyde). 
 
Figure 6.  
 
Figure 6. Appearance of cell pellets grown in LB supplemented with beta-carotene. From 
left to right: E. coli MKH13::pCI372, MKH13::pCI372-brpAL, MKH13::pCI372-brpAS and 
MKH13::pCI372-brpAatfA. 
 
Given that a number of previous studies have reported the use of an 
inducible vector to visualise pigmentation in cell pellets [46-50], we cultured 
the original fosmid clones (which can be induced due to Copy ControlTM 
capability of pCC1FOS fosmid vector) in the presence of beta-carotene and 
included an induction solution to induce the fosmid from low to high-copy 
number. The cell pellets developed an intense red/orange colour while cells 
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with an empty vector did not (Figure 7). To confirm that the BrpA protein was 
responsible for this phenotype, we cloned brpA in isolation into the pBAD 
inducible expression vector and transformed it into E. coli EPI300 and 
repeated the growth experiments. Again, the cell pellets developed a 
distinctive a red/orange colour (Figure 8).  
 
Figure 7.  
 
Figure 7. Appearance of cell pellets of clones grown in LB supplemented with beta-carotene 
and Copy Control
TM
 Induction solution (L-arabinose) (Epicentre Biotechnologies). From left 
to right: E. coli EPI300::pCC1FOS, SMG 1, SMG 6 and SMG 52. 
Figure 8.  
 
Figure 8. Appearance of cell pellets grown in LB supplemented with beta-carotene and L-
arabinose (Sigma). From left to right: E. coli EPI300::pBAD, EPI300::pBAD-brpAS, 
EPI300::pBAD-brpAL, and EPI300::pBAD-brpAatfA. 
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brpA also confers salt tolerance to E. coli EPI300 
The genes (brpAL, brpAS and brpAatfA) were also cloned into the 
pBAD expression vector and transformed into E. coli EPI300. All of the 
transformed strains exhibited increased salt tolerance relative to the host 
containing the empty pBAD vector, although EPI300::pBAD-brpAS, to a 
lesser extent, similar to our observations with MKH13 above (Figure 9B). 
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Figure 9.  
(A) 
 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
 
Figure 9. Growth of E. coli EPI300::pBAD and EPI300::pBAD-brpAS (P = 0.0008), 
EPI300::pBAD-brpAL (P = 0.0002) and EPI300::pBAD-brpAatfA (P = 0.0001) in (A) LB broth 
and (B) LB broth supplemented with 7% NaCl. All three strains had a statistically significant 
increased salt tolerance compared to EPI300 carrying an empty copy of the pBAD vector. 
Numbers in parentheses indicate significant P values (unpaired student t-test). All values are 
the average of triplicate experiments and error bars are representative of the standard error 
of the mean (SEM). 
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Effect of beta-carotene on survival in high-salt media 
 The effect of beta-carotene on survival of both E. coli MKH13 and 
EPI300 strains was assessed. Survival of strains carrying a plasmid-encoded 
copy of brpA was compared to controls (carrying an empty plasmid) in high-
salt media (3% NaCl for MKH13 and 7% for EPI300) in the presence and 
absence of beta-carotene after a 48-hour period, both aerobically and 
anaerobically (Figure 10). Anaerobic conditions were tested due to the 
oxygen (O2) requirement of beta-carotene 15,15’-monooxygenases for 
functionality. Beta-carotene did not provide an osmoprotective effect during 
salt stress to control strains or strains carrying a copy of the brpA gene under 
the conditions tested, however an increased salt tolerance phenotype was 
observed under both aerobic and anaerobic conditions. 
Figure 10.  
(A)                                                           (B)  
 
  
 
  
 
 
 
Figure 10. The effect of beta-carotene on the survival of MKH13 strains and EPI300 strains 
was assessed under aerobic and anaerobic conditions in (A) LB broth with 3% NaCl and (B) 
LB broth with 7% NaCl. Viable cells were determined by calculating the average CFU per 
millilitre after 48 hours. Results are representative of triplicate experiments and error bars 
are the standard error of the mean (SEM). 
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Transposon mutagenesis 
 Transposon mutagenesis was performed using the EZTn5 in vitro 
transposition system (Epicentre Biotechnologies) to create knock-out 
mutants of SMG 6. Clones harbouring a transposon insertion in the brpA and 
neighbouring genes were identified by PCR. The primer pair brpAatfA FP 
and RP were used to amplify this region, generating PCR products of ~1.4 kb 
in the absence of a transposon insertion and products of ~3.3 kb if the 
transposon was present (Figure 11A). Once positive clones were identified, 
the location of the transposon was confirmed by sequencing from the ends of 
the transposon. We identified four transposon mutants in SMG 6; namely 6-
EZTn #24, #26, #34 and #38. The location of the transposon insertions are 
presented in Figure 11B.  The aim was to identify clones that lacked 
pigmentation following transposition. Clones containing a transposon 
insertion do not display the same intense red pigmentation seen with SMG 6 
and although there is visibly less pigmentation, some residual colour 
nevertheless remains (Figure 11C). 
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Figure 11.  
 
Figure 11. EZTn5 transposon mutagenesis of SMG 6 was performed to 
identify mutants lacking pigmentation when grown in the presence of beta-
carotene. Clones positive for a transposon in this region of SMG 6 fosmid 
insert were identified by PCR, with amplicons of ~3.3kb indicative of an 
insertion event (Figure 11A). Approximate locations of transposon insertions 
in relation to brpA and neighbouring genes are presented in Figure 11B. 
Appearance of cell pellets of SMG 6 and transposon insertion mutants (EZTn 
#24, #26, #34 and #38) following growth in the presence of beta-carotene 
(Figure 11C). 
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Discussion 
 In the current study we have identified and characterised a novel salt 
tolerance locus from the human gut microbiome.  Functional assignment of 
its encoded protein, BrpA, using BLAST returned homologues mainly 
annotated as hypothetical or putative membrane proteins. The only clue to 
the possible function of the protein was that it also shared sequence 
similarity (albeit at <30%) to a proline symporter and a brp/blh-family beta-
carotene 15,15’-monooxygenase.  Sequence homologies of less than 30% 
are considered to be in the “twilight zone” and confidence of functional 
annotations diminishes below this threshold [51,52].  
Growth experiments in minimal media supplemented with L-proline 
and other osmoprotectants had no effect on growth or salt tolerance. The 
gene, which we have termed brpA, possibly encodes a putative brp/blh-
family beta-carotene 15,15’-monooxygenase. Such proteins have been 
shown to catalyse the conversion of beta-carotene into two molecules of all-
trans retinal (vitamin A aldehyde) (Figure 5) [24,25]. Growth of the 
metagenomic clone SMG 6 in the presence of exogenous beta-carotene 
resulted in the cell pellets with a distinctive orange/red colour. A number of 
other studies have shown that bacterial cells expressing plasmid encoded 
beta-carotene biosynthesis genes in addition to a brp/blh gene and a 
proteorhodopsin (PR) encoding gene adopt a similar colour due to the 
cleavage of beta-carotene to retinal and subsequent binding of retinal by 
proteorhodopsins in the cell membrane [46-49]. The absence of any obvious 
PR encoding gene on SMG 6 therefore, does not explain the presence of 
colour in the SMG clones’ cell pellet. Furthermore, when bprA was cloned in 
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isolation the cell pellets still had pigmentation, indicating that brpA alone is 
sufficient to confer this phenotype. There are however a few possible 
explanations for the pigmentation; in silico analysis reveals that brpA is 
predicted to have acyltransferase activity (COG 3274), as is atfA, the gene 
immediately upstream of brpA. The atfA gene was cloned in combination 
with brpA, however expression of both genes together had no appreciable 
effect on the degree of pigmentation or salt tolerance observed. Carotenoids 
and retinoids are hydrophobic, lipophilic molecules. The majority of 
carotenoids are found embedded in the hydrophobic core of lipid membranes 
and in lipid globules and other hydrophobic environments [53,54]. Acylated 
carotenoids have been shown to be inserted in the membrane and the 
predicted acyltransferase activity of BrpA may explain the cell pellet 
pigmentation in the absence of a rhodopsin protein [55]. In Staphylococcus 
aureus, an acyltransferase is a key enzyme in the biosynthesis pathway for 
the orange carotenoid staphyloxanthin [56]. This enzyme was initially thought 
to carry out the final step in staphyloxanthin biosynthesis, although more 
recently it has been shown that it is actually the penultimate step [57]. The 
transfer of a polar acyl group or acyl-containing groups such as hydroxyl or 
keto groups to carotenoids would be likely to enable their interaction with 
phosphate head groups of lipids, thus anchoring them within membranes 
[55,58]. 
The presence of a lipocalin motif was identified in a BLAST 
homologue of BrpA. Lipocalin proteins can bind hydrophobic molecules such 
as carotenoids and retinoids. It seems unlikely however, that this is the case 
with BrpA since the motif is quite different and lacks the characteristic 
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glycine-X-tryptophan (G-X-W) signature found in almost all lipocalins [59].  
The BrpA protein has seven predicted transmembrane regions, a 
characteristic shared with rhodopsin proteins [60]. It has previously been 
suggested that Brp/Blh-like proteins may be multifunctional and both cleave 
beta-carotene and subsequently transport or bind the derived all-trans 
retinal, although this has not been demonstrated experimentally [25]. 
Four transposon mutants of SMG 6 were identified in this study using 
PCR. It was expected to obtain mutants that lack pigmentation when grown 
in the presence of beta-carotene. While there is a clear visible difference in 
the appearance of the cell pellets of the mutants compared to SMG 6, each 
of the mutants retain some level of pigmentation, albeit to a lesser degree 
and with diminished colour intensity. Transposon insertion in genes upstream 
of brpA (mutants #24 and #34) indicates a polar effect mediating the 
reduction in the degree of pigmentation. It is surprising that some 
pigmentation remains in clones containing a transposon within the brpA gene 
(mutants #26 and #38), indicating residual carotenoid accumulation, possibly 
due to acyltransferase activity of atfA. 
 The %G+C content of individual genes on SMG 6 drops as low as 
30.64% for gene 25 (atfA), while its neighbouring gene, brpA, is 32.05%. In 
addition, only 12% of the top 100 BLASTP hits to BrpA are predicted to be 
from Gram-negative bacteria. The remaining 88% are represented in the 
main by proteins with similarity to the low G+C, Gram-positive Firmicutes 
phylum, mainly from the genera of Clostridium, Enterococcus and 
Streptococcus among others. Taken together, these observations suggest 
much of this region, including the especially low %G+C, atfA and brpA 
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genes, were acquired through a LGT event [61,62]. Indeed, in support of this 
there is evidence that brp/blh-type genes, along with rhodopsins, undergo 
frequent LGT events [46,63-65]. In beta-carotene producing bacteria, only 
these two genes are required to produce retinal which is bound to the 
rhodopsin protein giving the recipient bacterium the ability to harvest light 
energy non-photosynthetically and convert it to chemical energy. Acquiring a 
rhodopsin gene in the gut would be somewhat redundant owning to the 
aphotic nature of the gut environment. A brp/blh beta-carotene 
monooxygenase however could be beneficial to break down dietary-derived 
beta-carotene. 
 There were two possible start codons predicted for the brpA gene 
using the FGENESB gene prediction program. Using the “bacterial generic” 
parameter as closest organism, a gene (brpAS) encoding a 232 amino acid 
protein with the alternative initiation codon TTG (leucine) was predicted. 
Because a number of proteins encoded on SMG 6 shared 100% amino acid 
identity with Bacteroides thetaiotaomicron VPI-5482, this organism was also 
used as the “closest organism” parameter. Using B. thetaiotaomicron VPI-
5482 as “closest organism” predicted a gene (brpAL) encoding a 271 amino 
acid protein with an ATG (methionine) start codon. GeneMark also predicted 
ATG to be the start codon. Cloning and expression of the gene from both 
predicted start codons conferred salt tolerance to E. coli, although strains 
expressing the brpAL fragment had a shorter lag phase and reached a higher 
final OD. Initially, it seemed likely that ATG was the true start codon of brpA, 
however further manual inspection of the sequences upstream of both start 
codons revealed a characteristic Bacteroides -7/-33 promoter region 
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preceding the TTG codon that deviated from the consensus by only one 
nucleotide. There is also a potential Bacteroides-type promoter upstream of 
ATG, but at position -14/-30 (GGTATTTG/TTTT). It therefore seems likely 
that TTG is the actual start codon in Bacteroides. Interestingly, previous 
studies have shown that the use of alternative initiation codons, other than 
ATG, is a common feature of osmotolerance genes in a number of 
gastrointestinal pathogens [12,17]. The increased salt tolerance phenotype 
of brpAL compared to brpAS may be due to the fact that ATG is the most 
commonly utilised codon to initiate translation (~90% of genes) in E. coli [66] 
and also the presence of strong RBS (AGUAGGU) upstream of the ATG 
start codon, which differs from the E. coli consensus RBS (AGGAGGU) by 
only one nucleotide. Taken together, the ATG start codon and strong E. coli 
RBS likely gives rise to more efficient levels of transcription and translation, 
as well as increased expression of brpA in E. coli, at least under the 
conditions tested in the current study. It is of course possible that the two 
protein types (long and short) are expressed under different environmental 
conditions, as was previously reported for the multi-stress resistance locus 
HtrA [67]. 
The presence of a putative RpoS binding site is predicted upstream of 
the ATG start codon of brpA. The alternative sigma factor (sigma 38) RpoS is 
the master regulator of the general stress response induced during stationary 
phase in E. coli and other Gram-negative bacteria [68].  In addition RpoS 
regulates the expression of a large number of genes in response to various 
stresses, including salt stress [69-71]. There is also a putative OxyR binding 
site in the upstream region of brpA. OxyR is a regulator of the oxidative 
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stress response in many bacteria [72] and carotenoids can function as anti-
oxidants and can increase resistance to oxidative stress [73,74]. It may be 
possible that the brpA gene is transcribed from two promoters under different 
environmental conditions, similar to the type of regulation seen with the 
osmoprotectant transporter ProP in E. coli, where the proP gene is 
transcribed from promoter 1 (P1) primarily in response to changes in 
osmolarity and from promoter 2 (P2) during stationary phase [75,76]. 
 The BrpA amino acid sequence was used to BLAST search against all 
metagenomes from the HMP dataset at the lowest (1e-05) and highest (1e-50) 
e-value. Hits to BrpA were most abundant in the stool, supra-gingival plaque 
and tongue metagenome samples at the lowest e-value (Figure 3B). The 
majority of these hits had quite low percentage identities in the range of 25%-
35%. When the e-value cut-off was increased to 1e-50 only 13 putative BrpA 
homologues were identified and only from the stool metagenome samples 
(Figure 3A) and would therefore appear to be a rare gene found in some 
strains of Bacteroides thetaiotaomicron, which is one of the most abundant 
species in the human gut microbiome, having been shown to comprise 6% of 
all bacteria among the human gut microbiota [77]. It is interesting that 
homologues of this gene are found most abundantly in body sites (tongue, 
sub- and supragingival plaque and gut lumen/stool) where the microbiota 
would encounter beta-carotene (i.e. from dietary sources). 
 Carotenoids have been shown to protect cells from various 
environmental stresses such as osmotic, oxidative and light as well as 
reinforcing and providing increased membrane rigidity [54,74,78-80]. In this 
study, beta-carotene however did not provide any further increase in salt 
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tolerance under the conditions tested and therefore does not appear to 
function in an osmoprotective capacity. Acyltransferase enzymes have also 
been linked to various stress responses, including osmotic stress. For 
example, the acyltransferase HtrB, provides protection against and exhibits 
increased expression in response to heat, acid, oxidative and osmotic stress 
in Campylobacter jejuni and Salmonella typhimurium [81], while 
acyltransferases have also been linked to the stress response in 
Pseudomonas putida [82]. 
 In the current study we have used a combined functional 
metagenomic and bioinformatic approach to identify a novel gene from the 
human gut microbiome that has not previously been linked to salt tolerance. 
The gene, brpA, encodes a protein with homology to a brp/blh-family beta-
carotene 15,15’-monooxygenase. When expressed in E. coli, BrpA confers 
salt tolerance phenotype and cell pellets adopt a red/orange pigmentation 
when grown in the presence of exogenous beta-carotene.  
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Functional Environmental Screening of a 
Metagenomic Library Identifies stlA: A 
Unique Salt Tolerance Locus from the 
Human Gut Microbiome 
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Abstract 
Functional environmental screening of metagenomic libraries is a 
powerful means to identify and assign function to novel genes and their 
encoded proteins without any prior sequence knowledge. In the current study 
we describe the identification and subsequent analysis of a salt-tolerant 
clone from a human gut metagenomic library. Following transposon 
mutagenesis we identified an unknown gene (stlA, for “salt tolerance locus 
A”) with no current known homologues in the databases. Subsequent cloning 
and expression in Escherichia coli MKH13 revealed that stlA confers a salt 
tolerance phenotype in its surrogate host. Furthermore, a detailed in silico 
analysis was also conducted to gain additional information on the properties 
of the encoded StlA protein. The stlA gene is rare when searched against 
human metagenome datasets such as MetaHit and the Human Microbiome 
Project and represents a novel and unique salt tolerance determinant which 
appears to be found exclusively in the human gut environment. 
 
 
198 
 
Introduction 
The human gastrointestinal (GI) tract is home to hundreds of bacterial 
species [1] which play an important and complex role in host health, 
metabolism and physiology [2]. This relatively diverse community is 
dominated by two bacterial phyla; the Bacteroidetes and Firmicutes, with 
most of the remaining microbes represented by members of the 
Actinobacteria, Proteobacteria, Verrucomicrobia, and Fusobacteria [3]. A 
significant proportion (estimates range from approximately 50-80%) of this 
bacterial community has thus far proved recalcitrant to traditional laboratory 
culture [3,4], although that number is constantly decreasing [5-7]. The 
emergence of culture-independent techniques such as metagenomics in the 
past 10-15 years has enabled researchers to study these “unculturable 
organisms” (although “as-yet uncultured” would be more accurate) through 
direct sequencing of metagenomic DNA or through cloning and functional 
expression in a heterologous host - an approach referred to as functional 
genomics [8,9]. 
The human GI tract imposes numerous stresses on its resident and 
transient microbiota [10]. The ability to adapt to and resist conditions such as 
low pH, bile acids, elevated osmolarity, nutrient limitation, host immune 
factors and competing microorganisms is a determining factor in niche 
colonisation and proliferation [11].  Our research focuses specifically on the 
osmotic stress response. Bacteria generally elicit a phased response when 
challenged in such a manner, firstly by the rapid accumulation of potassium 
(K+) ions (primary response), followed by the synthesis or accumulation of 
osmoprotectant compounds (secondary response) [12-15]. A third 
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mechanism is also employed which can involve a broad range of genes that 
are seemingly unrelated to the primary and secondary responses [16-19]. 
These atypical, ancillary systems are arguably more interesting and provide 
a more complete view of the cellular response to osmotic stress in different 
bacteria and may also identify specific strategies employed by specific 
bacteria in distinct environments.   
Our aim was to identify novel genes encoding proteins that could 
confer a salt tolerance phenotype. It is hoped that the identification of 
atypical genes, which have not previously been linked to salt tolerance will 
help to broaden our understanding and possibly lead to the identification of 
novel and unusual systems that play as yet undefined roles in salt tolerance. 
While sequenced-based metagenomics can define the abundance and 
diversity of different bacteria within a given microbiome, it cannot enable 
researchers to assign novel functions to new or known genes. This task can 
only be achieved through functional screening of metagenomic libraries 
using activity-based assays. Approximately 30-40% of genes in a given 
genome will be annotated as hypothetical, conserved hypothetical or function 
unknown [20], while ~75% of functions important for life in the gut consist of 
uncharacterized orthologous groups and/or completely novel gene families 
[1], emphasising the significant degree of novelty that exists in these 
(meta)genomes.  
A previous study from our group identified five genes (which were 
previously annotated) from the human gut microbiome, to which a novel 
function of salt tolerance could be assigned [21]. In the current study, we 
describe the identification of a gene with no currently known homologues. 
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Bioinformatic analysis suggests that the gene encodes a putative membrane 
protein, while transposon mutagenesis and subsequent cloning and 
heterologous expression of the gene revealed that it conferred a salt 
tolerance phenotype in Escherichia coli. This study illustrates the power of 
functional environmental screening of metagenomic libraries as means to 
identify and assign a function to as yet unknown genes and their encoded 
proteins. 
 
Materials and methods 
Bacterial strains and growth conditions 
Bacterial strains and plasmids used in this study are listed in Table 1, 
while primers (Eurofins, MWG Operon, Germany) used are listed in Table 2. 
 E. coli EPI300::pCC1FOS (Epicentre Biotechnologies, Madison, WI, USA) 
was grown in Luria-Bertani (LB) medium containing 12.5g/ml 
chloramphenicol (Cm) and in 12.5g/ml chloramphenicol plus 50g/ml 
kanamycin (Kan) following EZ-Tn5 transposon mutagenesis reactions.  E. 
coli MKH13 [22] and Lactococcus lactis MG1363 [23] were grown in LB and 
M17 (+0.5% glucose; GM17 media) media respectively. Media were 
supplemented with 20µg/ml Cm for strains transformed with the plasmid 
pCI372 [24]. Media were supplemented with 1.5% (w/v) agar when required.  
Overnight cultures of E. coli were grown at 37°C with shaking, while L. lactis 
cultures were grown statically at 30°C. 
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Table 1. Strains, plasmids and transposon used in this study. 
Cm
R 
= chloramphenicol resistance; Kan
R
 = kanamycin resistance. 
 
 
 
 
 
 
 
Strain, plasmid or 
transposon 
Genotype or characteristic(s) Source or 
reference 
Strains   
E. coli EPI300 F
-
 mcrAΔ(mrr-hsdRMS-mcrBC)  
Φ80dlacZΔM15 ΔlacX74 recA1 endA1 
araD139 Δ(ara, leu)7697 galU galK λ
-
 rpsL 
nupG trfA dhfr; high-transformation 
efficiency of large DNA 
 
Epicentre  
Biotechnologies,  
Madison, WI, 
USA 
E. coli MKH13 MC4100Δ(putPA)101D(proP)2D(proU) 
 
[22] 
E. coli MKH13::pCI372 MKH13 containing pCI372 shuttle vector 
 
This study 
E. coli MKH13::pCI372-
stlA 
MKH13 containing pCI372 with stlA gene 
from human gut metagenomic library clone 
SMG 25  
 
This study 
 
 
L. lactis subspecies 
cremoris MG1363 
 
Plasmid-free Lactococcus strain [23] 
L. lactis MG1363::pCI372 
 
MG1363 containing pCI372 shuttle vector This study 
L. lactis 
MG1363::pCI372-stlA 
 
MG1363 containing pCI372 with stlA gene 
from human gut metagenomic library clone 
SMG 25  
 
This study 
Plasmids   
pCI372 Shuttle vector between E. coli and L. lactis, 
Cm
R  
 
[24] 
pCC1FOS 
 
Fosmid cloning vector, Cm
R
 Epicentre 
Biotechnologies,  
Madison, WI, 
USA 
Transposon   
EZ-Tn5 <oriV/ KAN-2> Hyperactive Tn5 transposon, Kan
R
, 
inducible high copy origin of replication – 
oriV 
Epicentre  
Biotechnologies,  
Madison, WI, 
USA 
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Table 2. Primers used in this study. 
Primer Sequence (5’ – 3’)a 
pCI372 FP CGGGAAGCTAGAGTAAGTAG 
 
pCI372 RP CCTCTCGGTTATGAGTTAG 
 
stlA FP 
 
AAAACTGCAGTTCTGGCAGCAGTGATTTTG 
stlA RP 
 
GCTCTAGACGGTCGAGCAAGGTAATAGG 
stlA-J FP 
 
TGCTCTTCCGAAGCAGTCAG 
stlA-J RP 
 
AGCATATCGAAGACGGCCAG 
stlA-OUT FP 
 
CTGCTCTGTTGATGGGGTTT 
stlA-OUT RP 
 
CGGGCAACTACAAGGATGAT 
stlA-IN FP 
 
TATGGGAGGGGCTACTACGG 
stlA-IN RP 
 
ACCCAGTTGCCAAGCATATC 
EZ-Tn FP-1 
 
GCCAACGACTACGCACTAGCCAAC 
 
EZ-Tn RP-1 
 
GAGCCAATATGCGAGAACACCCGAGAA 
 
aRestriction enzyme recognition sequences are underlined; FP= forward 
primer; RP= reverse primer. 
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Construction and screening of metagenomic library 
A previously constructed fosmid clone library [25,26], created from 
metagenomic DNA isolated from a faecal sample from a healthy 26 year old 
Caucasian male was used to screen for salt-tolerant clones. The library was 
screened as outlined previously [21]. Briefly, a total of 23,040 clones from the 
library were screened on LB agar supplemented with 6.5% (w/v) NaCl and 
12.5g/ml chloramphenicol using a Genetix QPix 2 XT colony 
picking/gridding robotics platform. Plates were incubated at 37°C for 2-3 
days and checked periodically for growth of likely salt-tolerant clones. 
 
Transposon mutagenesis  
Transposon mutagenesis was carried out in accordance with the 
manufacturer’s instructions, using the EZ-Tn5 <oriV/ KAN-2> in vitro 
transposition kit (Epicentre Biotechnologies).  E. coli EPI300 cells were 
transformed with the transposon reaction mixture and selected on plates 
containing Cm and Kan (12.5 and 50µg/ml, respectively).  The transposon 
insertion clones were subsequently replica plated onto LB with and without 
6.5% added NaCl.  Clones which grew on LB but not on LB + 6.5% NaCl 
suggested a likely insertion event in a gene involved in salt tolerance.  
Presumptive salt-tolerant knock-outs were grown overnight and a fosmid 
DNA extraction was performed.  The extracted fosmid containing 
metagenomic DNA was subjected to sequencing from the ends of the 
transposon using the primers EZ-Tn FP-1 and EZ-Tn RP-1 (Table 2.).  All 
sequencing was performed by GATC Biotech (Konstanz, Germany).   
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DNA manipulations 
Induction of fosmids from low to high copy number for downstream 
applications such as transposon mutagenesis and sequencing was 
performed as per manufacturer’s instructions and as described previously 
[21].  The Qiagen QIAprep Spin mini-prep kit was used to extract fosmids 
as per manufacturer’s instructions. PCR products were purified with a 
Qiagen PCR purification kit and digested with restriction enzymes XbaI and 
PstI (Roche Applied Science), followed by ligation using the Fast-Link DNA 
ligase kit (Epicentre Biotechnologies) to similarly digested plasmid pCI372. 
Electro-competent E. coli MKH13 and L. lactis MG1363 were transformed 
with the ligation mixture and plated on LB and GM17 agar respectively, 
containing 20µg/ml Cm for selection.  Colony PCR was performed on 
resistant transformants using a primer on the stlA gene (stlA FP) and a 
primer on the plasmid (pCI372 RP) to confirm the presence and size of the 
insert. 
Detection of the stlA gene in metagenomic DNA isolated from human 
stool samples was attempted using PCR. Twenty samples from the 
ELDERMET study [27], which consisted of five community (healthy), five 
long stay (frail) old subjects and five healthy young and five young  subjects 
with irritable bowel syndrome (IBS) were used as template DNA. 
Furthermore, five samples from healthy adults from a separate study {Knopp, 
2010 #464}  were also tested using the following primer pairs: stlA FP and 
stlA RP, stlA-J FP and stlA-J RP, stlA-OUT FP and stlA-OUT RP, stlA-IN FP 
and stlA-IN RP (see Table 2). 
 
 
 
205 
 
Growth experiments 
Cultures were grown overnight in appropriate media.  Cells were 
subsequently harvested, washed in one quarter strength sterile Ringer’s 
solution and re-suspended in fresh broth.  A 2% inoculum was sub-cultured 
in fresh broth containing the appropriate stress (i.e. sodium chloride (NaCl), 
potassium chloride (KCl), sucrose, glycerol, low pH or bile as required) and 
200µl was transferred to individual wells of a sterile 96-well micro-titre plate 
(Sarstedt Inc. Newton, USA).  Plates were incubated at 37°C (or 30° for L. 
lactis strains) for 24-48 hours in an automated spectrophotometer (Tecan 
Genios) which recorded the optical density at 595 nanometres (OD595nm) 
every hour.  For experiments using bile, uninoculated media containing bile 
were dispensed as blanks in the 96-well plate and their OD595nm values were 
subtracted from the corresponding inoculated wells to give the OD595nm for 
the microbial fraction. The data was subsequently retrieved and analysed 
using the Magellan 3 software program. Representative graphs were created 
using the Sigma Plot 10.0 software programme (Systat Software Inc, 
London, UK). Results are presented as the average of triplicate experiments, 
with error bars being representative of the standard error of the mean (SEM).  
 
BIOLOG Phenotype Microarray (PM) Assay 
The phenotype microarray (PM) osmolytes microplate (PM9) was 
used to compare the cellular phenotypes [29] of E. coli MKH13::pCI372 and 
MKH13::pCI372-stlA under 96 different conditions.  The BIOLOG PM 
protocol for E. coli and other Gram-negative bacteria was followed for 
preparation of the different inoculating fluid (IF) solutions (IF-0 and IF-10; 
 
 
206 
 
supplied by BIOLOG) and inoculation of the PM plates. Briefly, isolated 
colonies were added to IF-0 fluid until a cell suspension of 42% T 
(transmittance) was achieved.  This was subsequently diluted in IF-0 + dye 
mix A to achieve 85% T.  Finally, this was diluted in IF-10 + dye mix A and 
100ul was inoculated to each well of the PM 9 microplates.  Plates were 
incubated at 37ºC and readings were taken over a 24 hour period using an 
automated plate reader (BIOTEK Synergy 2) which measured the 
absorbance at 590nm.  
 
Sequencing and bioinformatic analysis 
The fosmid insert from clone SMG 25 was fully sequenced and 
assembled by GATC Biotech (Konstanz, Germany) using the GS FLX 
(Roche) pyrosequencing platform on a titanium mini-run.  Putative open 
reading frames were predicted using Softberry FGENESB bacterial operon 
and gene prediction software (available at www.softberry.com).  Retrieved 
nucleotide and translated amino acid sequences were functionally annotated 
by homology searches using the Basic Local Alignment and Search Tool 
(BLAST) using a maximum e-value cut-off of 1e-03, to identify homologous 
sequences from the National Centre for Biotechnology Information (NCBI) 
website: http://www.ncbi.nlm.nih.gov/blast/Blast.cgi.   
The following databases and tools were used to gain additional information 
on the StlA protein: Expasy ProtParam server, Conserved Domain Database 
(CDD), PROSITE motif search, SignalP 4.0, HMMER, TMHMM, HHPred, 
Softberry BProm promoter search (www.softberry.com), SOPMA, SWISS 
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MODEL, iTasser and QUARK. Relevant information and results can be found 
in Table 4 [30-41]. 
The Fold and Functional Assignment System (FFAS03) is a profile-
profile and fold recognition algorithm that can detect remote homology 
between proteins [42]. FFAS03 searches numerous databases including 
non-redundant NCBI protein sequence database (NCBI nr), Global Ocean 
Sampling (GOS) from JCVI (J. Craig Venter Institute), PDB (Protein Data 
Bank), SCOP (Structural Classification of Proteins), and COG (Clusters of 
Orthologous Groups), as well as numerous metagenome datasets (microbial 
metagenome samples from the Joint Genome Institute, human gut 
metagenome samples from the Hattori lab, human oral microbiome database 
from the Forsyth institute and GOS data from JCVI and CAMERA). 
Furthermore, FFAS03 searches against the MetaHit (Metagenomics of the 
Human Intestinal Tract) dataset [1], which contains over 3 million unique 
gene sequences from the human gut microbiome. The StlA protein sequence 
was submitted to the server to identify proteins with distant homology based 
on FFAS profiling or homologues by BLAST and PSI-BLAST (Position-
Specific Iterated BLAST) against the databases and metagenome datasets. 
The FFAS03 server can be found at: http://ffas.burnham.org/ffas-
cgi/cgi/document.pl 
The Integrated Microbial Genomes and Metagenomes (IMG/M) [43] is 
a data management system for the comparative analysis of metagenome 
sequence data. IMG/M-HMP [44] specifically contains metagenome data 
from the Human Microbiome Project (HMP) [45]. It contains 748 
metagenome datasets generated from sequencing samples from 17 different 
 
 
208 
 
body sites (number of samples from each site are in brackets); anterior nares 
(94), keratinised gingiva (6), buccal mucosa (122), hard palate (1), 
retroauricular crease (20), left (2) and right retroauricular crease (5), palatine 
tonsils (6), saliva (5), throat (7), tongue dorsum (133), sub- (8) and supra-
gingival plaques (127), mid-vagina (2), posterior fornix (60), vaginal introitus 
(3) and stool (147). It also provides tools for comparative analysis between 
hosted sequences and user supplied sequences. The StlA protein sequence 
was searched (maximum e-value cut-off of 1e-50) against all the available 
metagenomes (748) from the HMP as well against all bacterial (9049), 
archaeal (323), viral/phage (2809) and eukaryotic genome (183) sequences 
(both assembled and draft), as well as all sequenced plasmids (1193) and all 
other non-human metagenome datasets (representing >1,300 non-human 
samples) from diverse environments, including terrestrial, aquatic and host-
associated plants and animals (Supplementary File S1*) stored in the 
database at the time of writing (search date 19/09/13). The IMG/M-HMP 
server can be found at: http://img.jgi.doe.gov/cgi-bin/imgm_hmp/main.cgi. 
PhiSpy [46] was used to identify putative prophage genes and the 
boundaries of the putative prophage region on SMG 25.  
 
* Supplementary File S1 can be accessed on the PLOS ONE wesite at: 
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.008
2985;jsessionid=1EE719C721B576C1B180513AB3B44430 
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Taxonomic assignment of scaffolds 
 The scaffolds on which an stlA homologue was identified were 
subjected to BLASTX analysis (maximum e-value cut-off of 1e-50). The 
BLASTX results were downloaded and imported to MEGAN 4 (Metagenome 
Analyser 4software program [47] for taxonomic assignment. 
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Results 
Screening the metagenomic library 
Screening approximately 23,000 clones from a human gut 
metagenomic library led to the identification of 53 clones which were 
designated as conferring salt-tolerance (i.e. facilitating growth on LB 
supplemented with 6.5% NaCl, a concentration which inhibits the growth of 
the cloning host carrying an empty fosmid vector). Six clones (annotated Salt 
MetaGenome; SMG 1-6) grew within 24 hours and the remaining 47 grew in 
the following 24-48 hours. SMG 25 represents one of the “late-bloomers” and 
was chosen at random for analysis. End sequencing of the fosmid insert 
revealed it shared highest genetic identity to species from the genus 
Akkermansia, namely Akkermansia muciniphila ATCC BAA-835, 
Akkermansia muciniphila CAG:154 and Akkermansia sp. CAG:344. A 
muciniphila ATCC BAA-835, the type strain [48,49], is a mucin degrading 
member of the Phylum Verrucomicrobia which is commonly found in the 
human gut microbiome [50]. Growth was monitored spectrophotometrically, 
by measuring the optical density at 595nm (OD595nm). SMG 25 was shown to 
have a significant (unpaired student t-test, P <0.0001) growth advantage in 
the presence of NaCl compared to the EPI300 host strain carrying an empty 
fosmid vector (pCC1FOS) (Figure 1).   
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Figure 1.  
 
Figure 1:  Growth in LB broth supplemented with 6.5% NaCl.  Growth of E. 
coli EPI300::pCC1FOS host strain ( closed circle) and SMG 25 () open 
triangle) (P <0.0001). 
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Fosmid sequencing and analysis 
The fosmid insert from SMG 25 was fully sequenced and assembled 
by GATC Biotech (Konstanz, Germany) and was predicted to contain 45 
putative open reading frames that encode proteins (see Table 3). Translated 
nucleotide sequences were subjected to BLASTP analysis to identify 
homologous sequences in the database. Twenty-six of the genes encoded 
proteins corresponding to different species of Akkermansia (ranging from 34-
98% amino acid identity), but a sizeable proportion of the encoded proteins, 
approximately 27% (12/45) (highlighted in bold in Table 3) had no significant 
similarity to sequences in the database, indicating the presence of novel 
sequences. Overall, only 13 proteins could be assigned a putative function 
based on BLASTP searches, whilst the remaining genes encoded 
hypothetical or uncharacterised proteins. The full fosmid insert sequence of 
SMG 25 can be found in GenBank (accession number=JQ269600.1; 
gi=375342965). The G+C (guanine and cytosine) skew of the entire fosmid 
insert as well a picture of the G+C content of each individual gene are 
presented in Figure 7B and C respectively.  
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Table 3. List of putative proteins encoded on SMG 25 fosmid insert. 
Protein Length 
(aa) 
Highest similarity (BLASTP) Highest similarity organism (BLASTP) E-value % coverage % ID 
(Length of 
similarity, aa) 
Putative conserved domain(s) 
1 555 Serine/ threonine protein kinase Akkermansia sp. CAG:344 7.00E-53 50% 44% (285) None 
2 108 Hypothetical protein (Amuc_1368) Akkermansia muciniphila ATCC BAA-835 1.00E-04 86% 34% (98) None 
3 84 No significant similarity found n/a n/a n/a n/a n/a 
4 160 No significant similarity found n/a n/a n/a n/a n/a 
5 135 No significant similarity found n/a n/a n/a n/a n/a 
6* 257 No significant similarity found n/a n/a n/a n/a n/a 
7 157 No significant similarity found n/a n/a n/a n/a DnaJ zinc-finger 
8 201 Hypothetical protein O71_18246 Pontibacter sp. BAB1700 2.00E-06 36% 39% (77) DUF4339 
9 153 Hypothetical protein HALAR_0188 Halophilic archaeon DL31 1.00E-04 53% 36% (83) TM2  
10 320 Ankyrin repeat protein Synergistetes bacterium SGP1 2.00E-47 88% 45% (291) Ankyrin repeat 
11 73 Uncharacterized protein BN502_01474 Akkermansia muciniphila CAG:154 3.00E-04 54% 50% (40) None 
12 338 No significant similarity found n/a n/a n/a n/a n/a 
13 283 Uncharacterised protein BN502_01467 Akkermansia muciniphila CAG:154 0.00+00 100% 94% (283) DUF932 
14 99 Uncharacterized protein BN502_01466 Akkermansia muciniphila CAG:154 1.00E-59 100% 94% (99) None 
15 52 Uncharacterized protein BN502_01465 Akkermansia muciniphila CAG:154 2.00E-22 100% 98% (52) None 
16 160 Uncharacterized protein BN502_01464 Akkermansia muciniphila CAG:154 2.00E-99 100% 91% (160) None 
17 43 Uncharacterized protein BN502_01463 Akkermansia muciniphila CAG:154 4.00E-04 95% 90% (41) None 
18 317 Hypothetical protein (Amuc_1352 ) Akkermansia muciniphila ATCC BAA-835 9.00E-08 31% 40% (101) None 
19 79 No significant similarity found n/a n/a n/a n/a n/a 
20 159 Phage-associated protein Rhizobium lupini HPC(L) 3.00E-36 100% 52% (159) DUF4065, GepA 
21 264 Hypothetical protein EC2865200_1013 Escherichia coli 2865200 5.00E-26 67% 45% (181) None 
22 154 Uncharacterized protein BN502_01474 Akkermansia muciniphila CAG:154 2.00E-31 72% 56% (114) None 
23 514 No significant similarity found n/a n/a n/a n/a n/a 
24 129 No significant similarity found n/a n/a n/a n/a Fimbrial OM usher protein 
25 551 No significant similarity found n/a n/a n/a n/a n/a 
26 52 Hypothetical protein HALA3H3_770002 Halomonas sp. A3H3 2.00E-04 73% 63% (38) None 
27 657 H(+)-transporting two-sector ATPase Akkermansia sp. CAG:344 0.00E+00 88% 92% (584) TrkH superfamily 
28 445 MATE efflux family protein (Amuc_1131) Akkermansia sp. CAG:344 0.00E+00 95% 87% (445) MATE, NorM 
29 49 No significant similarity found n/a n/a n/a n/a n/a 
30 54 No significant similarity found n/a n/a n/a n/a n/a 
31 278 Putative uncharacterized protein Akkermansia sp. CAG:344 8.00E-56 100% 70% (279) None 
32 87 Putative uncharacterized protein Akkermansia sp. CAG:344 3.00E-31 100% 83% (87) None 
33 186 Hypothetical protein (Amuc_1127) Akkermansia muciniphila ATCC BAA-835 2.00E-61 81% 83% (153) None 
34 450 Dimethyladenosine transferase Akkermansia sp. CAG:344 0.00E+00 99% 91% (448) ksgA, NUDIX hydrolase 
35 393 UDP-galactopyranose mutase Chthoniobacter flavus Ellin428 7.00E-109 96% 52% (381) GLF, NAD binding 
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36 329 UDP-glucose 4-epimerase Akkermansia muciniphila ATCC BAA-835 0.00E+00 100% 96% (329) UDP_G4E_1_SDR_e 
37 55 Hypothetical protein (Amuc_1123) Akkermansia muciniphila ATCC BAA-835 6.40E-03 85% 43% (39) None 
38 511 Hypothetical protein (Amuc_1124) Akkermansia muciniphila ATCC BAA-835 0.00E+00 98% 86% (504) Isoprenoid_C2_like  
39 144 Sulphate transporter/anti-sigma factor antagonist Akkermansia muciniphila ATCC BAA-835 4.00E-89 100% 90% (144) STAS superfamily  
40 453 Putative uncharacterized protein Akkermansia sp. CAG:344 3.00E-180 99% 69% (454) DUF2851  
41 466 Glutamate decarboxylase Akkermansia muciniphila CAG:154 0.00E+00 100% 91% (466) AAT_I superfamily  
42 1217 Outer membrane auto-transporter protein Akkermansia sp. CAG:344 3.00E-96 100% 83% (1217) Auto-transporter superfamily 
43 142 Hypothetical protein (ANACAC_03730 ) Anaerostipes caccae DSM 14662 4.00E-55 99% 69% (141) NAT_SF domain 
44 132 GCN5-related N-acetyltransferase Akkermansia sp. CAG:344 8.00E-56 97% 81% (129) NAF_SF domain 
45 947 DNA polymerase III, alpha subunit Akkermansia muciniphila CAG:154 0.00E+00 100% 95% (938) DNA_polymerase_III  
 
Abbreviations and symbols: aa (amino acids); n/a (not applicable); %ID (% identity at amino acid level); DUF (Domain of Unknown Function); OM (outer 
membrane); Asterisk (*) indicates stlA gene product. Text in bold indicates that no homologues for these gene products were found following BLAST 
searches of NCBI database
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Transposon (EZ-Tn5) mutagenesis and cloning of the stlA gene 
Transposon mutagenesis was performed on clone SMG 25 and a 
transposon insertion in gene 6 was identified which eliminated the growth 
advantage under osmotic stress; this locus (designated stlA) is predicted to 
encode a protein of 257 amino acids which, at the time of writing, has no 
homologues in the database. The transposon insertion was found to be 
between amino acid position 136 (alanine) and 137 (glutamine) of the 
protein. The stlA gene was cloned, along with some flanking DNA that was 
predicted to contain the native promoter region (predicted with BProm 
program; see Table 4 for details), into the shuttle plasmid pCI372 and 
transformed into E. coli MKH13 and L. lactis MG1363. 
 
Growth experiments and BIOLOG phenotypic microarray 
E. coli MKH13 cells transformed with a plasmid bearing a copy of the 
stlA gene were grown in LB broth containing various concentrations of NaCl 
(from 0-5% w/v added NaCl). It was observed that a statistically significant 
(unpaired student t-test) growth advantage was conferred upon the stlA+ 
cells compared to control strain MKH13 carrying an empty plasmid in LB 
broth supplemented with both 3% (P =0.0019) and 4% NaCl (P <0.0001) 
(Figure 2B and C, respectively), while growth was similar in LB alone (Figure 
2A). 
 Due to the uncharacterised and non-homologous nature of the stlA 
gene and its encoded protein, growth of control strain MKH13 and stlA+ 
strains was compared under 96 different conditions using BIOLOGs 
phenotypic microarray (PM) technology [29] to identify possible further 
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phenotypic changes.  Strains were tested on BIOLOG plate PM9, which 
contains different osmotic stress conditions and osmolytes for analysis. In 
addition to NaCl, the results indicated stlA+ had an increased growth 
phenotype in the presence of potassium chloride (KCl). Confirmatory growth 
curves were performed in LB broth supplemented with a concentration of 4% 
KCl. A statistically significant (unpaired student t-test) growth advantage was 
observed for stlA+ in LB supplemented with 4% KCl (P <0.0001) compared to 
control strain MKH13 (Figure 2D).  
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Figure 2. Growth in LB broth and LB broth supplemented with 3 or 4% NaCl. 
Growth of E. coli MKH13::pCI372 () and E. coli MKH13::pCI372-stlA () in 
(A) LB broth, (B) LB broth + 3% NaCl (P =0.0470), (C) LB broth + 4% NaCl 
(P <0.0001) and (D) LB broth + 4% KCl (P <0.0001). P-values were 
determined using the student t-test (unpaired). 
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The stlA genes’ ability to increase salt tolerance was also tested in a Gram 
positive host; L. lactis MG1363. There was no observable increase in salt 
tolerance in L. lactis MG1363 carrying a plasmid encoded copy of stlA 
compared to L. lactis carrying an empty copy of the plasmid, while a similar 
growth rate and final OD value was observed for both strains in GM17 broth 
alone (Figure 3A and 3B)  
 
Figure 3.  
 
  
 
Figure 3. Growth of L. lactis MG1363::pCI372 and L. lactis 
MG1363::pCI372-stlA in GM17 broth and GM17 broth + 4% NaCl. The stlA 
gene did not provide a protective effect in a Gram-positive host under NaCl 
stress, which is noteworthy as the StlA protein is predicted to be inserted in 
the outer membrane. Results are presented as the average of triplicate 
experiments, with error bars being representative of the standard error of the 
mean (SEM). 
 
A                     GM17 broth
Time/ hrs
0 10 20 30 40 50
O
D
 5
9
5
 n
m
0.0
0.5
1.0
1.5
2.0
MG1363::pCI372
MG1363::pCI372-stlA
B                      GM17 + 4% NaCl
Time/ hrs
0 10 20 30 40 50
O
D
 5
9
5
 n
m
0.0
0.5
1.0
1.5
2.0
MG1363::pCI372
MG1363::pCI372-stlA
 
 
219 
 
Growth of both strains was also assessed under conditions of non-
ionic osmotic stress (in the form of glycerol and sucrose), low pH and in both 
porcine and human bile, as all three stress conditions are commonly 
encountered in the GI tract. Growth of both strains was inhibited at pH 2.5 
and pH 3.5, while no significant difference in growth was observed at pH 4.5 
or pH 5.5, in the presence of sucrose or glycerol, or in the presence of either 
porcine or human bile (Figure 4). 
 
Figure 4.  
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Figure 4. Growth of E. coli MKH13::pCI372 and E. coli MKH13::pCI372-stlA  
in LB broth supplemented with numerous stresses associated with the GI 
(gastrointestinal) tract, such as non-ionic osmotic stress, low pH and bile. A 
plasmid-encoded copy of the stlA gene did not confer increased tolerance to 
any of these stresses when expressed in E. coli MKH13. Results are 
presented as the average of triplicate experiments, with error bars being 
representative of the standard error of the mean (SEM). 
E                   LB (pH 4.5)
Time/ hrs
10 20 30 40 50
O
D
 5
9
5
 n
m
0.2
0.4
0.6
0.8
MKH13::pCI372
MKH13::pCI372-stlA
F                     LB (pH 5.5)
Time/ hrs
10 20 30 40 50
O
D
 5
9
5
 n
m
0.2
0.4
0.6
0.8
MKH13::pCI372
MKH13::pCI372-stlA
G                 LB + 0.2% porcine bile 
Time/ hrs
5 10 15 20 25
O
D
 5
9
5
 n
m
0.2
0.4
0.6
0.8
MKH13::pCI372
MKH13::pCI372-stlA
H                  LB + 0.5% porcine bile 
Time/ hrs
5 10 15 20 25
O
D
 5
9
5
 n
m
0.0
0.2
0.4
0.6
0.8
MKH13::pCI372
MKH13::pCI372-stlA
I                     LB + 1% human bile
Time/ hrs
5 10 15 20 25
O
D
 5
9
5
 n
m
0.0
0.2
0.4
0.6
0.8
MKH13::pCI372
MKH13::pCI372-stlA
 
 
221 
 
Bioinformatic analysis of StlA 
The databases and tools used to identify features of StlA are 
presented in Table 4 below, along with the results of the analyses. An 
illustration of the stlA gene and its associated features is presented in Figure 
7D. 
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Table 4. Bioinformatic analysis of StlA protein sequence. 
Database/ Tool used Comment(s) Feature(s) identified Ref. 
Expasy ProtParam  Allows the computation of various physical and chemical parameters for a given protein 
stored in Swiss-Prot or TrEMBL or for a user entered sequence 
Molecular weight = 28.62 kDa; Theoretical pI = 6.39 [38] 
Conserved domain 
database (CDD) 
Protein annotation resource that consists of a collection of well-annotated multiple sequence 
alignment models for ancient domains and full-length proteins. 
No conserved domains were detected [34] 
PROSITE motif search Consists of documentation entries describing protein domains, families and functional sites 
as well as associated patterns and profiles to identify them 
No motifs were detected [36] 
SignalP 3.0 Predicts the presence and location of signal peptide cleavage sites in amino acid sequences 
from different organisms 
Predicted signal peptide at position 1-35 [31] 
HMMER Searches sequence databases for homologs of protein sequences, and for making protein 
sequence alignments 
Predicted signal peptide at position 1-35; Four predicted TM 
regions and one disorder region 
[32] 
TMHMM Prediction of transmembrane (TM) helices in proteins Predicted four TM regions [41] 
HHPred Homology detection & structure prediction by HMM-HMM (Hidden Markov Model) 
comparison 
Detected outer membrane insertion C-terminal signal, 
OmpP85 
[37] 
BProm promoter search Prediction of bacterial promoters -10 box predicted 56 base pairs upstream of ATG start 
codon; TCTTATCAT; -35 box predicted 77 base pairs 
upstream of ATG start codon; TTGGCT 
www.softberry.com 
 
SOPMA Secondary structure prediction Alpha-helix; 166/257 residues = 64.6%; Extended strand; 
26/257 residues = 10.1%; Beta-turn; 18/257 residues = 
7.00%; Random coil; 47/257 residues = 18.3% 
[33] 
SWISS MODEL Automated protein structure homology-modelling server No similar or suitable template structures found [30] 
iTASSER  Protein structure and function predictions. 3D models are built based on multiple-threading 
alignments 
All 5 predicted 3D models had a C-score of -3.41 or less 
which are below the -1.50 threshold for a high-confidence 
prediction of structure 
[35,40] 
QUARK  Algorithm for ab initio protein folding and protein structure prediction, using amino acid 
sequence only. Since no global template information is used in QUARK simulation, the 
server is suitable for proteins which are considered without homologous templates 
Of the 10 predicted 3D models, the top template modelling 
(TM) score was 0.342 ±0.083, which is below the threshold 
of TM-score >0.50 for predicted correct fold 
[39] 
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IMG/M-HMP analysis 
The StlA protein sequence was screened against all available 
metagenomes from the human microbiome project (HMP) using BLASTP on 
the IMG/M-HMP website (http://img.jgi.doe.gov/cgi-bin/imgm_hmp/main.cgi) 
[45], which were sampled from 17 body sites giving a total of 748 samples.  
In addition, all available finished, permanent draft and draft genome 
sequences for Bacteria, Archaea, Eukarya and viruses/phages, as well as all 
available sequenced plasmids were searched using BLASTP for homologous 
sequences to StlA.  There was no significant similarity for the StlA protein to 
any of the bacterial, archaeal, eukaryotic, viral or plasmid 
genomes/sequences, nor to any non-human associated metagenomes (over 
1,300 samples from more than 200 metagenomes, see supplementary File 
S1*). The only similarity to StlA among the sampled microbiomes was to 
human stool microbiome samples, where 10 similar proteins from 8 different 
subjects (out of 100) (Table 5) were identified on different scaffolds. The date 
of the last search was on 19/09/13. The taxonomic assignment of the 
scaffolds can be seen in Figure 5. 
 
* Supplementary File S1 can be accessed on the PLOS ONE wesite at: 
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.008
2985;jsessionid=1EE719C721B576C1B180513AB3B44430
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Table 5. Gene, scaffold and subject information from which stlA homologues were found in Human Microbiome Project (HMP) dataset. 
 
Table 5. Information for stlA homologues found in HMP dataset, including scaffold and subject of origin. Symbols (* and ǂ) indicate detection of stlA homologue more than once from same subject. 
The StlA amino acid sequence was used to search against all 748 metagenome datasets from different body sites from the Human Microbiome Project (HMP) (1e-50 maximum e-value cut-off). Ten 
StlA homologues were identified in 8 different subjects. No StlA homologues were found in any other body site metagenome. 
 
 
 
Stool Microbiome 
Subject ID  
(Visit number) 
Gene ID 
 
Strand 
 
Start 
Coordinate 
End 
Coordinate 
 Length 
(bp) 
Length 
(aa) 
 
% ID to StlA (aa) Gene Product Name 
(stlA homologue) 
Scaffold Length 
(bp) 
Scaffold 
GC % 
N/A stlA (from clone SMG 25; this study) + 3193 3966 774 257 
 
 
100% (257)    
putative membrane 
protein 
44331  
(fosmid insert) 0.53 
*159753524 (2) SRS053214_LANL_scaffold_17021__gene_42707 - 25802 26569 768 255 
 
59% (237) hypothetical protein 33560 0.5 
*159753524 (3) SRS077730_LANL_scaffold_24345__gene_72567 + 2793 3560 768 255 
 
           59% (237) membrane protein 13529 0.49 
ǂ
764143897 (1) SRS015217_WUGC_scaffold_30292__gene_65222 - 463 1236 774 257 
 
82% (237) membrane protein 5672 0.5 
ǂ
764143897 (2) SRS051882_Baylor_scaffold_22757__gene_50812 - 1791 2564 774 257 
 
82% (237) membrane protein 7074 0.49 
160643649 (1) C2121591__gene_151559 + 1333 2157 825 274 
 
89% (234) membrane protein 5507 0.48 
158944319 (1) C3406971__gene_199744 - 248 1072 825 274 
 
80% (234) membrane protein 3122 0.52 
159591683 (2) SRS024549_LANL_scaffold_1815__gene_4559 - 4475 5248 774 257 
 
82% (237) membrane protein 10434 0.5 
158337416 (2) C2998990__gene_162710 + 340 972 633 211 
 
81% (211) hypothetical protein 974 0.45 
765013792 (1) SRS018656_WUGC_scaffold_544__gene_591 - 13762 14535 774 257 
 
83% (237) membrane protein 26364 0.51 
159510762 (2) SRS024075_LANL_scaffold_21370__gene_63545 - 21610 22320 711 236 
 
          82%  (216) hypothetical protein 35617 0.5 
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Figure 5. Taxonomic assignment of scaffold sequences from Human Microbiome Project on which an stlA homologue was 
found  
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The gene neighbourhoods around the genes homologous to stlA on 
each scaffold were investigated in an attempt to gain information on possible 
functions and conserved gene arrangements (Figure 6). The genes most 
commonly flanking the stlA homologues were on the same strand of DNA 
and encoded an ankyrin repeat protein (COG0666), a DnaJ class molecular 
chaperone with C-terminal zinc-finger domain (COG0484) and a predicted 
membrane protein (COG2314; Pfam05154 –TM2 domain). There are also a 
number of hypothetical proteins, for which no additional information is 
currently known. On two of the larger scaffolds, genes for a restriction 
modification system are present, as well as an integrase/site specific 
recombinase protein (COG4974; Pfam00589), indicating some of this region 
may have been acquired by lateral gene transfer (LGT) and may represent 
prophage DNA. A phage-associated protein is predicted to be encoded by 
gene 20 (designated “P” in Figure 7C) indicating the presence of a prophage 
on SMG 25 also.  The fosmid insert of SMG 25 was analysed with PhiSpy 
[46] to identify possible prophage genes and the boundaries of the prophage 
region. PhiSpy predicted the prophage region to run from the start of gene 3 
(nucleotide position 2024) to the end of gene 42 (nucleotide position 39972). 
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Figure 6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Gene neighbourhood region of the stlA gene from SMG 25 compared with 
gene neighbourhoods from scaffolds with a stlA homologue. Homologues of stlA 
were identified through similarity searches (BLASTP; 1e-50 cut-off) to the Human 
Microbiome Project (HMP) datasets. Ten stlA homologues were identified and only 
from the stool microbiome. A legend describing putative gene functions is presented 
below.  
 
 
228 
 
Legend:  hypothetical/membrane protein (stlA and homologues); Hypothetical protein;
 COG0838 - NADH:ubiquinone oxidoreductase;  COG0738 - Fucose permease;  
COG4974 - Site-specific recombinase, XerD; COG3550 - Uncharacterized protein related 
to capsule biosynthesis enzymes; COG3183 - Predicted restriction endonuclease;  
COG1451 - Predicted metal-dependent hydrolase; COG0610 - Type I site-specific 
restriction-modification system;  COG0732 - Restriction endonuclease;  COG0286 - 
Type I restriction-modification system methyltransferase subunit; COG1715 - Restriction 
endonuclease;  COG3857 - ATP-dependent nuclease;  COG2314 - Predicted 
membrane protein (TM2 domain); COG0484 - DnaJ-class molecular chaperone with C-
terminal Zn finger domain;  COG0666 - Ankyrin repeat protein;  COG0515 - 
Serine/threonine protein kinase;  COG4245 - Uncharacterized protein with von Willebrand 
factor (vWF) domain; COG4248 - Uncharacterized protein with protein kinase and helix-
hairpin-helix DNA-binding domains;  COG3943 - Virulence protein; COG2887 - RecB 
family exonuclease;  COG0667 - Predicted oxidoreductase;  COG1073 - Hydrolases of 
the alpha/beta superfamily; COG2207 - Transcriptional regulator, AraC-type DNA-binding 
domain-containing proteins;  COG1373 - Predicted ATPase (AAA+ superfamily); 
COG1961 - Site-specific recombinase, DNA invertase Pin homologs; COG3177 - 
Filamentation induced by cAMP protein; COG4889 - Predicted helicase 
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FFAS03 analysis 
The FFAS03 server [42] was used to detect distant homology and fold 
recognition to StlA. FFAS analysis was also carried out on the protein 
sequences encoded by the neighbouring genes of stlA on SMG 25, which 
also lacked any homologues in the databases (i.e. gene 3, 4, 5 and 7; gene 6 
is stlA). The results of FFAS03 analysis are summarised in Figure 7A).  
In addition to a profile-profile and a fold and functional assignment, the 
FFAS03 server also carries out a BLAST and PSI-BLAST search of the user 
sequence against numerous databases and metagenome datasets. The StlA 
protein was found to share significant similarity to a protein from two 
individuals from the MetaHit dataset [1]. These sequences corresponded to 
samples MH0011 (a healthy Danish female) and V1.CD-14 (a Spanish 
female with Crohn’s disease) which shared 60% identity (over 210 amino 
acids) and 82% identity (over 224 amino acids) respectively to StlA.  
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Figure 7.  
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Figure 7. Bioinformatic analysis of SMG 25 fosmid insert. 
(A) FFAS03 analysis of the StlA protein and the encoded proteins of flanking 
genes was performed to identify putative distant structural homologues. A 
score of -9.50 or lower is considered significant. (B) Representation of the 
G+C skew of the entire fosmid insert of SMG 25. (C) Representation of the 
gene arrangement on SMG 25. Gene lengths are approximately to scale and 
colour coding represents G+C content of each individual gene which can be 
determined from the G+C content gradient bar. The presence of a phage-
associated gene and clear separation in G+C content over the length of the 
fosmid insert indicates much of this region may have been acquired via 
lateral gene transfer (LGT). Phage-associated gene is marked “P”, while the 
stlA gene is indicated with an asterisk (*) symbol. Genes are numbered as 
indicated in Table 3 and as mentioned in the text. Numbering of some 
shorter genes has been excluded for clarity. Selected nucleotide positions (in 
base pairs) are displayed in bold italic font above genes. (D) A detailed view 
is presented of the nucleotide and amino acid sequence of the stlA gene and 
StlA protein respectively. The putative start codon is in green, while a 250 
base-pair region upstream of this is shown to include putative -35 and -10 
promoter regions (underlined) and a predicted rpoD transcription factor 
binding site (in bold). Amino acids surrounded by grey box indicate the 
predicted signal sequence of StlA and those highlighted in blue represent 
four transmembrane regions. The location of the EZTn5 transposon insertion 
is indicated with a red triangle. 
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Detection of stlA in metagenomic DNA from human stool samples 
using PCR 
The primer pair (stlA FP and stlA RP) initially used to amplify the stlA 
gene for cloning was unable to amplify PCR products in any of the 
metagenomic DNA samples (isolated from human stool microbiota), so a set 
of primers (stlA-J FP and stlA-J RP) were designed to amplify an internal 
fragment of the gene. This set of primers amplified numerous products of the 
correct size but these were found to be false positives following sequencing. 
An alignment was generated for StlA and homologous sequences from the 
stool microbiome from the HMP and MetaHit datasets to identify the most 
highly conserved regions (Figure 8) and different primer pairs were designed 
(stlA-OUT FP and RP; stlA-IN FP and RP). Two of the 25 metagenomic DNA 
samples tested (isolated from human faecal samples from ELDERMET [27] 
and another study {Knopp, 2010 #464}) generated PCR products of the 
correct size, which were confirmed to be stlA homologues following 
sequencing by using the stlA-IN FP and RP primer pair. One positive PCR 
product shared 72% nucleotide identity over approximately 300 base pairs 
(BLASTN versus stlA gene) and 64% identity (over 100 amino acids) using 
BLASTX, while one ELDERMET [27] sample was positive (community care/ 
healthy old) and confirmed by sequencing (87% identity over 339 nucleotides 
and 85% identity over 112 amino acids). 
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Figure 8. Multiple sequence alignment of StlA protein sequence with HMP and MetaHit homologues. 
                              10        20        30        40        50        60        70        80        90 
                                                                          *         *     *********   * *   *** ** ** 
(A) -----------------MDTVRQRQGLGIKRSMLTALLMGFCCLFYAPEAFSQEESSALPKQSGLDEDMAKGVALVKQRYGEQLRNQYMGGATTAKEYAIGALRMENDIAKAEA  97 
(B) -----------------MNTIRHVQGAWFKKRILTVLLLGVCCLFYPHNALSQDEPSTPPQKTGMQLDMEKGMEQARKRSGDQLYNQYMGGATTAGQYAIGAAQMENAIAEAER  97 
(C) -----------------MNTVRQRQRLGIKRSILTALLMGFCFLFYTPEAFSQDEPGSPPKKSGLAEDMEKGIAQANQRYGQQLYQQYMGGATTAKECAIGVLRMENAIAEAEG  97 
(D) MQAKSYPDGINTNTNITMNTVRQRQRLGIKRSILTALLMGFCCLFYAPEAFSQDEPGAPSQRTAMDDDFDKSMAQARQQYGNRLYQQYMGGATTAKERAIGVLRMENAIAEAEG 114 
(E) -----------------MNTVRQRQRLGIKRSILTALLMGFCFLFYTPEAFSQDEPGSPPKKSGLAEDMEKGIAQADQRYGQQLYQQYMGGATTAKECAIGVLRMENAIAEAEG  97 
(F) -----------------MNTVRQRQRLGIKRSILTALLMGFCFLFYTPEAFSQDEPGSPPKKSGLAEDMEKGIAQANQRYGQQLYQQYMGGATTAKECAIGVLRMENAIAEAEG  97 
(G) -----------------MNTIRHVQGAWFKKRILTVLLLGVCCLFYPHNALSQDEPSTPPQKTGMQLDMEKGMEQARKRSGDQLYNQYMGGATTAGQYAIGAAQMENAIAEAER  97 
(H) --------------------------------------MGFCFLFYTPEAFSQDEPGSPPKKSGLDEDMEKGIAQARQQYGNRLYQQYMGGATTAKERAIGVLRMENAIAEAEG  76 
(I) -----------------MNTVRQRQRLGIKRSILTALLMGFCFLFYTPEAFSQDEPGSPPKKSGLAEDMEKGIAQANQRYGQQLYQQYMGGATTAKECAIGVLRMENAIAEAEG  97 
(J) MQAKSCREAINTNTNITMNTVRQRQRLRIKRSILTALLMGFCFLFYTPEAFSQEESSALPKQSGLDEDMAKGIALAKQRYGEQLRNQYMGGATTAKEYAIGALRMENDIAKAEG 114 
(K) ----------------------------------------------------------------MQAEFDKGTAQNRKRYGDQVYDQYMGGTTTAGQKAVGAAQMENAIAVAEG  50 
(L) --------------------------------------MGFCFLFYTPEAFSQDEPGSPPKKSGLDEDMEKGMAQARQQYGNRLYQQYMGGATTAKERAIGALRMENAIAEAEG  76 
 
            *    *  ** ***     *      * ***  **  ***** ***   **   *          **  *** *   ** ** *   ****** *****  ******  * ** 
(A) EGNTSLANALRQQLAMAQRTNEWYNGELQQKADAGDTRAQRELDEYYAFMKTVEGSSPAGSFPFLISIISGLLLYGYIVLLSPKDATINRKTLIPWCVGLAVFDMLGNWVNQSW 211 
(B) NGNTGRANMLREQLARANSNNQWYLNELKQKADAGDAGAQRELNEYYELIKTSTPSLP--AVPFVVSIIFGLLFYWCMVLFSPRDTILNRKTLILWCVGLTVFDMLGNLTNSSW 209 
(C) KGDTAQANALRQQLARAQSNNEWSIGHLQQKANVGDTRAQRELDEYYAFMKTVEGSSPGEAFPFLISIISGLLLYGYIVLLSPKDATINRKTLIPWCVGLAIFDMLGNWVNQSW 211 
(D) KGDTAQANALRQQLAMAQSNNEWSTGHLQQKANAGDTRAQRELDEYYAFMKTVEGSSPGEAFPSLISIISGLLLYGYIVLLSPKDATINRKTLIPWCVGLAIFDMLGNWVNQSW 228 
(E) KGDTAQANALRQQLAMAQSNNEWSIGHLQQKANVGDTRAQRELDEYYAFMKTVEGSSPGEAFPFLISIISGLLLYGYIVLLSPKDATINRKTLIPWCVGLAIFDMLGNWVNQSW 211 
(F) KGDTAQANALRQQLARAQSNNEWSIGHLQQKANVGDTRAQRELDEYYAFMKTVEGSSPGEAFPFLISIISGLLLYGYIVLLSPKDATINRKTLIPWCVGLAIFDMLGNWVNQSW 211 
(G) NGNTGRANMLREQLARANSNNQWYLNELKQKADAGDAGAQRELNEYYELIKTSTPSLP--AVPFVVSIIFGLLFYWCMVLFSPRDTILNRKTLILWCVGLTVFDMLGNLTNSSW 209 
(H) KGDTAQANALRQQLAMAQSNNEWSTGHLQQKANAGDTRAQRELDEYYAFMKTVEGSSPGEAFPFLISIVSGLLLYGYIVLLSPKDATINRKTLIPWCVGLAIFDMLGNWVNQSW 190 
(I) KGDTAQANALRQQLARAQSNNEWSIGHLQQKANVGDTRAQRELDEYYAFMKTVEGSSPGEAFPFLISIISGLLLYGYIVLLSPKDATINRKTLIPWCVGLAIFDMLGNWVNQSW 211 
(J) EGNTELANMLRQQLAAVQQANQISNTELQQKANVGDTRAQRELDEYYAFMKTVEGSSPGEAFPFLISIISGLLLYGYIVLLSPKDATINRKTLIPWCVGLAIFDMLGNWVNQSW 228 
(K) KGDTAQADMLRQQLARANSNNQWYLNELKQKADAGDAGAQRELNEYYELIKTSTPSLP--AVPFVVSIIFGLLFYWCMVLFSPRDTILNRKTLILWCVGLTVFDMLGNLTNSSW 162 
(L) KGDSTQANYLRQQLAMAQSNNEWANGKLQQKANAGDTRAQRELDEYYAFMKTVKGSSSADLFPFLISIISGLLLYGYIVLLSPKDATINRKTLIPWCVGLAIFDMLGNWVNQSW 190 
 
         **** * * **  ** *  ****    **  ***  
(A) LFLFVEILIILVVARNFQCSWKRSFAILGLMLVSILILGGLLPLFF 257 
(B) LFLFGEVLAILLIARSFKYSWKRTFSFLGIVLVSVLILGGLLTTFL 255 
(C) LFLFVEILVILVVARNFQCSWKRSFAILGLMLVSILILGGLLPLFF 257 
(D) LFLFVEILVILVVARNFQCSWKRSFAILGLMLVSILILGGLLPLFF 274 
(E) LFLFVEILVILVVARNFQCSWKRSFAILGLMLVSILILGGLLPLFL 257 
(F) LFLFVEILVILVVARNFQCSWKRSFAILGLMLVSILILGGLLPLFF 257 
(G) LFLFGEVLAILLIARSFKYSWKRTFSFLGIVLVSVLILGGLLTTFL 255 
(H) LFLFVEILIILVVARNFQCSWKRSFAILGLMLVSILILGGLLPLFF 236 
(I) LFLFVEILVILVVARNFQCSWKRSFAILGLMLVSILILGGLLPLFF 257 
(J) LFLFVEILVILVVARNFQCSWKRSFAILGLMLVSILILGGLLPLFL 274 
(K) LFLFGEVLAILLIARSFKYSWKRTFSILGIVLVSVLILGGLLTTFL 208 
(L) LFLFVEILVILVVARNFQCSWKRSFAILGLMLVS------------ 224  
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Figure 8. Multiple sequence alignment of StlA protein sequence with HMP and MetaHit homologues. Black 
shading indicates regions of 100% amino acid identity. Putative transmembrane regions for StlA, predicted by 
TMHMM, are indicated with red boxes. Truncated or partial sequence fragments from HMP were not included (n=4). 
Information on the protein sequences (A) – (J) is indicated in the legend below.  
(A) StlA protein sequence; (B) SRS053214_LANL_scaffold_17021__gene_42707;  
(C) SRS024549_LANL_scaffold_1815__gene_4559; (D) C3406971__gene_199744;  
(E) SRS018656_WUGC_scaffold_544__gene_591; (F) SRS015217_WUGC_scaffold_30292__gene_65222;  
(G) SRS077730_LANL_scaffold_24345__gene_72567; (H) SRS024075_LANL_scaffold_21370__gene_63545; 
(I) Baylor_scaffold_22757__gene_50812; (J) C2121591__gene_151559;  
(K) MetaHit_MH0011_GL0108025[Complete]locus=scaffold6530_52:7938:8564 
(L) MetaHit_V1_GL0100177 [Complete] locus=scaffold36986_1:2178:2888.
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Discussion 
Functional screening of metagenomic libraries has the power to reveal 
novel functions for known genes or to identify completely novel genes and 
proteins. In the present study we describe the identification of an unknown 
protein (annotated StlA) from the human gut microbiome, which lacks any 
current homologues in the databases. The encoding gene (stlA), when 
expressed in E. coli, conferred a salt tolerance phenotype and may represent 
a novel stress resistance gene found exclusively among the human gut 
microbiota. This builds on previous work by our group, where we identified a 
novel function (i.e. increased salt tolerance) for five previously annotated 
genes (galE, mazG and murB) when expressed in E. coli [21].  
Sequencing of the full fosmid insert from SMG 25 revealed an 
interesting gene landscape (Table 3), with approximately 58% of the 
predicted genes encoding proteins which shared highest genetic identity to 
different species of Akkermansia and 27% having no homologues in the 
databases. The Akkermansia-associated proteins and the “unknown” 
proteins are interspersed with proteins associated with different phyla such 
as Bacteroidetes/Chlorobi group, Synergistetes, Proteobacteria, Chlamydiae/ 
Verrucomicrobia group and Firmicutes, as well as Archaea. The percentage 
identity at the amino acid level ranges from 36-69%, revealing a diverse 
range of proteins encoded within approximately 44kb of fosmid insert DNA 
(Table 3).  
The G+C content of the entire fosmid insert is 52.97%, which is close 
to the average G+C content (55.8%) of the A. muciniphila genome [49]. The 
region from position 2024 (gene 3) to position 20148 (gene 26), which mainly 
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consists of unknown genes or non-Akkermansia-associated genes has a 
lower G+C content of 47.97%. The region of the fosmid containing mainly 
Akkermansia-associated genes (from gene 27 at position 20120 to the end of 
the fosmid) has a G+C content of 56.73%, in line with the A. muciniphila 
genome (55.8%). A putative prophage region was predicted (using PhiSpy) 
to be present on SMG 25, running from gene 3 to 42 inclusive. It is difficult to 
say how reliable this prediction is because the criteria used by PhiSpy to 
predict prophage genes are strongly assisted by the degree of relatedness of 
the PhiSPy training genome sets and the genome/ DNA of the query 
organism [46]. Unfortunately PhiSPy does not contain an Akkermansia or 
Verrucomicrobial training genome, which would increase the predictive value 
of the result. However, by looking at the G+C skew of SMG 25 and the G+C 
content of each individual gene on SMG 25 (Figure 7B and C, respectively), 
it seems the prophage could indeed begin at gene 3, but it is possible that it 
ends somewhere between gene 23 and 26, as there is a clear difference in 
G+C content visible between this region and from gene 27 to 45 at the 3’-end 
of the fosmid (Figure 7B and C). Taken together, this data suggests that 
much of this region may have been acquired through LGT.  
StlA is predicted to be a 257 amino acid, 28.62kDa membrane protein 
with four transmembrane regions. No conserved domains or motifs were 
detected, indicating the novelty of the protein. A signal peptide and a C-
terminal outer membrane insertion signal are predicted to be present, 
suggesting that StlA may be exported to and inserted in the outer membrane.  
Furthermore, StlA possesses C-terminal phenylalanine residues, which are 
characteristic of, and highly conserved in, outer membrane proteins [51]. A 
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detailed illustration of these features is presented in Figure 7D, along with 
putative promoter and transcription factor binding sites. The outer membrane 
itself is an important mediator to external stresses, serving as a permeability 
barrier and protecting the cell from compounds in the environment, while 
outer membrane proteins, specifically porins, play an significant role in the 
cellular responses to salt and osmotic stress [15,52,53].  It is noteworthy, 
given the likely location in the outer membrane, that StlA did not confer a salt 
tolerance phenotype on a Gram-positive host (L. lactis) (Figure 3). 
 Predictive 3D modelling was carried out with SWISS MODEL [30] and 
iTasser [35,40]. However, the results were not statistically significant, most 
likely due to the lack of any suitable template structure in the databases to 
build an appropriate model. Ab initio structure prediction was attempted 
using QUARK [39] as no template information is required and is thus suitable 
for proteins with no homologues. Again the results were not significant, but 
this is most likely due to the inherent difficulty and current limited ability of ab 
initio prediction. Successful cases of ab initio prediction have been limited to 
proteins of 100 residues or less and the fact remains that there are really no 
methods to predictively fold proteins of >200 amino acids without template 
modelling at present [39]. 
As no sequence-based homology for StlA could be determined with 
BLAST analysis, a more sensitive profile-profile comparison with FFAS03 
[42] was used to detect remote homology through fold and structure 
recognition, as proteins with a similar structure or fold can have a common 
function in the absence of any sequence similarity. The highest score for StlA 
corresponded to a hypothetical protein from Caulobacter crescentus, which 
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has a TspO/MBR domain. Members of this group are involved in 
transmembrane signalling and are located in the outer membrane [54,55]. 
They are associated with the major outer membrane porins (in prokaryotes) 
and with the voltage-dependent anion channel (in mitochondria), which links 
with the earlier observation that StlA may be inserted in the outer membrane. 
Such proteins have also been linked to desiccation stress in the bacterium 
Bradyrhizobium japonicum [56]. 
FFAS analysis of the encoded proteins in the gene neighbourhood of 
stlA on SMG 25 revealed some structural similarities to DnaJ and another 
type of molecular chaperone for the encoded proteins of genes 3, 4 and 7, 
while gene 5 encodes a protein with some structural similarity to a human 
voltage-gated calcium channel to which TspO has been linked, and it also 
shares a structural homology to Herpes virus latent membrane protein 1 
(LMP 1). In addition to DnaJ, the predicted product of gene 7 also exhibited 
structural similarity to an anti-termination protein from the Qin prophage. This 
could indicate some of this region was acquired via integration of a phage 
into the host chromosome. The novelty of the sequences may point to an 
uncharacterized phage. It is also noteworthy that gene 20 on SMG 25 is 
predicted to encode a phage-associated protein, while on two of the larger 
scaffolds from the stool microbiome samples, a gene encoding a phage 
integrase protein is present, revealing a commonality of such genes in this 
region. An elegant study by Wang and co-workers, has demonstrated 
prophage DNA plays a significant role in host resistance to numerous 
stresses, including osmotic stress, through deletion of each of nine 
prophages in E. coli [57]. The phage-associated protein on SMG 25 shares 
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52% identity with a similar protein from Rhizobium lupini HPC(L) (100% 
coverage over 159 amino acids), Interestingly, this organism was recently 
sequenced following isolation from a saline desert soil [58]. Rhizobium 
species belong to the phylum Proteobacteria and, based on taxonomic 
assignment with MEGAN 4, proteobacterial sequences were found on all the 
larger scaffolds with an stlA homologue (Figure 5) and may indicate the 
origin of the phage. Furthermore, a number of genes on SMG 25 are 
predicted to encode proteins that share a high level of similarity to halophilic 
and halotolerant microorganisms (Table 3). For example, gene 8 and 9 are 
predicted to encode hypothetical proteins with similarity to Pontibacter sp. 
BAB1700 and a halophilic archaeon, respectively. Pontibacter species are 
halotolerant members of the phylum Bacteroidetes and have been isolated 
from saline and marine environments, while gene 26 is predicted to encode a 
protein with similarity to Halomonas, a genus of halophilic Proteobacteria 
with biotechnological and medical relevance [59-61]. It seems possible the 
phage originated in a “salty” environment such as saline soil, a salt lake, a 
solar saltern or marine ecosystem.  
When compared against all the available samples from the HMP, 
homologues of the stlA sequence were found to be present only in stool 
microbiome samples. Furthermore, no homologous sequences were found in 
any bacterial, archaeal, eukaryotic or viral genome sequences, or in any 
sequenced plasmids. This indicates that stlA gene is extremely rare in the 
sequences tested and may be a gut-specific gene and present only in 
species of low abundance, as no homologues were found in any of the 
common or dominant members of the human gut microbiome. In addition, we 
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could only detect stlA homologues by PCR in two of 25 metagenomic DNA 
samples isolated from stool. Gene neighbourhood analysis around the stlA 
homologues revealed they were most often found in combination with genes 
encoding DnaJ-type molecular chaperones (COG0484), an ankyrin repeat 
protein (COG0666) or a predicted membrane protein containing a TM-2 
domain (COG02314), which is also similar to the gene organisation on SMG 
25.  
DnaJ-domain proteins are molecular chaperones that aid protein 
folding, prevent aggregation and repair damaged proteins following cellular 
stress [62]. They are members of the heat shock protein (Hsp) family, which 
have been shown to play important roles in the response to numerous stress 
conditions including osmotic stress and also can act as co-chaperones by 
stimulating the activity of other chaperones such as DnaK [63-65]. TM2 
domain proteins are composed of a pair of alpha helices connected by a 
short linker. The function of this domain is unknown; however it occurs in a 
wide range of protein contexts. It occurs most often on its own or in tandem 
with another TM2 domain, but interestingly, the third most frequent 
association is with a DnaJ domain. 
Ankyrin-repeat proteins are found across all three domains of life and 
modulate a number of diverse functions through protein-protein interactions 
[66]. The repeat has been found in proteins of diverse function [67,68] and 
these proteins have also been linked to cellular stress responses, including 
osmotic stress [69-71]. 
With information gained from gene neighbourhood analysis and 
distant structural homology we can speculate as to the mechanisms of salt 
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tolerance conferred by stlA. Overall, stlA and its neighbouring genes share 
common features that categorise them as stress responsive and may 
therefore constitute a stress operon. Three of the five encoded unknown 
proteins share a distant structural homology to chaperones. These 
chaperones could play a role in protein disaggregation and folding following 
stress as outlined above, or they could guide StlA through the periplasm and 
assist in inserting it in the membrane, although the latter situation would 
require E. coli chaperones to function in a similar capacity when stlA is 
cloned in isolation. StlA itself, being a predicted membrane protein could act 
as a sensor to external stresses or indeed stabilise the outer membrane 
during stress. It is noteworthy that the most significant homology predicted by 
FFAS for StlA was to a TspO/MBR protein which is involved in membrane 
signalling and is associated with voltage-dependent anion channels in 
mitochondria.  
In conclusion, we have identified a novel salt tolerance gene, stlA, 
from the human gut microbiome through functional screening of a 
metagenomic library. The gene is rare among the HMP and MetaHit datasets 
and has no bacterial, archaeal, viral, plasmid or eukaryotic homologues in 
the current databases. Furthermore, no homologues were found in any non-
human metagenome datasets nor in any of the human microbiome datasets 
(HMP and MetaHit) other than stool, indicating it is gut specific and present 
in a novel species of low abundance. The stlA gene appears to be on a 
prophage, indicating it may have been acquired (along with some of its 
neighbouring genes) through a LGT event and may confer a competitive 
advantage to its particular host species under stressful conditions in the gut 
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or if there is an absence of or deficiency in some of the classical 
osmotolerance systems, such as in C. jejuni [72].  
Overall this study illustrates the utility of functionally screening 
metagenomic libraries to assign a function to a completely novel gene and its 
encoded protein and suggests that novel mechanisms of osmotolerance may 
exist in different environmental niches. Mining (gut) microbiomes and the 
development of more sensitive and innovative screening assays will facilitate 
the discovery of novel stress resistance genes, antibiotics, 
biopharmaceuticals and bio therapeutics for use in biotechnology, medicine 
and health [73-77]. 
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 Functional metagenomics can provide a means to access novel genes 
from as yet uncultured bacteria and to subsequently assign a function to the 
encoded proteins. Since its emergence as a research field many novel genes 
encoding diverse proteins such as rhodopsins, esterases, lipases, proteases 
and antibiotics have been identified in diverse environments [1-6]. 
Metagenomic strategies have also been employed to study the human gut 
microbiota, leading to the discovery of novel genes which encode β-
glucuronidases, bile salt hydrolases (BSH’s), antibiotic resistance 
determinants, NF-Kβ modulators and proteins involved in intestinal 
colonisation [7-11]. Metagenomics has been used to identify novel salt 
tolerance genes in pond water [12,13]; however, no one to our knowledge 
has investigated the human gut microbiome as source of novel salt tolerance 
genes. With this in mind, a functional metagenomic approach was employed 
to identify novel genes from the human gut microbiota involved in the 
osmotic stress response.  
 The osmotic stress response involves a number of phases; firstly the 
uptake of potassium (K+), followed by the synthesis or uptake of compatible 
solutes (osmoprotectants) comprise the primary and secondary responses, 
respectively [14-16]. Ancillary systems, which encompass a broad range of 
cellular processes, also play an important role in the global cellular osmotic 
stress response. Much research has focused on elucidating the mechanisms 
of the primary and secondary response, but comparatively less information is 
available regarding more diverse genes involved in the overall cellular 
response.  Consequently, this thesis has focused on identifying novel 
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ancillary components of the overall osmotic stress response, thus giving a 
broader and more comprehensive view of the range of genes involved.  
 Chapter II describes an initial screen of a human gut microbiota 
metagenomic library to identify salt-tolerant clones and the subsequent 
characterisation of a number of these clones. From a screen of over 20,000 
clones, fifty-three salt tolerant clones were identified and annotated as SMG 
1-53 (salt metagenome 1-53). Transposon mutagenesis identified five novel 
salt tolerance genes from clones SMG 3, SMG 5 and SMG 25. The genes 
shared homology to murB, mazG (x2) and galE (x2), which had not been 
previously linked to salt tolerance. The genes originate from species of 
common members of the gut microbiota such as Collinsella, Akkermansia 
and Eggerthella. Cloning and subsequent expression of each gene in 
isolation conferred a significantly increased salt tolerance phenotype to 
Escherichia coli. To our knowledge, this chapter represents the first study to 
identify such novel genes from the human gut microbiota. 
 Chapter IV details the in silico identification of a brp/blh family beta-
carotene 15,15’-monoxygenase (BrpA) as a novel salt tolerance determinant. 
Initially pursued for further investigation because BrpA shared homology to a 
proline symporter, it later transpired that while it did confer a salt tolerance 
phenotype, BrpA (when expressed from an inducible expression vector) also 
resulted in cell pellets acquiring a red/orange colour when grown in the 
presence of exogenous beta-carotene, indicating incorporation of 
carotenoids in the cell membrane. Furthermore, the brpA gene appears to 
have been acquired via lateral gene transfer (LGT); having a low percentage 
G+C content (~32%) compared to many of the other genes on the fosmid 
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insert. Finally, brpA homologues are found most abundantly in the stool, 
supra-gingival plaque and tongue metagenomes from the Human 
Microbiome Project (HMP) dataset.  
 In Chapter V we report the identification of stlA (salt tolerance locus 
A), a novel salt tolerance gene with no current known homologues in the 
non-redundant sequence databases. The stlA gene was identified following 
transposon mutagenesis of clone SMG 25. E. coli cells expressing stlA had a 
significantly higher tolerance to sodium chloride (NaCl) stress. An in silico 
analysis revealed stlA and a number of other genes on the SMG 25 fosmid 
insert were encoded on a prophage, possibly indicating the importance of 
these genes for niche adaptation. Furthermore, when searched against 
metagenomic datasets from the Human Microbiome Project (HMP) and 
MetaHit, stlA appears to be extremely rare, with only 10 homologues found 
between both datasets and present only in stool microbiome samples, 
indicating StlA may be a gut-specific protein and found in a species of low 
abundance. This is further emphasised by the fact that StlA homologues 
were not found in any other non-human metagenomic datasets (>1300 
samples), nor in any finished, draft or permanent draft genome sequences 
from bacteria, archaea, viruses, eukaryotes or plasmids. StlA represents the 
first protein of its kind to be identified and functionally characterised. 
Overall this thesis describes the identification of a number of novel 
salt tolerance genes from the human gut microbiota using a functional 
metagenomic approach and represents a significant contribution to the 
literature on the bacterial stress response. By employing a functional 
metagenomic approach, genes without any obvious connection to the 
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osmotic stress response have been identified. We cannot rule out completely 
the possibility that the acquired salt tolerance is an artefact of expression of 
these genes in E. coli; having said that, we feel it is likely they also act as salt 
tolerance genes in their original host(s) and put forward what we feel are 
plausible theories on their mechanisms of action. It would be interesting to 
test the salt tolerance of the various host species in wild-type and knock-out 
mutant backgrounds. However, owing to the diversity and uncultured nature 
of some of these species, the development of the genetic tools to manipulate 
and test this was simply not feasible. This being apparent from the outset, 
the main aim was to identify novel genes that could confer increased salt 
tolerance to a heterologous host using a functional metagenomic approach. 
One must also keep in mind that some novel salt tolerance genes will have 
been missed by our screen, owing to the well documented expression issues 
for foreign DNA in E. coli due to incompatibilities of transcriptional, 
translational and post-translational machinery between heterologous host 
and the organism from which metagenomic DNA originated. 
 On a broader scale salt tolerance genes such as those identified 
during the course of this thesis could be used to increase both the 
processing and host-associated stress resistance of probiotic 
microorganisms, ultimately increasing gastrointestinal persistence and 
therapeutic efficacy. Some of these genes could perhaps be candidates for 
novel drug targets also. Indeed, as outlined in Chapter III (addendum to 
Chapter II), murB and galE as well as components of toxin-antitoxin (TA) 
systems such as mazG have been utilised or investigated as novel drug 
targets [17-20].  
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A recent study by Gaddy and co-workers [21] raises some interesting 
questions regarding salt intake and the microbiota. The study found that 
gerbils fed a high salt diet and infected with cagA+ Helicobacter pylori 
developed gastric cancer at higher rates than controls. The cagA gene 
encodes a bacterial oncoprotein, CagA, and is upregulated in response to 
salt, both in vitro and in vivo. Considering that many virulence, virulence-
associated and of course salt tolerance genes themselves are often 
upregulated in response to salt, it is interesting to speculate on the effect of a 
high dietary salt intake on the gut microbiota. For instance, does a high salt 
intake result in quantifiable changes to the composition of the gut microbiota 
or could high salt intake promote the growth of certain species or provide a 
cue to opportunistic pathogens to initiate a process of infection or 
inflammation under certain conditions? Previous studies have shown that 
fluctuations in osmolarity can trigger changes in gene expression in 
pathogenic bacteria such as Salmonella and Listeria monocytogenes 
signalling a transition to invasive infection [22,23]. Furthermore, changes in 
intestinal ion transport and more specifically increased sodium (Na+) 
concentration in NHE3 (Na+/H+ exchanger isoform 3) deficient mice results in 
changes to the microbiota and increases in Bacteroides thetaiotaomicron 
[24], whilst deficiencies in sodium absorption and consequently increases in 
luminal osmolarity are associated with chronic gastrointestinal conditions 
such as IBD (inflammatory bowel disease) and thus have implications for the 
microbial community composition. Studies to examine the effect (if any) of 
high dietary salt intake on the composition of the gut microbiota and on the 
pathophysiology of the intestinal mucosa may be a worthwhile endeavour. 
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 In conclusion, this thesis represents the first study to identify novel salt 
tolerance genes from the human microbiota and illustrates the utility of 
functional metagenomics for novel gene discovery in complex environmental 
niches. Overall, it provides a more comprehensive view of and expands our 
knowledge in relation to the diverse systems employed by bacteria in 
response to osmotic stress. 
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This appendix contains results of additional experiments carried out 
during the course of the thesis. The following work represents an initial 
characterisation of clone SMG 9, but not to the same extent as other clones 
detailed in the preceding chapters. 
BIOLOG phenotypic microarray (PM) assay was used to identify 
possible osmotolerance-related phenotypes of SMG 9. Using plate PM 9 
(Figure 1), which contains 96 different osmotic stress conditions and 
osmolytes, indicated that SMG 9 had the ability to utilise L-carnitine in the 
presence of 6% sodium chloride (NaCl), as revealed by the development of a 
purple colour in the corresponding well of plate PM9 (Figure 2A). No colour 
development was observed in plates inoculated with the control strain 
carrying an empty fosmid vector, E. coli EPI300::pCC1FOS (Figure 2B).
 
  
 
 
2
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Figure 1. Layout of BIOLOG PM 9 osmolyte plate. 
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Figure 2.  
 
 
Figure 2. Appearance of PM 9 plates after incubation for 24 hours at 37°C.  
(A) Control EPI300::pCC1FOS and (B) SMG 9. PM plates measure cellular 
respiration colorimetrically via reduction of a tetrazolium dye with electrons 
from NADH generated during the process of respiration. Strongly 
metabolised substrates generate a more intense purple colour. Development 
of a strong purple colour can be seen in well B12 in Figure 2B (circled in 
red), which was inoculated with SMG 9, while no colour development is 
visible in B12 of the control plate. This indicates SMG 9 has a greater ability 
to transport and utilise L-carnitine compared to the EPI300::pCC1FOS host 
strain. 
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Figure 3. Kinetic data measured by BIOLOG Omnilog system. 
Colour formation within each well was measured by BIOLOG’s Omnilog 
machine, which produces a colour coded graph. Kinetic data from two clones 
can be compared. EPI300::pCC1FOS is shown in red and that from SMG 9 
is shown in green. The green colour indicates more rapid metabolism by 
SMG 9 under the conditions in the well (6% NaCl + L-carnitine). 
 
Growth experiments were performed in M9 minimal media containing a 
range of NaCl concentrations (0-6%) in the presence and absence of 1mM L-
carnitine to investigate the phenotype further. 
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Figure 4.  
(A)             (B) 
 
 
 
 
 
(C)             (D) 
 
 
 
 
 
 
Figure 4. Growth of E. coli EPI300::pCC1FOS and SMG 9 in (A) M9 minimal 
media, (B) M9 minimal media + 4% NaCl, (C) M9 minimal media + 5% NaCl 
and (D) M9 minimal media + 6% NaCl.  
Legend: E. coli EPI300::pCC1FOS ( black circle); SMG 9 ( red triangle); 
E. coli EPI300::pCC1FOS + 1mM L-carnitine ( green square); SMG 9 + 
1mM L-carnitine (, yellow diamond). 
 
Figure 4A shows growth of both clones in M9 media in the presence and 
absence of 1mM L-carnitine. In the presence of L-carnitine, SMG 9 displays 
a growth defect, while growth is similar under all other conditions. In the 
presence of 4% NaCl there is no difference in growth between clones either 
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in the presence or absence of L-carnitine (Figure 4B). At 5% NaCl however, 
SMG 9 has a significant growth advantage compared to EPI300::pCC1FOS 
both in the presence and absence of 1mM L-carnitine (Figure 4C). The 
positive effect of L-carnitine on the growth of SMG 9 is evident with cells 
entering logarithmic phase growth sooner and reaching a much higher final 
optical density (OD595nm).  A similar effect for L-carnitine is seen for 6% NaCl. 
 
Sequencing of SMG 9 fosmid insert 
The SMG 9 fosmid insert was sequenced using the GS-FLX platform 
(Roche) on a Titanium mini-run. Gene prediction with FGENESB 
(www.softberry.com) and functional annotation of predicted amino acid 
sequences using BLASTP (Table 1) was performed as described in the 
preceding chapters. 
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Table 1. Proteins predicted to be encoded on SMG 9 fosmid insert 
Functional assignment is based on BLASTP of amino acid sequences predicted by Softberry’s FGENESB. Abbreviations: # a.a = number of predicted amino 
acids; %ID = % identity at the amino acid level; N/A = not applicable.  
 
Gene # Putative Encoded Function # a.a Closest Hit Organism % 
Coverage 
e-value % ID Domains 
1 ATP-dependent chaperone ClpB  554 Bacteroides sp. CAG:545 97% 0.00E+00 99% COG0714; AAA ATPase 
2 Preprotein translocase SecG subunit  121 Bacteroides sp. CAG:545 100% 3.00E-77 100% SecG 
3 Putative uncharacterized protein  187 Bacteroides sp. CAG:545 100% 3.00E-134 100% None detected 
4 Putative uncharacterized protein  177 Bacteroides sp. CAG:545 86% 3.00E-108 99% LptE 
5 Transcriptional regulator  432 Bacteroides sp. CAG:545 100% 0.00E+00 99% AAA ATPase; sigma-54 interaction domain; HTH_8 bacterial 
regulatory protein, Fis family domain 
6 Putative uncharacterized protein  545 Bacteroides sp. CAG:545 100% 0.00E+00 99% TadD 
7 Putative uncharacterized protein  1015 Bacteroides sp. CAG:545 100% 0.00E+00 99% SecD, SecF 
8 OmpA/MotB domain protein  618 Bacteroides sp. CAG:545 71% 0.00E+00 99% PD40, similar to WD40 domain 
9 Putative uncharacterized protein  155 Bacteroides sp. CAG:545 100% 4.00E-106 100% NfeD 
10 uPF0365 protein AL1_06760  317 Bacteroides sp. CAG:545 100% 0.00E+00 99% YdfA_immunity superfamily 
11 Putative uncharacterized protein  142 Bacteroides sp. CAG:545 100% 1.00E-97 98% Lipocalin_4 
12 Subtilisin-like serine protease  678 Bacteroides sp. CAG:545 100% 0.00E+00 99% Peptidase_S8_S53 superfamily 
13 Uncharacterized protein  812 Bacteroides sp. CAG:545 99% 0.00E+00 99% None detected 
14 RagB/SusD family protein  547 Bacteroides sp. CAG:545 100% 0.00E+00 99% Two SusD superfamily 
15 Outer membrane receptor for 
ferrienterochelin and colicins  
1068 Bacteroides sp. CAG:545 100% 0.00E+00 100% Can_B2; Plug; OM channel; OMP_RagA_SusC 
16 Alpha-L-fucosidase-like  513 Bacteroides sp. CAG:545 100% 0.00E+00 98% COG3669; Alpha_L_fucos; F5_F8_Type_C 
17 Putative uncharacterized protein  446 Bacteroides sp. CAG:545 100% 0.00E+00 99% DHQ_FE-ADH (Dehydroquinate iron aldehyde dehydrogenase) 
18 Major facilitator superfamily 
MFS_1  
487 Bacteroides sp. CAG:545 100% 0.00E+00 100% MFS; UhpC, sugar phosphate permease 
19 ThiF family protein  242 Bacteroides sp. CAG:545 100% 4.00E-174 98% YgdL_like 
20 Putative uncharacterized protein  649 Bacteroides sp. CAG:545 100% 0.00E+00 98% Glyco_hydro_97 
21 DNA mismatch repair protein MutS  894 Bacteroides sp. CAG:545 98% 0.00E+00 99% PRK05399; MutS-I; MutS_II; MutS_III; ABC_MutS_1 
22 Glycosyl transferase group 1  378 Bacteroides sp. CAG:545 100% 0.00E+00 99% RfaG 
23 No significant similarity found 68 Bacteroides sp. CAG:545 N/A N/A N/A N/A 
24 Hypothetical protein Fjoh_3657  162 Flavobacterium johnsoniae 
UW101 
80% 4.00E-25 40% AdkA, archaeal adenylate kinase 
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Following sequencing and functional annotation of predicted amino 
acid sequences on the SMG 9 fosmid insert no obvious L-carnitine transport 
or utilisation proteins could be identified. Transpsoson mutagenesis was 
attempted using the EZTn5 in vitro transposition system but this proved to be 
unsuccessful. Two genes (gene 5 and 18, indicated in bold in Table 1), which 
we felt may be likely to have a possible role in L-carnitine utilisation were 
cloned in isolation to examine the phenotype further. Gene 5 is predicted to 
encode a sigma54-dependent transcriptional regulator, while gene 18 is 
predicted to encode a major facilitator superfamily (MFS) transporter. The 
genes were annotated as sdtR and mfsT, for sigma-dependent 
transcriptional regulator and major facilitator superfamily transporter, 
respectively. MFS transporters can have broad substrate specificity and are 
sometimes involved in the uptake of osmoprotectant compounds, while we 
reasoned that the transcriptional regulator could be positively or negatively 
regulating host EPI300 genes, contributing the L-carnitine-associated 
phenotype. 
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Figure 5.  
(A)                                                         (B) 
 
 
 
 
 
 
 
 
 
 
 
(C)                                                         (D) 
 
 
 
 
 
 
 
 
 
 
Figure 5. Growth of MKH13::pCI372 and MKH13::pCI372-mfsT in (A) M9 
minimal media, (B) M9 minimal media + 2% NaCl, (C) M9 minimal media + 
3% NaCl and (D) M9 minimal media + 4% NaCl.  
Legend: E. coli MKH13::pCI372 ( black circle); MKH13::pCI372-mfsT ( 
red triangle); MKH13::pCI372 + 1mM L-carnitine ( green square); 
MKH13::pCI372-mfsT + 1mM L-carnitine (, yellow diamond). 
 
The mfsT gene did not confer salt tolerance to MKH13 and L-carnitine had 
no effect on growth under normal conditions (M9 minimal media) or in the 
presence of NaCl.
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Figure 6.  
 
(A)                                                         (B) 
 
 
 
  
 
 
 
 
 
 
 
(C)                                                         (D) 
 
 
 
 
 
 
 
 
 
 
Figure 6. Growth in of E. coli MKH13::pCI372 ( black circle) and 
MKH13::pCI372-sdtR ( open triangle) in (A) LB broth and LB broth 
supplemented with (B) 2% NaCl, (C) 3% NaCl and (D) 4% NaCl. 
 
Cloning and expression of sdtR in MKH13 conferred a significant salt tolerance 
phenotype when grown in at both 3% and 4% NaCl (Figure 6C and 6D, 
respectively) compared to MKH13::pCI372, while no difference in growth was 
observed in media lacking NaCl (Figure 6A). 
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(A)                                                         (B) 
 
 
 
 
 
 
 
 
 
 
Figure 7. Growth of EPI300::pCI372 and EPI300::pCI372-sdtR in (A) M9 
minimal media and (B) M9 minimal media + 6% NaCl. 
Legend: E. coli EPI300::pCI372 ( black circle); EPI300::pCI372 + 1mM L-
carnitine ( red triangle); EPI300::pCI372-sdtR ( green square); 
EPI300::pCI372-sdtR + 1mM L-carnitine (, yellow diamond). 
 
Cloning an expression of sdtR in EPI300 resulted in an increase in salt 
tolerance compare to wild-type EPI300 carrying an empty copy of the plasmid 
pCI372. Addition of 1mM L-carnitine increased the growth rate and final optical 
density of both strains, but its effect on the sdtR+ strain was not significant 
relative to the EPI300::pCI372 control. 
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(A)                                                    (B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Growth of E. coli EPI300::pCC1FOS and SMG 9 in (A) M9 minimal 
media, (B) M9 minimal media + 5% NaCl.  
Legend: E. coli EPI300::pCC1FOS ( black circle); SMG 9 ( red triangle); E. 
coli EPI300::pCC1FOS + 1mM L-carnitine ( green square); SMG 9 + 1mM L-
carnitine (, yellow diamond). 
 
Further experiments revealed SMG 9 had lost the original phenotype seen in 
earlier experiments. Comparison of Figure 8A and 8B with Figure 4A and 4C, 
respectively illustrates this. 
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                   “And that’s the end of that chapter...!” 
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On Antonie van Leeuwenhoek’s work in the 1670’s: 
...“ But to find a whole world of microbes inside himself and in 
everyone around him, to discover that man is populated, was a cause 
for great excitement and for wonder and rejoicing. It was a discovery 
about ourselves, something spectacular; it turned a corner and 
opened a new vista.” 
               -  Theodor Rosebury, Life On Man, 1969. 
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